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ABSTRACT 
 
A female is born with a finite number of ovum-containing follicles, responsible for 
maintaining lifetime female fertility prior to menopause.  Follicle quality and number can be 
compromised by ovotoxicant exposures; the chemotherapy drug cyclophosphamide (CPA) 
depletes ovarian follicles resulting in increased risks for infertility in female cancer 
survivors.  In comparison, 7,12-dimethylbenz[a]anthracene (DMBA), liberated from burning 
of organic compounds, destroys all stage ovarian follicles.  CPA and DMBA must be 
bioactivated to their active, ovotoxic, metabolites phosphoramide mustard (PM) and DMBA-
1,2-epoxide, 3,4-diol, respectively.  This dissertation investigated ovarian PM and DMBA 
exposures using a neonatal rat whole ovary culture method, to increase understanding for 
mechanisms driving PM- and DMBA-induced follicle depletion.   
           Investigations of PM metabolism demonstrated that microsomal epoxide hydrolase 
(Ephx1) plays a role in detoxification of PM and while increased glutathione (GSH) levels 
lessened PM ovotoxicity, surprisingly, depleting (GSH) had no impact, rending the role of 
GSH in PM metabolism as inconclusive and requiring additional studies.  Generation of an 
ovotoxic, volatile PM metabolite, presumably chloroethylaziridine (CEZ), was identified, 
independent of ovarian metabolism, suggesting that PM is not the only ovotoxic metabolite 
of CPA.   
            Autophagy induction during PM-induced ovotoxicity was confirmed via 
identification of autophagosome formation by transmission electron microscopy and altered 
mRNA and protein levels of key autophagy genes.  Pathway manipulations of PI3K and 
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mTOR to inhibit or activate autophagy, respectively, revealed that PI3K inhibition had no 
effect on PM-induced ovotoxicity while, mTOR activation prevented PM-induced follicle 
depletion.   
 Depletion of large preantral follicles along with altered mRNA levels of autophagy 
genes were also demonstrated with low-dose acute DMBA exposure.  Induction of additional 
ovarian responses, including xenobiotic metabolism, oxidative stress and PI3K signaling 
were also observed in these experiments. 
Taken together, this dissertation supports that ovotoxicant exposure induces ovarian 
chemical biotransformation and autophagy in addition to a number of other protective 
responses.  A thorough understanding of the detrimental effects of PM, CEZ and DMBA 
exposures are required before advancements towards preservation of the ovarian follicle 
reserve can progress.   
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Chapter 1.  INTRODUCTION 
 
The ovary 
The major mammalian female reproductive organ is the ovary, which is primarily 
comprised of structures called follicles.  These follicles contain the oocyte or “egg” that can be 
surrounded by up to two somatic cell types, at initial development stages by granulosa cells and 
at later stages of follicular development by theca cells.  The granulosa and theca cells cooperate 
to produce the sex steroid hormones, the estrogens (17β-estradiol; E2) and progesterone, as well 
as communicate with the oocyte to maintain viability.  At birth, the ovarian follicle reserve is 
established and generally accepted as a non-replenishing pool, thus this finite number of follicles 
is essential to support fertility throughout the lifespan of a woman via production of a fertilizable 
gamete (Hirshfield, 1991). 
 
Ovarian folliculogenesis 
The earliest follicular stage is the primordial follicle, which is arrested in prophase I of 
meiosis, potentially being maintained through the lifetime of a woman, until receiving a signal to 
become activated and recruited to the growing follicle pool.  At this time, the granulosa cells 
transition from a squamous to cuboidal state and begin dividing while the oocyte starts to grow.  
As shown in Figure 1, the follicle will progress through the primary stage, one granulosa cell 
layer surrounding the oocyte, and further onwards to the secondary stage, two layers of granulosa 
cells encasing the oocyte.  Subsequently, a fluid-filled cavity develops, namely the antrum, and 
the theca cells are recruited from the ovarian stroma to comprise the outermost layer of the 
follicle.  At this stage, the antral follicle is now luteinizing hormone (LH) and follicle stimulating 
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hormone (FSH) responsive and generating E2, which are key factors to the induction of 
ovulation, the expulsion of the oocyte from the follicle and ovary into the fallopian tube.  The 
remaining follicular cells will luteinize to form the corpus luteum (CL), which produces 
progesterone to maintain a pregnancy or degenerates to complete the menstrual cycle. 
Although ovulation is the ultimate physiological endpoint for an oocyte, the natural fate 
for the majority of follicles is atresia (follicle death).  Many primordial follicles will be activated 
from the follicular reserve, but only one percent will complete the cycle to ovulation, thus the 
other 99% will die, because once activated, they cannot remain indefinitely in the growing pool 
or retreat to the quiescent ovarian reserve (Hirshfield, 1991).  On average, by the age of 51 (Jick 
and Porter, 1977), all the follicles are depleted and ovarian failure, or menopause, ensues, 
reducing circulating E2 levels and increasing the risk of osteoporosis and heart disease 
(Hirshfield, 1991; Greendale et al., 1999).  Unfortunately, this innate depletion of follicles can be 
accelerated by chemical exposures that target and kill follicles ultimately resulting in premature 
ovarian failure (POF) (Jick and Porter, 1977; Hoyer and Sipes, 1996; Borman et al., 2000).   
 
Chemical-induced ovotoxicity 
Ovotoxicants range from compounds found in plastics, pesticides, industrial and 
environmental pollutants to even Federal Drug Administration (FDA) approved drugs such as 
chemotherapeutics.  Chemicals that deplete all follicular stages include the environmental 
toxicant 7,12-dimethylbenz[a]anthracene (DMBA), while other ovotoxicants, such as the 
industrial compound 4-vinylcyclohexene diepoxide (VCD), can target specific follicular stages; 
in the case of VCD the targets for destruction are the primordial and small primary follicles 
(Flaws et al., 1994; Devine et al., 2002; Rajapaksa et al., 2007; Igawa et al., 2009).  An 
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ovotoxicant’s target follicle type is important in determining the ultimate reproductive outcome.  
VCD for instance, will cause POF, but will do so by eliminating the smallest follicles, which will 
initially allow some follicles to ovulate and fertility to continue until the ovarian reserve has been 
irreversibly depleted.  Thus, the individual will have limited and delayed signs of decreased 
fertility, although the ovarian reserve is actively being reduced.  In contrast, compounds targeting 
the larger follicles will elicit rapid signs of reduced fertility, evidence by altered menstruation or 
infertility.  However, once the female is removed from this exposure, fertility can resume via 
recruitment of follicles out of the ovarian reserve which was not targeted, thus these compounds 
cause a reversible, temporary form of infertility (Hoyer and Keating, 2014).   
Another important aspect to consider in reproductive toxicology is the age of the 
individual at the time of the exposure.  A younger age does not equate a higher risk of chemical-
induced infertility.  As depicted in Figure 2, at birth, a female will have about two million 
follicles, a number that will only decline over time, yielding roughly 300,000 follicles remaining 
at the age of puberty (menarche) (Faddy et al., 1992; Wallace and Kelsey, 2004).  This large pre-
pubertal ovarian reserve can hinder the detrimental reproductive effect of ovotoxicants, simply 
due to the higher number of primordial follicles present in the ovary at the time of exposure.  For 
example, a twelve-year-old girl can receive up to 18 Gy of radiation before being considered 
sterile, while a 45-year-old woman can withstand only 9 Gy before sterilization occurs (Wallace 
et al., 2005). 
Of additional concern is the fact that there is sometimes a latent impact of endocrine 
disrupting and reproductive toxicants, a classic example of this is diethylstilbestrol (DES), which 
was FDA approved to prevent miscarriages in women in the 1950s (Veurink et al., 2005).  
Although no adverse effects were reported in the women administered DES, it was discovered 
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during the 1970s that the female offspring of those DES-exposed mothers were at an increased 
risk of developing a rare vaginal cancer (Herbst et al., 1971; Veurink et al., 2005).  In addition, a 
trans-generational impact of DES continues to be evident with reproductive complications now 
being discovered in the granddaughters and grandsons of DES exposed women (Blatt et al., 
2003).   
 
Ovarian chemical biotransformation 
Although the effects of ovotoxicant are staggering, fortunately, to some extent, the ovary 
is capable of defending itself by eliciting protective responses such as xenobiotic metabolism, 
autophagy, DNA repair and activation of cell survival pathways.  For example, many 
biotransformation enzymes are present in the ovary to combat the effects of ovotoxic metabolites 
produced by hepatic metabolism or those that may have traveled through the bloodstream to 
access the ovary directly.  The parent compound, or initial compound of exposure, is often not 
the active, ovotoxic form.  4-vinylcyclohexene (VCH), released during the manufacturing of 
rubber, pesticides, plastics and flame-retardants (Rappaport and Fraser, 1977), is bioactivated by 
enzymes from the cytochrome P450 family (CYPs) to form the active and ovotoxic metabolite 
VCD (Fontaine et al., 2001a; Fontaine et al., 2001b; Cannady et al., 2003; Rajapaksa et al., 
2007).  Notably, however, VCH has also been shown to be detoxified in the ovary by 
microsomal epoxide hydrolase (EPHX1), thus demonstrating the ability of an enzyme to elicit a 
protective response in the ovary (Flaws et al., 1994; Cannady et al., 2002). 
Xenobiotic metabolism genes, like EPHX1, and their transcription factors have 
demonstrated their key roles in the ovarian response to chemicals.  The transcription factor 
nuclear factor erythroid 2-related factor 2 (NRF2), for example, is bound to Kelch-like ECH-
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associated protein 1 (KEAP1) until a stress occurs causing its release and translocation to the 
nucleus where it is then able to bind the antioxidant response elements (ARE) of genes (Itoh et 
al., 1999; McMahon et al., 2003; Ma et al., 2004).  In mice deficient for NRF2, liver expression 
of the glutathione-S-transferase (GST) genes, a family of enzymes known for catalyzing the 
conjugation of GSH to xenobiotics for their excretion, was reduced to only 3-20% when 
compared to their wild-type littermates (Chanas et al., 2002).  GST isoform pi (GSTP), 
suggested to play a direct role in DMBA detoxification, has been shown to be transcriptionally 
activated by the binding of NRF2 (Ikeda et al., 2004).  Another important xenobiotic metabolism 
transcription factor is aryl hydrocarbon receptor (AHR), which activates genes by binding to 
xenobiotic response elements (XRE) found in the promoter of target genes (Hankinson, 1995).  
 
Phosphatidylinositol-3 kinase signaling 
One important player in the ovarian xenobiotic response is the phosphatidylinositol-3 
kinase (PI3K) signaling pathway, which plays a vital role in primordial follicle viability 
(Yoshida et al., 1997; Parrott and Skinner, 1999) and control of recruitment of follicles out of the 
ovarian reserve (Yoshida et al., 1997; Kissel et al., 2000; Castrillon et al., 2003; Reddy et al., 
2005; John et al., 2008).  Initiation of the PI3K pathway in the primordial follicles occurs when 
the granulosa-cell-expressed kit ligand (KITLG) binds to the oocyte-expressed receptor, cKit 
(Manova et al., 1990; Orr-Urtreger et al., 1990; Horie et al., 1991; Ismail et al., 1996).  The 
resulting autophosphorylation of cKit drives the activation of the PI3K pathway (Roskoski, 
2005) leading to phosphorylation and nuclear translocation of AKT (pAKT), thereby regulating 
pro-survival activities such as growth, survival and cell cycle entry (Datta et al., 1999). 
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In addition to promoting follicle survival, the PI3K pathway governs primordial 
activation and recruitment into the growing follicle pool, which also contributes to the overall 
protective response of the ovary.  Current evidence suggests this is achieved via pAKT actions 
on forkhead transcription factor family member FOXO3 (Reddy et al., 2005).  When Foxo3 was 
knocked out in mice, the lack of FOXO3 resulted in POF, which was determined to be a result of 
accelerated recruitment of primordial follicles into the growing pool, followed by inevitable 
atresia of the over-abundantly activated follicles (Castrillon et al., 2003).  Complementary to the 
results from the Foxo3 knockout mice, oocyte-specific FOXO3 overexpression halted activation 
of primordial follicles (Castrillon et al., 2003), thus suggesting a pivotal role for FOXO3 and the 
PI3K pathway in the determination of follicle growth and survival as well as the maintenance of 
the ovarian reserve.  
 
Programmed cell death in the ovary 
 Although the importance of the ovarian protective response to xenobiotic 
exposure is apparent, the ovary must maintain a balance between pro-survival and pro-death, 
presumably, to ensure that the best quality oocytes are ovulated.  Historically, apoptosis was the 
pro-death process attributed to causing atresia; however, studies now suggest that autophagy may 
be a key alternate or concurrent process in follicular death (Escobar et al., 2008; Rodrigues et al., 
2009; Gannon et al., 2012).  The process of autophagy occurs through the identification and 
encapsulation of cytoplasmic contents and organelles that are destined for degradation.  The 
autophagosome, a double-membraned vesicle, transports the unwanted material to the lysosome 
where the two structures merge to form the autolysosome and digest the constituents (de Duve, 
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2005; Mizushima, 2007).  In yeast, 35 genes have been found to be involved with autophagy, and 
being an evolutionary conservation process, many of these genes have been found to have 
mammalian homologues, including but not limited to beclin-1 (Becn1), autophagy-related 7 
homolog (Atg7) and microtubule-associated proteins 1A/1B light chain (LC-3) (Muller and 
Reichert, 2011).  
At birth, a time of large follicle depletion, ovarian expression of pro-apoptotic genes are 
unchanged and the expression of genes involved with autophagy are increased in mice 
(Rodrigues et al., 2009).  Another study reported finding classic markers of both apoptosis, 
(cleaved caspase-3 expression and TUNEL staining) and autophagy (increased LAMP1 
expression) in atretic ovaries from 1-28 day old rats (Escobar et al., 2008).  In addition to atretic 
activity, interestingly, and demonstrative of the complexity of this process, autophagy has also 
been suggested as a mode for ovarian follicle survival (Gawriluk et al., 2011).  PND1 
homozygous Atg7 knockout mice lacked any apparent germ cells while Becn1
+/-
 mice had a 56% 
reduction in germ cells compared to control (Gawriluk et al., 2011).  Taken together, these 
previous studies support that autophagy is an active ovarian process with the potential to be a 
fundamental regulator of the important balance of follicle life and death.   
 
Polycyclic aromatic hydrocarbons 
For decades, smoking cigarettes has been recognized to decrease the age of menopause 
onset (Jick and Porter, 1977), and this effect has since been accredited to the ovotoxic properties 
of polycyclic aromatic hydrocarbons (PAHs) like DMBA, benzo(a)pyrene (BaP), and 3-
methylcholanthrene (3MC) (Mattison et al., 1983; Vahakangas et al., 1985).  These ovotoxicants 
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are produced by the burning of any organic material, thus evoking widespread exposure via 
cigarette smoke, car exhaust, and charred food (Gelboin, 1980).  Murine studies of these PAHs 
have clearly indicated the ability of these compounds to kill follicles (Mattison and Schulman, 
1980; Mattison et al., 1983; Borman et al., 2000) with the following order of ovotoxic potency in 
mice being DMBA > 3MC > BaP (Mattison and Thorgeirsson, 1979).  Co-administration of 
alpha-naphthoflavone, an AHR inhibitor, during exposure to each PAH prevented primordial 
follicle depletion in mice, suggesting that these PAHs must be bioactivated in order to elicit 
ovotoxic effects (Mattison and Thorgeirsson, 1979).   
Ovarian bioactivation of DMBA, in particular, has been well characterized.  Using both 
in vivo and in vitro methods, follicle depletion was observed with lower concentrations of the 
DMBA metabolite, DMBA-3,4-diol, than DMBA itself, thus indicating the metabolite’s higher 
ovotoxic potency (Igawa et al., 2009).  Furthermore, by competitively inhibiting EPHX1 using 
cyclohexene oxide (CHO), DMBA-induced follicle depletion was prevented, while DMBA-3,4-
diol-induced ovotoxicity was unaffected, indicating that EPHX1, the same enzyme that 
metabolizes VCH to a lesser toxic metabolite, was required for the bioactivation of DMBA in the 
ovary (Rajapaksa et al., 2007; Igawa et al., 2009).  DMBA biotransformation begins with 
metabolism by CYP1B1 and EPHX1 to form the more potent DMBA-3,4-diol metabolite, which 
undergoes further biotransformation via epoxidation by CYP1A1 or CYP1B1 to form the 
ultimate ovotoxic metabolite DMBA-3,4-diol-1,2-epoxide (Bengtsson et al., 1983; Miyata et al., 
1999; Shimada et al., 2003; Kleiner et al., 2004; Rajapaksa et al., 2007; Igawa et al., 2009). 
Follicle destruction by DMBA is thought to be achieved by damaging the oocyte first, 
followed by rapid somatic cell loss (Morita and Tilly, 1999), ultimately resulting in follicle loss 
by apoptosis (Tsai-Turton et al., 2007).  Investigation of the role of glutathione (GSH) and the 
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production of reactive oxygen species (ROS) in DMBA-induced ovotoxicity revealed that ROS 
generation was increased by DMBA exposure despite the lack of effect on ovarian GSH 
concentration within the ovary (Tsai-Turton et al., 2007) However, when GSH levels were 
decreased in cultured preovulatory follicles prior to DMBA exposure an increase in apoptosis 
was observed and complementary to study, when supplemented with GSH, DMBA-induced 
apoptosis was reduced (Tsai-Turton et al., 2007).   
Despite considerable knowledge about the bioactivation of DMBA, less is known about 
its detoxification.  The protective effect observed when supplementing follicles with GSH prior 
to DMBA exposure suggests GSH may play a role in the detoxification of DMBA.  One study 
supporting this hypothesis utilized mice deficient in GSTP, which in turn increased their 
sensitivity to the tumorigenic effects of DMBA, therefore, suggesting GSTP as detoxifying 
enzyme for DMBA (Henderson et al., 1998).  This role was further investigated by evaluating 
the ovarian activity of GSTP and other GST isoforms mu (GSTM) and alpha (GSTA) following 
DMBA exposure in neonatal rat ovaries.  While no increase in mRNA levels were found in Gstm 
or Gsta following DMBA exposure, mRNA and protein levels of GSTP increased in DMBA 
treated ovaries relative to control, adding further support to GSTP’s role in ovarian DMBA 
detoxification 2012 (Bhattacharya and Keating, 2012).  
 In the neonatal rat ovary, during LY294002-induced PI3K inhibition, EPHX1 levels are 
increased and subsequently, likely due to increased bioactivation by EPHX1, DMBA follicle 
depletion is worsened (Keating et al., 2009; Bhattacharya et al., 2012).  The results from this 
study suggest that PI3K may have a regulatory role for EPHX1, which was investigated further 
by a evaluating the effect of PI3K inhibition on other xenobiotic genes.  Using the same PI3K 
inhibition conditions, the levels of GSTM, GSTP and AHR were also increased, supporting PI3K 
10 
 
 
as a regulator of these xenobiotic metabolism genes (Bhattacharya and Keating, 2012).  This role 
was further supported by an observed increase in genes downstream of PI3K following DMBA 
exposure (Sobinoff et al., 2011), therefore providing additional evidence of the PI3K pathway 
having a direct impact on the ovotoxicity of DMBA.   
 
Chemotherapeutics 
Published in the book Ovarian Toxicology as a subsection of 
Chapter 2: Ovarian Metabolism of Xenobiotics, 2013 
 
It is estimated that over 1.6 million people in the United States will be diagnosed with 
cancer in 2012 (Siegel et al., 2012).  Compared to 1977 when the 5-year survival rate was 49%, 
67% of cancer patients will now survive at least 5 years post-diagnosis (Siegel et al., 2012).  
Early detection and advanced medical treatments are likely attributable to factors responsible for 
these enhanced survival rates.  However, as cancer survival rates increase, a growing number of 
survivors are facing the consequences of their treatment, which unfortunately for many women 
includes POF and infertility.   
A number of antineoplastic agents can cause female infertility, including busulfan, 
cisplatin, and CPA.  In 1956, the first observed ovotoxic chemotherapy effects were induced by 
busulfan, which caused all patients (n = 4) to be premenopausal three months into therapy (Louis 
et al., 1956).  Busulfan is an alkylating agent, which acts by cross-linking DNA to interfere with 
cell replication (Jackson et al., 1959). 
Cisplatin (cis-diamminedichloroplatinum (II): CDDP), a nonalkylating agent, is also an 
ovotoxic antineoplastic chemical.  CDDP is a platinum-based chemotherapy that, similar to 
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alkylating agents, reacts with DNA, inhibiting DNA synthesis and causing apoptosis.  CDDP is 
used to treat a variety of cancers including breast, ovarian, lung, and head and neck cancers with 
side effects that include nephrotoxicity and ovotoxicity (Dobyan et al., 1980; Nakai et al., 1982; 
Wallace et al., 1989).  Studies in rats have demonstrated that a single dose of CDDP decreased 
primordial follicles by 25%–35% and increased follicular cysts and apoptosis (Borovskaya et al., 
2004).  Repeated CDDP exposure in rats depleted the total number of follicles, increased 
postimplantation loss rates, and decreased litter number (Matsuo et al., 2007; Nozaki et al., 
2009).  There is evidence that CDDP causes DNA laddering, chromatin condensation and arrest 
of the cell cycle at the G2 phase (Barry et al., 1990; Boersma et al., 1996; Schmitt et al., 2004).  
Additionally, in vivo and in vitro studies reported that CDDP induced the production of ROS 
(Kopke et al., 1997; Satoh et al., 2003), which may also contribute to CDDP-induced ovarian 
damage.   
The metabolism of CDDP is slowly being deciphered, and while it remains unclear if 
CDDP is enzymatically biotransformed, it is hypothesized that CDDP-containing chloride 
ligands are displaced by water yielding a positive charged platinum compound that reacts with 
DNA, thus cross-linking the strands and inhibiting DNA synthesis (McEvoy, 1992), which 
ultimately leads to cell apoptosis involving the Bcl-2 and Bax pathways (Barry et al., 1990; 
Boersma et al., 1996; Schmitt et al., 2004). 
CPA is an antineoplastic prodrug that acts as an alkylating agent to treat, alone or in 
combination, a variety of cancers and autoimmune disorders.  CPA was FDA approved in 1959 
and is also known by its brand names: Cytoxan, Clafen, and Neosar.  CPA is administered orally 
or intravenously to patients of all ages and has a wide range of side effects including alopecia, 
nausea, immunosuppression, and infertility (Fraiser et al., 1991).  Infertility is particularly 
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concerning for females because CPA destroys primordial follicles (Plowchalk and Mattison, 
1991).   
In a similar manner as that of DMBA, CPA is inactive until it is metabolized, primarily 
by hepatic CYP enzymes, inducing production of a number of active and inactive metabolites.  
The bioactivation step that contributes greatly to CPA induced ovotoxicity is the C-4 oxidation 
of CPA to form 4-hydroxycyclophosphamide (4-HC), followed by interconversion to the open-
ring form, aldophosphamide, which fragments to phosphoramide mustard (PM) and acrolein 
(Ludeman, 1999; Pinto et al., 2009).  Previous research has found 4-HC to be an ovotoxic 
metabolite of CPA, because 4-HC can easily pass through the cell membrane and produce PM 
intracellularly (Ludeman, 1999; Desmeules and Devine, 2006).  PM is known to be the 
antineoplastic metabolite of CPA (Shulman-Roskes et al., 1998), and its formation is required for 
ovotoxicity in vitro (Plowchalk and Mattison, 1991) and in vivo (Desmeules and Devine, 2006).  
However, PM can undergo another spontaneous reaction to form the volatile, cytotoxic 
metabolite chloroethylaziridine (CEZ) (Rauen and Norpoth, 1968; Shulman-Roskes et al., 1998), 
1998), which, due to its higher cell permeability (Hata and Watanabe, 1994) and longer half-life 
compared to PM (Lu and Chan, 2006), may also contribute to CPA-induced ovotoxicity 
(Desmeules and Devine, 2006).   
Previous studies have demonstrated that in vitro CPA and/or PM exposures target 
primordial follicles in mice (Plowchalk and Mattison, 1991) and antral follicles in rats 
(Desmeules and Devine, 2006) at concentrations relevant to human exposures (Struck et al., 
1987; Desmeules and Devine, 2006).  The specific ovarian cell-type targeted depends on the 
follicle type, such that in smaller follicles, oocytes are being targeted, while in larger follicles, it 
is the granulosa cells (Desmeules and Devine, 2006).  Granulosa cells of primary follicles are 
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stained positively for caspase-3 and terminal deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL) (evidence of apoptosis) following PM exposure; thus, it was concluded that 
apoptosis is responsible for those cells’ death (Desmeules and Devine, 2006).  However, it is 
acknowledged that due to the close interaction and communication between the granulosa cells 
and the oocyte, it is difficult to determine exactly which cell type is the initial ovotoxic target 
(Desmeules and Devine, 2006). 
Evidence suggests that the detoxification of CPA and its metabolites occur by NADPH 
oxidation via aldehyde dehydrogenases and GSH conjugation via the GSTs, with the precise 
mechanisms remaining to be determined (Pinto et al., 2009).  Further, these mechanisms may 
vary between follicle types (Desmeules and Devine, 2006).  Studies also suggest that a 
spontaneous GSH conjugation to PM can occur, thus lessening both the toxic and therapeutic 
effects of CPA (Colvin et al., 1993; Colvin, 1994; Dirven et al., 1994; Shulman-Roskes et al., 
1998).  The stability of CEZ has also been demonstrated to decrease with excess GSH (Shulman-
Roskes et al., 1998), supporting detoxification roles for GSH conjugation to CPA, PM and CEZ. 
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Figures 
 
 
Figure 1.  Ovarian follicular development.  (Keating and Hoyer, 2009; With Copyright 
Permission)  
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Figure 2.  Natural follicle number decline over time.   
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Abstract 
The finite ovarian follicle reserve can be negatively impacted by chemical exposures 
including the anti-neoplastic agent, cyclophosphamide (CPA).  CPA requires bioactivation to 
phosphoramide mustard (PM) to elicit its therapeutic effects however; in addition to being the 
tumor-targeting metabolite, PM is also ovotoxic.  In addition, PM can break down to a cytotoxic, 
volatile metabolite, chloroethylaziridine (CEZ).  The aim of this study was initially to 
characterize PM-induced ovotoxicity in growing follicles.  Using PND4 Fisher 344 rats, ovaries 
were cultured for 4 days before being exposed once to PM (10 or 30 µM).  Following eight 
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additional days in culture, relative to control (1% DMSO), PM had no impact on primordial, 
small primary or large primary follicle number, but both PM concentrations induced secondary 
follicle depletion (P < 0.05).  Interestingly, a reduction in follicle number in the control-treated 
ovaries was observed.  Thus, the involvement of a volatile, cytotoxic PM metabolite (VC) in 
PM-induced ovotoxicity was explored in cultured rat ovaries, with control ovaries physically 
separated from PM-treated ovaries during culture.  Direct PM (60 µM) exposure destroyed all 
stage follicles after 4 days (P < 0.05).  VC from nearby wells depleted primordial follicles after 4 
days (P < 0.05), temporarily reduced secondary follicle number after 2 days, and did not impact 
other stage follicles at any other time point.  VC was determined to spontaneously liberate from 
PM, which could contribute to degradation of PM during storage.  Taken together, this study 
demonstrates that PM and VC are ovotoxicants, with different follicular targets, and that the VC 
may be a major player during PM-induced ovotoxicity observed in cancer survivors.  
 
Introduction 
Cyclophosphamide (CPA) is used, alone or in combination, to treat an array of cancers 
and autoimmune disorders, and elicits numerous undesirable health side effects including 
alopecia, nausea, immunosuppression and infertility (Fraiser et al., 1991).  As a prodrug, CPA 
requires bioactivation to the metabolite phosphoramide mustard (PM) in order to induce anti-
neoplastic effects (Shulman-Roskes et al., 1998).  Bioactivation of CPA to PM occurs through a 
cascade of reactions (Fig. 1) that are initiated primarily by the hepatic cytochrome P450 enzymes 
(CYPs) isoforms 2B and 3A (Philip et al., 1999).  These CYPs hydroxylate CPA to form 4-
hydroxycyclophosphamide, which is non-enzymatically transformed to the open-ring metabolite, 
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aldophosphamide.  Aldophosphamide fragments, producing the compounds acrolein and PM 
(Ludeman, 1999).   
Interestingly, PM can further transform into a volatile, cytotoxic compound 
chloroethylaziridine (CEZ; Rauen and Norpoth, 1968; Lu and Chan, 1996).  CEZ was first 
identified as a volatile metabolite of CPA in 1968, when approximately 2% of the CPA 
administered was shown to be exhaled as CEZ from the lungs of exposed rats (Rauen and 
Norpoth, 1968).  CEZ was also found to be responsible for the airborne cytotoxicity, observed in 
untreated cells cultured adjacent to cells exposed to CEZ-producing compounds, termed the 
“neighboring well effect” (Flowers et al., 2000).  Although the generation of CEZ has been 
demonstrated both in vivo and in vitro, determining the relative contribution of CEZ to CPA-
induced cytotoxicity has proven difficult due to the compound’s volatility and the instability of 
its precursor, PM.  CEZ plasma concentrations were shown to peak 5 minutes after intravenous 
PM administration in rats (Lu and Chan, 2006).  An additional study demonstrated that following 
complete degradation of PM in solution, 85% of the solution’s cytotoxicity remained due to the 
generation and continued presence of CEZ (Chan et al., 1994).  Taken together, these studies 
support that CEZ is a major degradation product of CPA/PM and suggests that CEZ may play a 
key role in the toxicity of CPA.   
CPA-induced side effects are of growing concern as cancer survival rates continue to 
improve.  In particular, increased cancer survival rates have resulted in a greater number of 
female cancer survivors affected by CPA-induced infertility (Linet et al., 1999; Sklar et al., 
2006; Pulte et al., 2008).  Female fertility is dependent on the quality of oocytes, which are 
maintained within the ovary as follicular structures, consisting of a meiotically-arrested oocyte 
surrounded by granulosa cells.  The ovarian follicular reserve is established at birth and 
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progressively declines until menopause or ovarian failure, the point at which no follicles remain 
(Hirshfield, 1991).  Chemical exposures, including CPA, accelerate follicular death and 
subsequent decline of the follicular reserve leading to premature ovarian failure (POF), thus 
causing permanent infertility (Plowchalk and Mattison, 1991).  Aside from sustaining fertility, 
the survival of these follicles is important to overall female health; POF increases the risk of 
various health conditions including osteoporosis and heart disease (Greendale et al., 1999).  
CPA-induced infertility is attributed to the generation of PM because, in addition to being 
the anti-neoplastic metabolite, PM is also recognized as the ovotoxic CPA metabolite (Plowchalk 
and Mattison, 1991; Desmeules and Devine, 2006).  However, CEZ has also been suggested to 
be ovotoxic due to observed loss of primordial follicles induced by a volatile breakdown product 
of PM in a neonatal rat ovarian culture model (Desmeules and Devine, 2006).  Therefore, in 
addition to PM, CEZ may be at least partially responsible for both the anti-neoplastic and 
ovotoxic properties of CPA.  The purpose of the current study was initially to determine the 
impact of acute exposure to PM on large growing follicles, which led to the characterization of 
the ovotoxicity of a volatile compound (VC), presumably CEZ, liberated from PM using a 
neonatal rat ovary culture system.  Specifically, the temporal pattern of PM- and VC-induced 
follicle loss was characterized, the requirement of ovarian tissue for VC liberation was 
determined and the impact of storage on PM-induced ovotoxicity at -20
o
C was evaluated.    
 
Materials and Methods 
Reagents:  
Bovine serum albumin (BSA), ascorbic acid, transferrin, formaldehyde, dimethyl sulfoxide 
(DMSO) were purchased from Sigma Aldrich Inc. (St. Louis, MO).  Dulbecco’s Modified Eagle 
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Medium: nutrient mixture F-12 (Ham) 1x (DMEM/Ham’s F12), Albumax, penicillin (5000U/ml) 
Hank’s Balanced Salt Solution (without CaCl2, Mg Cl2, or MgSO4) were obtained from 
Invitrogen Co. (Grand Island, NY).  Millicell-CM filter inserts and 48-well cell culture plates 
were obtained from Millipore (Billerica, MA) and Corning Inc. (Corning, NY), respectively.  
Phosphoramide mustard was obtained from the National Institutes of Health National Cancer 
Institute (Bethesda, MA).   
 
Animals:  
Fisher 344 (F344) rats were housed one per plastic cage and maintained in a controlled 
environment (22 ± 2ºC; 12h light/12h dark cycles).  The animals were provided a standard diet 
with ad libitum access to food and water and allowed to give birth.  The University of Arizona 
and Iowa State University Institutional Animal Care and Use Committee approved all 
experimental procedures.   
 
Ex vivo ovarian cultures:   
Ovaries were collected from female postnatal day (PND) 4 F344 rats and cultured as described 
by Devine et al., 2002.  Ovaries were removed, trimmed of oviduct and other excess tissue, and 
placed onto a Millicell-CM membrane floating on 250 µl of previously 37ºC equilibrated 
DMEM/Ham’s F12 medium containing 1 mg/ml BSA, 1 mg/ml Albumax, 50 µg/ml ascorbic 
acid, 5 U/ml penicillin and 27.5 µg/ml transferrin per well in a 48-well plate.  A drop of medium 
was placed on top of each ovary to prevent dehydration and maintained at 37ºC and 5% CO2.   
 Effect of single exposure PM on growing follicles: Ovaries (n = 3/treatment) were 
cultured for four days to allow large primary and secondary follicles to develop in culture before 
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being treated once with vehicle control media (1% DMSO), PM (10 µM or 30 µM) and 
maintained in culture for an additional eight days.  These concentrations were based on those 
previously described (Petrillo et al., 2011). 
 
Ovotoxicity time course:  
Ovaries (n = 3-4/treatment) were treated on alternate days with vehicle control DMSO (1%), PM 
(60 µM) or VC for 2, 4 or 6 days.  These PM concentrations were chosen to achieve a 
phenotypic endpoint of approximately 50% primordial follicle loss and to achieve sufficient VC 
liberation for ovotoxicity evaluation.  All PM-treated ovaries were maintained in a separate 
incubator from the control-treated ovaries (CT).  VC-exposed ovaries were cultured in control 
media in the same incubator as the PM treated ovaries, but on separate plates from the PM 
samples, thus the ovaries were exposed to the volatile metabolite liberated from PM-treated 
wells.   
 
Evaluation of ovarian-required VC generation: 
 Ovaries (n = 4) were cultured for six days in control media adjacent to wells that were treated on 
alternate days with PM (60 µM) but did not contain an ovary (Fig. 2).   
 
Evaluation of PM degradation during storage: Cultured ovaries (n = 4) were treated on alternate 
days with freshly suspended PM (“New”) or with previously suspended PM, which had been 
stored for two years in DMSO at -20°C (“Old”).  Ovaries were cultured for six days in separate 
incubators to reduce VC-induced ovotoxicity as a confounding factor.  
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Histological evaluation of follicle numbers:  
Following treatment, ovaries were placed in 4% paraformaldehyde fixative for 2 hours, washed 
and stored in 70% ethanol, paraffin embedded, and serially sectioned (5 µM) at the histology 
laboratory in the Department of Veterinary Pathology (Iowa State University).  Every 6
th
 section 
was mounted and stained with hematoxylin and eosin.  Healthy oocyte-containing follicles were 
identified and counted in every 6
th
 section.  Unhealthy follicles were identified from healthy 
follicles by the appearance of pyknotic bodies and intense eosinophilic staining of oocytes.  
Healthy follicles were classified and enumerated according to Flaws et al., 1994.  Slides were 
blinded to prevent counting bias.   
 
Statistical analysis: 
Comparisons were made between treatments for follicle count experiments using Analysis of 
Variance (ANOVA) and t-tests compared treatment with control data at each individual time-
point.  All statistical analysis was performed using Prism 5.04 software (GraphPad Software).  
Statistical significance was defined as P < 0.05.   
 
Results 
Effect of single PM exposure on growing ovarian follicles. 
To gain an understanding of the impact of PM on growing ovarian follicles, PND4 rat ovaries 
were cultured for four days in control media in order for larger follicles to develop prior to 
exposure.  Ovaries were treated with vehicle control, 10 µM PM or 30 µM PM and maintained in 
culture for eight additional days.  Ovaries were histologically evaluated, follicles classified and 
enumerated.  Neither concentration of PM induced loss of primordial (Fig. 3A), small primary 
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(Fig. 3B) or large primary (Fig. 3C) follicles.  However, PM exposure caused secondary follicle 
loss (P < 0.05) at both concentrations (Fig. 3D).  This experiment demonstrates that even single 
acute exposure of PM can deplete ovarian follicles.   
 
Temporal pattern of PM- and VC-induced follicle loss. 
To determine the temporal pattern of PM-induced ovotoxicity, as well as investigate the 
liberation of VC and evaluate the ovotoxicity of VC relative to PM, PND4 rat ovaries were 
cultured in medium containing vehicle control (Fig. 4A), PM (60 µM; Fig. 4B) or VC (Fig 4C) 
for 2, 4, or 6 days.  The plate containing control ovaries was removed to a separate incubator.  
The VC-exposed ovary was placed onto a membrane floating on control medium, maintained on 
a separate culture plate but in the same incubator as the culture plate containing an ovary floating 
on PM-treated media.  Media was replaced on alternate days and culture was maintained for 2, 4 
or 6 days.  Following culture, ovaries were sectioned, stained with hematoxylin and eosin and 
healthy follicles were classified and counted.   
 After two days of exposure, there was no impact of PM on follicle number (Fig. 4D-G).  
However, following four days of culture, PM induced primordial (Fig. 4D), small primary (Fig. 
4E) and large primary follicle (Fig. 4F) loss (P < 0.05).  After six days of PM exposure, 
primordial (Fig. 4D), small primary (Fig. 4E) and large primary (Fig. 4F) follicles were depleted 
(P < 0.05).   
 Primordial (Fig. 4D) follicle numbers were reduced by VC exposure (P < 0.05) after four 
days, however with the exception of loss (P < 0.05) of secondary follicles after two days of 
exposure (Fig. 4G), VC did not impact the number of small primary, large primary, or secondary 
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follicles, indicating that while PM can deplete all stage follicles, that the primary target of VC is 
likely the primordial follicle.   
 Compared to control, ovaries exposed to either PM or VC had a distinct empty ring 
between the oocyte and the granulosa cells, which occurred most obviously in the larger follicles, 
but also occurred in the small follicle types.  It appears the oocyte has shrunk away from the 
granulosa cells resulting in an observable “gap” induced by PM (Fig. 4B) and VC (Fig. 4C) 
exposure. 
 
Biotransformation requirement for CEZ liberation from PM   
To determine whether VC generation requires ovarian biotransformation, PND4 rat ovaries were 
cultured for six days in control media in Incubator A (Fig. 2).  In Incubator B ovaries were plated 
adjacent to wells lacking an ovary.  The wells that did not contain an ovary were treated on 
alternate days with PM (60 µM) to allow for potential spontaneous, ovarian-independent 
generation of VC.  The neighboring, untreated ovaries were evaluated for ovotoxicity via follicle 
classification and counting.  Relative to control, primordial (Fig. 5A) and small primary follicles 
(Fig. 5B) were depleted (P < 0.05) as a result of ovarian-independent generation of VC.  Also, 
there were very few large primary and complete absence of secondary follicles in the VC 
exposed ovaries, though variation in the CT-treated ovaries negated statistical significance.  
Thus, there is no requirement for ovarian enzyme-mediated biotransformation of PM to VC. 
 
Impact of storage condition on PM degradation 
We observed an apparent loss of potency in terms of ovotoxicity of PM aliquots stored for 
approximately two years in DMSO.  To confirm this observation and evaluate PM degradation 
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under -20 °C storage conditions, PND4 ovaries were cultured with either two-year old PM 
(“Old”; 60 µM) or newly dissolved PM (“New”; 60 µM) on alternate days for six days.  
Following hematoxylin and eosin staining, follicles were classified and counted.  Equal 
primordial follicle numbers (Fig. 6A) were observed between new and old PM aliquots.  
However, new PM caused loss (P < 0.05) of small primary (Fig. 6B) and large primary (Fig. 6C) 
follicles, compared to old PM aliquots.  Additionally, there were no secondary follicles present 
in the ovaries exposed to new PM (Fig. 6D).  These data indicate the importance of proper 
storage conditions when evaluating cytotoxicity of PM.   
 
Discussion 
The primordial follicle pool encompasses the ovarian follicle reserve and the 
maintenance of these irreplaceable structures is essential for female fertility.  If activated to grow 
and mature out of the primordial follicle pool, follicles will either progress toward ovulation or 
die by atresia.  The balance of these processes is vital to preserving fertility throughout the 
lifespan of a female.  Chemical exposures can disturb this balance leading to increased activation 
out of the follicle reserve (Keating et al., 2009) as well as increased atresia (Hu et al., 2001a; Hu 
et al., 2001b), which if continued, can ultimately result in infertility or POF.  If an ovotoxicant 
targets the large pre-ovulatory follicles, once the exposure ceases, the primordial follicles can 
still be recruited and develop to ovulation, thus only inducing temporary infertility (Keating and 
Hoyer, 2009).  However, if the primordial follicles are depleted, permanent infertility will ensue. 
Our initial goal of this study was to investigate the impact of a single PM exposure on the 
growing follicle pool, which revealed that a single exposure to PM depleted secondary follicles.  
Interestingly, the control follicle numbers in this experiment were lower than expected compared 
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to our previous experiments using the same culture system (Keating et al., 2009; Bhattacharya 
and Keating, 2012).  PM is capable of partitioning to generate a volatile, cytotoxic compound, 
CEZ, which occurs within the same pH range as our ovarian culture system (Colvin et al., 1976; 
Lu and Chan, 1996; Shulman-Roskes et al., 1998).  The potential ovotoxicity of a volatile 
metabolite of CPA was suggested in a study due to an observed “neighboring well effect” 
(Flowers et al., 2000) in cultured neonatal rat ovaries (Desmeules and Devine, 2006). 
Ovotoxicity of this volatile PM metabolite, however, remains uncharacterized.  This present 
study evaluated the generation of a volatile compound from PM, which we strongly believe is 
CEZ and designate as VC, and determined the ovotoxicity of this compound relative to that of 
PM using a neonatal rat ovary culture system.     
 To confirm our hypothesis that VC was being generated in the culture system, PND4 
control ovaries were cultured in a separate incubator from those exposed to PM and VC to 
eliminate contamination from the volatile compound.  Thus, in another incubator, PM exposed 
ovaries were in one culture plate and a second culture plate contained ovaries in control media 
that were being evaluated for the volatile compound exposure.  Histological evaluation 
demonstrated that VC depletes primordial follicles, while PM is ovotoxic to primary and 
secondary follicles ultimately leading to depletion of all follicle types.  This could potentially be 
due to increased recruitment from the primordial follicle pool to replace depleted, more 
developed follicles, as has been shown previously with CPA (Kalich-Philosoph et al., 2013) and 
another ovotoxic compound, 4-vinylcyclohexene diepoxide (Keating et al., 2009).  VC exposure 
reduced the number of secondary follicles after 2 days of exposure, which could indicate that 
either the VC depleted the secondary follicles or that their development was hindered.  The 
numbers of secondary follicles at this stage were very low (~2 per ovary in controls) and there 
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was a lot of variability within the PM-treated ovaries, thus whether this observed VC-induced 
reduction of secondary follicles is physiologically relevant is unclear.  It is important to note that 
PM exposed ovaries are exposed simultaneously to VC thus complicating compound-specific 
analysis.  Nonetheless, this experiment confirmed that a volatile compound, which literature 
strongly supports is CEZ, is ovotoxic and liberated from PM in this culture system.   
   Our next objective of this study was to determine if ovarian tissue is required for the 
biotransformation of PM to VC.  This was achieved by culturing an ovary that did not receive 
any chemical treatment adjacent to a PM-treated well that lacked an ovary.  We hypothesized 
that if ovarian tissue is indeed required for the volatile compound formation that no ovotoxicity 
would be observed in the untreated ovary.  Follicle depletion was observed in the untreated 
ovary, further confirming that an ovotoxic and volatile compound, was liberated spontaneously 
from the well that contained PM.  This experiment clearly demonstrates that VC generation is 
independent of ovarian tissue, which agrees with a prior study that reported that the reaction of 
PM to CEZ can occur spontaneously (Colvin et al., 1976; Engle et al.,1979; Watson et al.,1985; 
Shulman-Roskes et al., 1998), thus providing additional evidence that CEZ is likely the volatile 
compound produced.  It is also probable that the ovarian tissue plays a role in detoxification of 
CEZ, however, this was outside the scope of the current study, but an avenue that we are 
pursuing.    
 Following completion of these experiments, PM, which had been suspended in DMSO 
and stored at -20ºC, was used for additional histological studies.  We noticed observably less 
ovotoxicity induced by PM.  In order to confirm this suspicion, we determined the impact of 
storage on PM-induced ovotoxicity.  While this may seem just a routine laboratory analysis, we 
thought it important to highlight for future investigators using PM.  Follicle enumeration 
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revealed that the “old” PM was less ovotoxic compared to the “new” PM, therefore, suggesting 
that PM degraded while stored at -20
o
C.  Although the short half-life of PM is known, the 
apparent degradation of frozen PM was unexpected but noteworthy. 
  Many studies question the toxicity of PM due to its inability to enter cells because of the 
molecules polarity, and although this study does not directly address this question, the results 
again suggest that the volatile compound, likely CEZ, could be the primary or sole active 
metabolite of CPA.  Separating the effects of VC from PM is challenging since the ovaries 
treated with PM are also receiving the highest VC exposure.  When VC exposed ovaries are 
maintained on a separate plate from PM, VC appears to primarily target the primordial follicles, 
however, when VC ovaries were cultured in wells adjacent to PM, all follicular stages were 
depleted by VC similarly to those directly treated with PM.  In addition, whether the exposure is 
acute compared to chronic is worthy of consideration since a single exposure of PM depleted 
only secondary follicles, but not other follicular stages, although the “controls” were likely 
receiving concurrent exposure to the VC in this experiment.  Thus, proximity to VC (i.e. the 
concentration of VC), stage of follicular development, and length of exposure and storage 
conditions are important considerations in these studies.    
Overall, these studies depict both the complexity and ovotoxicity of PM and VC, which 
reinforces the need to gain a better understanding of the health impacts and chemical 
characteristics of these CPA metabolites.  This study’s novel characterization of VC ovotoxicity 
is particularly concerning because, if, like rats (Rauen and Norpoth, 1968), it is being exhaled in 
the form of CEZ from patients receiving CPA treatment, individuals in close proximity to the 
patient would then be at risk of CEZ exposure.  Previous studies have shown that healthcare 
workers have trace amounts of chemotherapy metabolites in their urine with one study detecting 
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a high level of airborne CPA in the outpatient clinics compared to the pre-treatment preparation 
rooms (Odraska et al., 2011), thus further supporting that CEZ may be expired from the lungs of 
patients and exposing individuals in the vicinity.  Whether the level of CEZ expired would be 
clinically relevant is as yet unknown, but this study strongly supports that the VC liberated from 
PM metabolism is an ovotoxicant worthy of further investigation.  
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Figure 1.  CPA metabolism.   
CPA metabolism is initiated by CYP2B and CYP3A to form 4-hydroxycyclophosphamide, which 
is non-enzymatically transformed to aldophosphamide.  Fragmentation of aldophosphamide 
forms PM and further partitioning of PM forms CEZ.  Adapted from Hong and Chan, 2006. 
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Figure 2.  Experimental design to evaluate VC exposure. 
Control (1% DMSO)-treated PND4 rat ovaries (indicated in yellow) were cultured for 6 days in 
Incubator A.  In a separate incubator, Incubator B, a PM-treated well that lacked an ovary was 
plated adjacent to a well containing an ovary floating above control media.    
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Figure 3.  Effect of single PM exposure on growing ovarian follicles.   
PND4 rat ovaries were cultured for 4 days in control media and exposed to a single 1% DMSO 
(vehicle control) or PM (10 µM or 30 µM).  Following eight additional days of culture, follicles 
were classified and counted:  (A) Primordial Follicles; (B) Small Primary Follicles; (C) Large 
Primary Follicles; (D) Secondary Follicles.  Values (A-D) are mean ± SE total follicles 
counted/ovary, n=3; * = different from control in each follicle type, P < 0.05. 
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Figure 4.  Temporal pattern of PM- and VC-induced ovotoxicity. 
Cultured PND4 rat ovaries were exposed to (A) control treatment (1% DMSO; CT), (B) PM (60 
µM) or (C) VC on alternate days for 2, 4 or 6 days (Example shown on day 6).  Follicles were 
classified and counted:  (D) Primordial Follicles; (E) Small Primary Follicles; (F) Large Primary 
Follicles; (G) Secondary Follicles.  Values (D-G) are mean ± SE total follicles counted/ovary, 
n=3-4; * = different from control, P < 0.05; † = different from control, P < 0.10; # = different 
from PM, P < 0.05. 
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Figure 5.  Ovarian-mediated biotransformation requirement for VC liberation from PM. 
PND4 rat ovaries were cultured for 6 days  in control media adjacent to wells that lacked an 
ovary but contained PM (60 µM).  Control-treated ovaries (CT) were cultured in a separate 
incubator.  Follicles were classified and counted:  (A) Primordial Follicles; (B) Small Primary 
Follicles; (C) Large Primary Follicles; (D) Secondary Follicles.  Values (A-D) are mean ± SE 
total follicles counted/ovary, n=4; * = different from CT, P < 0.05. 
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Figure 6.  Impact of storage on PM degradation.   
Cultured PND4 rat ovaries were exposed on alternate days to stored (“Old”) PM or freshly 
resuspended (“New”) PM for 6 days.  Follicles were classified and counted:  (A) Primordial 
Follicles; (B) Small Primary Follicles; (C) Large Primary Follicles; (D) Secondary Follicles.  
Values (A-D) are mean ± SE total follicles counted/ovary, n=4; * = different from control in each 
follicle type, P < 0.05. 
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Abstract 
The anti-neoplastic prodrug, cyclophosphamide, requires biotransformation to 
phosphoramide mustard (PM), which can partition to the volatile chloroethylaziridine (CEZ).  
PM and CEZ are ovotoxic, but their ovarian biotransformation remains unclear.  Thus, this study 
investigated mechanisms driving PM and CEZ metabolism through utilization of cultured 
postnatal day 4 (PND4) Fisher 344 (F344) rat whole ovaries exposed to vehicle control (1% 
DMSO) or PM (60 µM) on alternate days for 2 or 4 days.  Quantification of mRNA levels via an 
RT
2
 profiler PCR array and target specific RT-PCR found increased mRNA levels of key 
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xenobiotic metabolism genes including microsomal epoxide hydrolase (Ephx1) and glutathione 
S-transferase isoform pi (Gstp).  Compared to control, Western blot analysis determined 
increased protein abundance of GSTP and EPHX1 after 2 or 4 d, respectively, of PM exposure.  
PND4 ovaries were treated with (1% DMSO), PM (60 µM), cyclohexene oxide to inhibit 
EPHX1 (CHO; 2 mM) or PM + CHO for 4 d.  PM-induced follicle loss was greater in ovaries 
exposed to PM with CHO, suggesting a detoxification role for EPHX1 in PM metabolism.  
PND4 ovaries were also treated with (1% DMSO), PM (60 µM), BSO (Glutathione (GSH) 
depletion; 100 µM), GEE (GSH supplementation; 2.5 mM), PM ± BSO or PM ± GEE for 4 d. 
Results suggest that addition of GSH prevented PM-induced follicle loss, while GSH depletion 
had no effect on PM ovotoxicity.  Lastly, the effect of GSH levels on CEZ liberation and 
ovotoxicity was evaluated.  Both untreated and GEE-treated PND4 ovaries were plated adjacent 
to ovaries receiving PM + GEE or PM + BSO treatments.  Less CEZ-induced ovotoxicity was 
observed with both GEE and BSO treatments indicating reduced CEZ liberation from PM.  
Collectively, this study supports that the ovary is capable of xenobiotic metabolism, which can 
influence the ovotoxicity of CPA-derived metabolites.  
 
Introduction 
 As cancer survival rates increase, concern is growing for the survivor’s quality of life 
post-treatment.  In the U.S. alone, there are an estimated 7.2 million female cancer survivors and 
360,000 of these women are under the age of 40 (Siegel et al., 2012).  In addition, the National 
Cancer Institute estimates that by 2015, 1 in every 250 adults will be survivors of childhood 
cancer.  For female cancer survivors, a major concern that can affect the quality of life post-
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treatment is the increased risk for premature ovarian failure (POF), which similar to menopause, 
renders the female infertile.   
 The anti-neoplastic drug, cyclophosphamide (CPA), when included in the chemotherapy 
regimen of breast cancer patients, led to a significant increase in the number of women 
experiencing POF (Bines et al., 1996).  POF is a result of the depletion of the finite ovarian 
follicle pool (Hirshfield, 1991).  Follicles are the structures encompassing the oocyte, or “egg”, 
with granulosa cells (small preantral follicles) and theca cells (antral follicles) surrounding the 
gamete.  Primordial follicles are the most premature follicle type and due to their inability to be 
replenished, it is critical that primordial follicles remain viable to ensure fertility of the female.  
CPA induces POF via the targeting of these primordial follicles for atresia (follicle death) 
(Plowchalk and Mattison, 1991).    
 Similar to women, studies in rodents have shown that CPA exposure targets the 
primordial follicles in mice (Plowchalk and Mattison, 1991; Desmeules and Devine, 2006) and 
antral (the developmental stage prior to ovulation) follicles in rats (Jarrell et al., 1991) at 
concentrations relevant to human exposures (Struck et al., 1987; Desmeules and Devine, 2006).  
The results from these studies coincide with the human side effects, such as amenorrhea, 
premature menopause and infertility, reported by women and young girls who have undergone 
CPA treatment (Sanders et al., 1988; Suarez-Almazor et al., 2000).  Each of these side effects is 
a direct result of follicle loss which alters steroid production and regulation of hormones required 
to maintain normal menses and fertility. 
Although CPA exposure results in these detrimental effects, when administered, CPA is 
not in its active form.  CPA is a prodrug that must be bioactivated by the patient’s hepatic 
metabolism in order for the chemotherapeutic effects to occur.  Cytochrome P450 enzymes 
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(CYP), primarily in the liver, initiate CPA biotransformation, which then continues non-
enzymatically to form the active, antineoplastic metabolite phosphoramide mustard (PM) 
(Shulman-Roskes et al., 1998; Ludeman, 1999).  In addition to targeting cancer cells, PM is also 
the ovotoxic metabolite of CPA, both in vivo (Plowchalk and Mattison, 1991) and in vitro 
(Desmeules and Devine, 2006).  Interestingly, PM is capable of partitioning further to form the 
volatile metabolite, CEZ, (Rauen and Norpoth, 1968; Shulman-Roskes et al., 1998) that is also 
ovotoxic (Desmeules and Devine, 2006; Madden et al., 2014).    
 Although the bioactivation of CPA is well established, information on the mechanism of 
detoxification of this drug is lacking.  The evidence available suggests that CPA and metabolites 
are detoxified by NADPH oxidation and glutathione (GSH) conjugation (Pinto et al., 2009), with 
variation in mechanisms occurring among follicle types (Desmeules and Devine, 2006).  GSH 
conjugation to PM can occur spontaneously or non-spontaneously (Yuan et al., 1991; Dirven et 
al., 1994).  Non-spontaneous GSH conjugation to PM likely occurs via the glutathione S-
transferase (GST) family of enzymes, which are the predominate enzymes involved in GSH 
conjugation and detoxification of xenobiotics.  Specifically, GSH, in excess, has been shown to 
decrease the stability of CEZ (Shulman-Roskes et al., 1998) and, furthermore, GSH has been 
shown to reduce the generation of CEZ from PM by promoting an alkylation reaction, not the 
CEZ-forming hydrolysis reaction (Shulman-Roskes et al., 1998).   
 The conjugation of GSH to PM has been reported to replace one or both of the chlorides 
of PM (Dirven et al., 1994); however, it is unclear whether this reaction leads to a less toxic, 
detoxified PM metabolite.  Thus, this study investigated the role of GSH in PM-induced 
ovotoxicity through the manipulation of the GSH levels present during PM exposure via 
glutathione ethyl ester (GEE), a cell-permeable GSH derivative able to supplement the amount of 
51 
 
 
GSH present, and DL-buthionine-(S,R)-sulfoximine (BSO), an inhibitor of the synthesis of GSH, 
to deplete the GSH concentrations in the ovary.   
 In addition to GSH conjugation, which is a phase II detoxification reaction, PM likely 
also undergoes phase I biotransformation, such as hydroxylation.  This has been demonstrated to 
be a key reaction in the biotransformation of other ovotoxicants.  7,12-
dimethylbenz[a]anthracene (DMBA), for example, is bioactivated to its ovotoxic form by 
hydroxylation via the action of the enzyme microsomal epoxide hydrolase (EPHX1) (Rajapaksa 
et al., 2007; Igawa et al., 2009).  However, EPHX1 activity results in the formation of an 
inactive tetrol form of 4-vinylcyclohexene diepoxide (VCD), thereby providing a detoxification 
role for VCD, in contrast to its role in DMBA bioactivation (Flaws et al., 1994; Cannady et al., 
2002).  In congruence with the DMBA and VCD examples, we hypothesize that EPHX1 is active 
in the ovarian biotransformation of PM and in order to gain insight as to which role, 
bioactivation or detoxification, EPHX1 performs in the presence of PM, we used the competitive 
inhibitor of EPHX1 cyclohexene oxide (CHO). 
Briefly, to test the hypotheses presented, we utilized a neonatal rat ovarian culture system 
to characterize the biotransformation of PM in the absence of hepatic contribution, using qRT-
PCR and Western blotting to evaluate enzymes that are involved in PM metabolism.  In addition, 
manipulation of ovarian GSH and EPHX1 levels were achieved using chemical approaches in 
order to gain insight into the role of these classic metabolism players and the impact they could 
have with respect to the reproductive outcome.   
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Materials and Methods 
Reagents:  
Bovine serum albumin (BSA), ascorbic acid, transferrin, 2-β-mercaptoethanol, 30% 
acrylamide/0.8% bisacrylamide, ammonium persulphate, glycerol, N’ N’ N’ N’-
tetrathylethylenediamine (TEMED), Tris base, Tris HCL, sodium chloride, Tween-20, 
phosphatase inhibitor, protease inhibitor, BSO, CHO, and GEE were purchased from Sigma 
Aldrich Inc. (St. Louis, MO).  Dulbecco’s Modified Eagle Medium: nutrient mixture F-12 (Ham) 
1x (DMEM/Ham’s F12), Albumax, penicillin (5000U/ml) Hank’s Balanced Salt Solution 
(without CaCl2, Mg Cl2, or MgSO4) were obtained from Invitrogen Co. (Grand Island, NY).  
Millicell-CM filter inserts, anti-GSTP and anti-GSTM were obtained from Millipore (Billerica, 
MA).  RNeasy Mini kit, QIA Shredder kit, RNeasy Mini Elute kit, Quantitect ™ SYBR Green 
PCR kit RT
2
 First Strand kit, RT
2
 SYBR Green Mastermix, and the Drug Metabolism RT
2
 
Profiler PCR arrays were purchased from Qiagen Inc. (Valencia, CA).  RNAlater and 48-well 
cell culture plates were obtained from Ambion Inc. (Grand Island, NY) and Corning Inc. 
(Corning, NY), respectively.  PM was acquired from the National Institutes of Health National 
Cancer Institute (Bethesda, MA).  All primers were obtained from the DNA facility of the Iowa 
State University office of biotechnology (Ames, IA).  Ponceau S was purchased from Fisher 
Scientific (Waltham, MA).  SignalFire™ ECL Reagent and anti-rabbit, HRP-link secondary 
antibody was purchased from Cell Signaling Technology® (Danvers, MA).  Anti- EPHX1 
antibody was purchased from Detroit R&D (Detroit, MI) and goat anti-rabbit and donkey anti-
goat HRP-labeled secondary antibodies were obtained from Southern Biotech (Birmingham, AL) 
and Santa Cruz (Dallas, TX), respectively. 
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Animals:  
Fisher 344 (F344) rats were housed one per plastic cage and maintained in a controlled 
environment (22 ± 2ºC; 12h light/12h dark cycles).  The animals were provided a standard diet 
with ad libitum access to food and water, and allowed to give birth.  The Iowa State University 
Institutional Animal Care and Use Committee’s approved all experimental procedures.   
 
In vitro ovarian cultures:   
Ovaries were collected from female postnatal day (PND) 4 F344 rats (Devine et al., 2002) after 
euthanasia.  Both ovaries were removed, trimmed of excess tissue and placed onto a Millicell-
CM membrane floating on 250 µl of previously 37ºC equilibrated DMEM/Ham’s F12 medium 
containing 1 mg/ml BSA, 1 mg/ml Albumax, 50 µg/ml ascorbic acid, 5 U/ml penicillin and 27.5 
µg/ml transferrin per well in a 48-well plate.  A drop of medium was placed on top of each ovary 
to prevent dehydration.  Ovary cultures containing PM treatments were cultured in a separate 
incubator from other treatments to eliminate contamination from the ovotoxic, PM-generated 
volatile metabolite (Madden et al., 2014). 
 
RNA isolation and quantitative real-time polymerase chain reaction (qRT-PCR):  
Ovaries were stored in RNAlater at -80ºC following 2 or 4 d of in vitro culture.  Ovaries (n=3; 
10 ovaries per pool) were homogenized and added to a QIAshredder column before proceeding 
to total RNA isolation using an RNeasy Mini kit.  RNA concentration was performed with 
RNeasy Mini Elute kit and total RNA isolated was quantified with a NanoDrop (λ = 260/280 nm; 
ND 1000; Nanodrop Technologies Inc., Wilmington, DE).   
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RT
2
 PCR array 
According to the manufacturer’s protocol, total RNA (250 ng) was reverse transcribed to cDNA 
using the RT
2
 first-strand kit and pipetted into Drug Metabolism RT
2
 Profiler PCR array, which 
contains 96-wells, each containing a gene-specific primer set, therefore one plate tested 96 genes 
per each sample.  The PCR protocol utilized was a 10 min hold at 95ºC and 40 cycles of 
denaturing at 95ºC for 15 s and a combined annealing and extension for 1 minute at 60ºC.  Each 
gene was normalized to both housekeeping genes hypoxanthine phosphoribosyltransferase 
(Hprt) and ribosomal protein, large, P1 (Rplp1), as recommended by the company-provided 
analysis software.  There was no effect of PM on mRNA levels of either of these two 
housekeeping genes.  The online SABiosciences RT² Profiler™ PCR Array Data Analysis 
software quantified the changes in mRNA levels using the 2
-ΔΔCt 
method. 
 
Individual gene target RT-PCR 
Total RNA (250 ng) was reverse transcription to cDNA with the Superscript III One-Step RT-
PCR System (Invitrogen).  Using an Eppendorf mastercycler (Hauppauge, NY) and Quantitect 
™ SYBR Green PCR kit (Qiagen Inc. Valencia, CA), PCR amplification of the following genes 
was performed: Ephx1 (forward: 5’-GGCTCAAAGCCATCAGGCA-3’; reverse: 5’-
CCTCCAGAAGGACACCACTTT-3’) Gstp (forward: 5’-GGCATCTGAAGCCTTTTGAG-3’; 
reverse: 5’-GAGCCACATAGGCAGAGAGC-3’) and Gstm (forward: 5’-
TTCAAGCTGGGCCTGGAC-3’; reverse: 5’-CAGGATGGCATTGCTCTG-3’).  The RT-PCR 
protocol used was a 15 min hold at 95ºC and 40 cycles of denaturing at 95ºC for 15 s, annealing 
temperature of 58ºC, and extension at 72ºC for 15 s.  Gapdh was used as the housekeeping gene 
for normalization as no change in its mRNA levels was observed between treatments.  PM-
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induced changes in mRNA levels were quantified using the 2
-ΔΔCt 
method (Livak and 
Schmittgen, 2001; Pfaffl, 2001). 
 
Protein isolation and Western blot analysis: 
PND4 ovaries (n=3; 10 ovaries per pool) were homogenized in 200 µl of ice-cold tissue lysis 
buffer and protein quantified using a standard BCA protocol on a 96-well assay plate.  Total 
protein (15 µg) was separated on a 10% SDS-PAGE and transferred to a nitrocellulose 
membrane.  Prior to 1 hr blocking in 5% milk, equal protein loading was confirmed by Ponceau 
S staining.  Membranes were then incubated at 4 ºC with their respective, specific primary 
antibodies [Rabbit Anti-GSTM, Rabbit Anti-GSTP, Goat Anti-EPHX1].  Following 48 - 72 hrs 
of incubation, donkey anti-rabbit or porcine anti-goat secondary antibody was added and 
membranes were incubated with shaking for 1h at room temperature.  Autoradiograms were 
visualized on X-ray films in a dark room after 10 min incubation of membranes with 1X 
SignalFire™ ECL reagent.  Densitometry of the appropriate sized bands was measured using 
Image Studio Lite Version 3.1 (LI-COR Biosciences, Lincoln, NE) which eliminates background 
noise.  Values were normalized to Ponceau S staining. 
 
Competitive inhibition of EPHX1: 
On alternate days, ovaries (n=4-6) were treated with vehicle control media (1% DMSO), PM (60 
µM), CHO (2 mM) or PM (60 µM) + CHO (2 mM) for 2 or 4 d.  The concentration of CHO was 
determined by a previous study (Igawa et al., 2009).   
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GSH depletion and supplementation: 
Ovaries were treated on alternate days with DMSO (1%), PM (60 µM), GEE (2.5 mM), BSO 
(100 µM), PM (60 µM) ± GEE (2.5 mM), PM (60 µM) ± BSO (100 µM) or left untreated to 
evaluate the effect of the neighboring well CEZ liberation from PM.  BSO and GEE 
concentrations and the addition of BSO 8 hrs prior to PM treatment were based on conditions 
described in a previous study (Tsai-Turton and Luderer, 2006).  As previously reported, CEZ 
exposed ovaries were cultured in control media in the same incubator as PM-containing 
treatment, thus the ovaries were exposed to the volatile metabolite, presumably CEZ, liberated 
from PM (Madden et al., 2014).  
 
Histological evaluation of follicle numbers:  
Following treatment, ovaries were placed in 4% paraformaldehyde for 2 hours, washed and 
stored in 70% ethanol, paraffin embedded, and serially sectioned (5 µM).  Every 6
th
 section was 
mounted and stained with hematoxylin and eosin.  Healthy oocyte-containing follicles were 
identified and counted in every 6
th
 section.  Unhealthy follicles were distinguished from healthy 
follicles by the appearance of pyknotic bodies and intense eosinophilic staining of oocytes.  
Healthy follicles were classified and enumerated according to Flaws et al., 1994.  Slides were 
blinded to prevent counting bias.   
 
Statistical analysis: 
Treatment comparisons for follicle count experiments were performed using Analysis of 
Variance (ANOVA).  Quantitative RT-PCR and Western blot data were analyzed by t-test 
comparing treatment with control raw data at each individual time point.  All statistical analysis 
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was performed using Prism 5.04 software (GraphPad Software).  Statistical significance was 
defined as P < 0.05, with a trend for a difference considered at P < 0.1.   
 
Results 
 
Investigation of xenobiotic biotransformation genes involved in the ovarian response to PM 
exposure 
To gain insight into the ovarian genes that are activated during PM exposure, a drug metabolism 
RT
2
 Profiler PCR array was performed on PND4 rat ovaries (n=3, 10 ovaries per pool) cultured 2 
or 4 d with vehicle control (1% DMSO) or PM (60 µM) exposure on alternate days.  After 2 d of 
PM exposure, of the 89 genes tested, 4 were undetectable, 7 genes had altered (P < 0.05) gene 
expression and 1 gene, Chst1, was trending towards significance (P < 0.10) compared to the 
control (Table 1).  Following 4d of PM exposure, 6 genes were undetected, 24 genes had altered 
(P < 0.05) gene expression and 4 genes had a tendency for altered (P < 0.10) mRNA abundance 
in response to PM, relative to control (Table 1).  The results of this PCR array are summarized in 
Table 1.  
 
Effect of PM exposure on xenobiotic biotransformation gene expression 
To both validate gene expression changes observed in the RT
2
 PCR array data and to determine 
changes in genes of interest that were not present on the array, primers were designed for 
candidate ovarian xenobiotic metabolism genes in PM metabolism.  PND4 ovaries (n=3, 10 
ovaries per pool) were cultured for 2 or 4 d in control media (1% DMSO) or PM (60 µM) to 
capture the molecular changes occurring prior to PM-induced follicle depletion (Madden et al., 
2014).  Following 2 d of PM exposure, there was no effect of treatment on Gstp or Gstm mRNA 
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level compared to CT (Fig. 1B and C).  However, after 4 d of PM exposure Gstp was increased 
(P < 0.05; 0.86-fold), relative to control (Fig. 1C).  At 2 d, Ephx1 mRNA expression showed a 
tendency toward being increased (P < 0.1; 1.17-fold), followed by a large PM-induced increase 
in Ephx1 mRNA expression after 4d (P < 0.05; 4.63-fold) (Fig. 1A). 
 
PM-induced changes in protein levels of xenobiotic metabolism genes 
In order to confirm the mRNA changes observed after PM exposure, protein levels were 
quantified in cultured PND4 ovaries (n=3, 10 ovaries per pool) exposed to control media or 
media containing PM for 2 and 4 d.  Compared to control, following 2 d of PM exposure, GSTP 
protein levels were increased (P < 0.05), but there was no effect of PM on GSTP protein level 
after 4d of exposure (Fig. 1F).  GSTM protein levels also increased (P < 0.05) following 2 days 
of PM exposure, but decreased (P < 0.05), relative to control, after 4 d (Fig. 1E).  There was a 
trend for a PM-induced increase (P < 0.10) in EPHX1 protein levels after 2 d, followed by a 
large increase in EPHX1 after 4 days (Fig. 1D). 
 
Evaluation of the role of EPHX1 in PM metabolism 
EPHX1 was competitively inhibited by CHO in the neonatal culture system to evaluate the role 
of the enzyme in PM metabolism.  PND4 ovaries (n = 4-6) were cultured for 4 d with vehicle 
control (1% DMSO), PM (60 µM), CHO (2 mM), or PM (60 µM) + CHO (2 mM).  PM and PM 
+ CHO treated ovaries were cultured at separate times, in a separate  incubator from the control 
ovaries to prevent control treated ovaries from being exposed to the volatile compound liberated 
from PM in our culture system (Madden et al., 2014).   
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 There was no effect of CHO treatment on primordial or large primary follicle number 
(Fig. 2A and C), however, CHO treatment alone lowered small primary and secondary follicles 
when compared to control (Fig. 2B and D).  As previously reported (Madden et al., 2014), PM 
induced (P < 0.05) primordial (Fig. 2A), small primary (Fig. 2B), large primary (Fig. 2C) and 
secondary follicle loss compared to control (Fig. 2D).  When EPHX1 was inhibited by CHO, in 
conjunction with PM exposure, greater (P < 0.05) primordial and small primary follicle loss was 
observed relative to PM alone (Fig. 2A and B).   
 
Impact of ovarian GSH level manipulation on PM ovotoxicity 
In order to gain an understanding for the impact of GSH manipulation during PM ovotoxicity, 
PND4 ovaries (n = 4-6) were cultured for 4 d with DMSO (1%), PM (60 µM), GEE (2.5 mM), 
BSO (100 µM), PM (60 µM) ± GEE (2.5 mM) or PM (60 µM) ± BSO (100 µM).  All PM-
containing treatments were cultured in a separate incubator from other treatments to eliminate 
CEZ contamination (Madden et al, 2014).   
As previously reported, compared to control, PM depleted all follicle types after 4 d of 
culture (Madden et al, 2014).  The addition of GSH alone, via GEE, depleted (P < 0.05) 
primordial, small primary and large primary follicles (Fig. 3A-C), relative to control, with the 
number of small primary follicles being reduced to PM levels (Fig 3B).  The supplementation of 
GSH via GEE in the presence of PM, reduced PM-induced follicle loss in all follicle types (Fig 
3).  
When GSH levels were depleted (P < 0.05) via the inhibition of GSH synthesis with 
BSO, BSO alone reduced (P < 0.05) the number of primordial and small primary follicles (Fig. 
4A and B), while there was no effect on large primary follicles (Fig. 4C) and a trend (P < 0.1) for 
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an increase in the number of secondary follicles (Fig. 4D) was observed relative to control.  
Similar to PM, compared to control, the inclusion of BSO with PM resulted in depletion (P < 
0.05) of all follicle stages, with no difference in follicle loss observed relative to PM (Fig 4). 
  
Impact of altered GSH levels on CEZ liberation and ovotoxicity 
To evaluate the effect of altered ovarian GSH level on the generation of CEZ from PM and also 
to investigate the effect of GSH supplementation on CEZ ovotoxicity, cultured PND4 ovaries (n 
= 4-6) were treated for 4 d with DMSO (1%), PM (60 µM), GEE (2.5 mM), BSO (100 µM).  In 
addition, ovaries were cultured in wells that received no treatment but were placed adjacent to 
wells containing and ovary that was exposed to PM + BSO or PM + GEE to evaluate the impact 
of GSH manipulation on CEZ generation from PM.  These treatments were named Liberation 
(Lib.) PM + BSO or Lib. PM + GEE, respectively.  Lastly, ovaries were treated with GEE (2.5 
mM) or BSO (100 µM) in wells that were placed beside those that received PM + BSO (100 µM) 
or PM + GEE (2.5 mM) treatments in order to evaluate the effect of altered GSH on CEZ 
ovotoxicity.  These treatments were designated CEZ + GEE and CEZ + BSO, respectively.  This 
scheme is depicted in Figure 5.  All ovaries receiving PM-containing treatments were cultured in 
a separate incubator from other treatments to eliminate CEZ contamination (Madden et al., 
2014).   
 As previously reported, the volatile compound liberated from PM, presumably CEZ, 
depletes (P < 0.05) all follicle stages after 4 d of exposure (Madden et al., 2014).  Relative to 
control, there was no primordial, large primary or secondary follicle loss induced by the GEE + 
CEZ or Lib PM + GEE treatments (Fig 6A, C and D).  Small primary follicle depletion, 
however, was impacted by the GEE + CEZ treatment and further worsened to PM levels by the 
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Lib. PM + GEE treatment (Fig 6B).  BSO + CEZ and Lib PM + BSO exposures had no effect on 
follicle number at any stage of development, compared to control (Fig 7).    
 
Discussion 
 In 2012, an estimated 1.6 million people were diagnosed in the U.S. with cancer and 67% 
of these individuals will now survive at least five years post-diagnosis, compared to a 49% in 
1977 (Siegel et al., 2012).  Increasing the cancer survival rate is a great medical feat, yet 
coincides with an increasing concern for patient quality of life post-cancer treatment.  For the 
patients receiving chemotherapy and/or radiation for their cancer treatment, the risk of reduced 
fertility and sterility is heightened (Byrne et al., 1992; Sklar et al., 2006).  This is especially true 
for women, because unlike the testes, the ovary is unable to replenish its gamete pool.  The 
ovarian follicle reserve established at birth is responsible for sustaining the fertility of a woman 
throughout her lifespan, thus if depleted, the woman will undergo POF (Hirshfield, 1991).  
 One chemotherapy drug demonstrated to increase the risk of POF is CPA (Bines et al., 
1996).  However, to elicit the anti-neoplastic effects, CPA must be bioactived to PM, which is 
ovotoxic (Plowchalk and Mattison, 1991; Desmeules and Devine, 2006) and potentially further 
to the volatile compound CEZ (Flowers et al., 2000; Madden et al., 2014).  This bioactivation of 
CPA to PM has been well characterized in various tissues.  The detoxification of CPA and its 
metabolites, on the other hand, is lacking clarity.  Previous studies have demonstrated that GSH 
conjugation of PM occurs (Dirven et al., 1994), which is assumed to represent a detoxification 
reaction, but this has not been confirmed.  Therefore, this study used a PND4 rat ovary culture 
system to investigate the role of GSH in PM metabolism and CEZ liberation, as well as 
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involvement of EPHX1, which has previously demonstrated to have an important role in the 
biotransformation of other ovotoxicants.  
 In the current study, following PM exposure, EPHX1 was found to be increased at both 
transcriptional and translational levels suggesting its involvement in PM metabolism.  Previous 
reports have found that EPHX1 bioactivates DMBA to its ovotoxic form (Rajapaksa et al., 2007; 
Igawa et al., 2009), while detoxifying the ovotoxicant VCD (Flaws et al., 1994; Cannady et al., 
2002).  Thus, in order to evaluate the role of EPHX1 in PM metabolism, a competitive inhibitor 
of EPHX1, CHO, was used to block the action of EPHX1 during PM-induced follicle depletion.  
The lack of EPHX1 activity worsened PM-induced follicle loss therefore suggesting that EPHX1 
is involved in the detoxification of PM.    
 As an epoxide hydrolase, EPHX1 action adds a hydrogen to the epoxide group of a 
chemical, which to our knowledge, is not included in the chemical structure of PM and its 
metabolites.  Interestingly, however, CEZ, the volatile and ovotoxic metabolite of PM (Madden 
et al., 2014) is an aziridine compound capable of hydroxylation and may be the metabolite being 
detoxified by EPHX1 (Watabe and Suzuki, 1972), and this is an area for future investigation but 
outside the scope of the experiments described herein. 
 In addition to EPHX1, the mRNA encoding several other genes implicated in GSH 
conjugation catalysis and usage were altered by PM exposure.  At a time prior to PM-induced 
follicle loss (Madden et al., 2014), the protein levels of GSTM and GSTP were increased.  
Interestingly, we observed a subsequent decrease in GSTM levels after 4d of PM.  We have 
previously demonstrated that GSTM negatively regulates ovarian apoptosis signal-regulating 
kinase 1 (ASK1) through protein interactions (Bhattacharya et al., 2013), thus a decline in 
GSTM protein could indicate that this negative regulation is being relieved and the cell being 
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pushed towards an apoptotic fate as has been observed with ovarian DMBA exposure 
(Bhattacharya et al., 2013).  These data support that the Gstp and Gstm genes are responsive to 
and involved in the ovarian response to PM exposure.        
 By manipulating the levels of GSH present in the ovary, the impact of GSH on PM 
ovotoxicity was investigated.  The supplementation of GSH with GEE during PM exposure 
restored follicle numbers to the GEE alone levels, with the exception of the large primary 
follicles where PM + GEE completely restored follicle loss to control levels.  Surprisingly, GEE 
alone caused follicle loss in nearly all the follicle stages investigated indicating that an excess in 
GSH may be detrimental to follicles.  Unexpectedly, in the opposing experiment, when GSH 
levels were depleted by BSO, which blocks an enzyme essential to the synthesis of GSH, there 
was no impact on PM-induced follicle loss.  These results question the involvement of GSH 
conjugation in lessening the toxicity of PM, since lack of GSH did not alter PM-induced follicle 
loss.  Our data are in agreement with a study that found that depleting glutathione levels in rat 
embryo did not have an impact on PM-induced embryotoxicity, but did increase the toxicity of 
another CPA metabolite, acrolein (Slott and Hales, 1987).  Similarly, using rat hepatocytes and 
K562 human chronic myeloid leukemia cell in culture, another study found that PM did not 
impact the level of cellular GSH in either cell type, again, in contrast to acrolein, which depleted 
GSH levels.    
 Interestingly, the ovulated murine oocyte has an 8-10 mM GSH concentration (Calvin et 
al., 1986; Perreault et al., 1988), which is amongst the highest of any cell-type (Zuelke et al., 
2003), and a prior study found that GSH concentration increased with age in mice in association 
with an decrease in CPA sensitivity (Mattison et al., 1983), but literature review failed to provide 
the GSH concentrations in small primary follicle and, of particular interest, for the primordial 
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pool.  Knowing the GSH level in the primordial follicle would aid in interpretation of our results 
as well as improve our general understanding of primordial follicles and the mechanisms 
protecting this irreplaceable pool.  
 Another important aspect of the present study was the evaluation of the effect of ovarian 
GSH levels on CEZ generation from PM.  Previous studies report that excess GSH will reduce 
the generation and stability of CEZ (Shulman-Roskes et al., 1998), thus we hypothesized that 
increasing GSH levels during PM exposure would reduce CEZ liberation, subsequently leading 
to reduced CEZ-induced follicle loss.  When PM exposure was supplemented with GSH, our 
hypothesis was confirmed.  However, surprisingly, when the levels of ovarian GSH were 
depleted during PM exposure, CEZ-induced follicle loss was also prevented.  The physiological 
relevance of this result is unclear.  It may be that BSO is not depleting ovarian GSH to a great 
enough extent to affect CEZ liberation.  It could also be that a direct chemical reaction between 
BSO and PM is occurring to block the release of CEZ, but both scenarios render further 
investigation.   
 If, in the case of GSH supplementation and depletion, CEZ liberation is inhibited, this 
may partly explain the reduced follicle loss observed in the PM + GEE compared to PM 
treatments.  The ovotoxicity of CEZ has been demonstrated and lack of CEZ liberation is 
suggested by our data.  Taken together, continued investigation of CEZ is required to understand 
the ovotoxic activity of this volatile, PM-generated metabolite is required.  
   In summary, the results from this study suggest that EPHX1 is involved in the 
detoxification of PM.  Interestingly, excess GSH by itself impaired follicle viability, but GSH 
supplementation did reduce PM-induced follicle depletion.  Depletion of GSH did not affect PM-
induced ovotoxicity, thus the role of GSH in PM metabolism and ovotoxicity remains unclear.  
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The prevention of PM-induced follicle loss, potentially by the overexpression of EPHX1, could 
have profound implications for fertility preservation following cancer treatment with CPA, 
leading to an improved quality of life for millions of female cancer survivors.  
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Figures 
  2d mRNA 4d mRNA 
Gene Name Symbol P-value 
Fold 
Change P-value 
Fold 
Change 
ATP-binding cassette, sub-family B (MDR/TAP), member 1A Abcb1a 0.001770*  3.58 0.001727*   3.19 
ATP-binding cassette, subfamily B (MDR/TAP), member 1B Abcb1b 0.000727*   5.78 0.022683*   5.2 
ATP-binding cassette, subfamily B (MDR/TAP), member 4 Abcb4 0.515728   -1.13 0.371106   -1.15 
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 Abcc1 0.219424   1.37 0.316561   1.18 
Amiloride binding protein 1 (amine oxidase, copper-containing) Abp1 0.757141   -1.04 0.483421   -1.23 
Alcohol dehydrogenase 1 (class I) Adh1 0.477045   -1.4 0.006091*   1.87 
Alcohol dehydrogenase 4 (class II), pi polypeptide Adh4 0.152026   -1.7 0.218344   1.13 
Aryl hydrocarbon receptor Ahr 0.753902   -1.08 0.116944   1.22 
Aminolevulinate, delta-, dehydratase Alad 0.326891   -1.24 0.277063   -1.13 
Aldehyde dehydrogenase 1 family, member A1 Aldh1a1 0.244120   -1.8 0.827029   -1.05 
Arachidonate 15-lipoxygenase Alox15 0.569599   1.18 0.391079   -1.22 
Arachidonate 5-lipoxygenase Alox5 0.086132†   1.31 0.776196   -1.02 
Apolipoprotein E Apoe 0.801956   -1.13 0.429921   1.16 
Aryl hydrocarbon receptor nuclear translocator Arnt 0.464792   -1.28 0.000838*   -1.29 
ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial) Asna1 0.404698   -1.34 0.820665   1.01 
Biliverdin reductase A Blvra 0.233480   -1.44 0.044453*   -1.15 
Biliverdin reductase B (flavin reductase (NADPH)) Blvrb 0.251273   -1.44 0.381607   1.06 
Carboxylesterase 1E Ces1e 0.718231   -1.05 0.865172   -1.01 
Carboxylesterase 2C Ces2c 0.620531   -1.41 0.084619†   2.11 
Carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 Chst1 0.096756†   -2.16 0.020954*  -1.79 
Catechol-O-methyltransferase Comt 0.398608   -1.2 0.205772   -1.1 
Cytochrome b5 reductase 3 Cyb5r3 0.425607   -1.22 0.458036   -1.12 
Cytochrome P450, family 17, subfamily a, polypeptide 1 Cyp17a1 0.884331   1.06 0.579077   -1.29 
Cytochrome P450, family 19, subfamily a, polypeptide 1 Cyp19a1 0.721957   -1.57 0.009580*   -6.16 
Cytochrome P450, family 1, subfamily a, polypeptide 1 Cyp1a1 0.896459 -1.49 0.045311* 5.21 
Cytochrome P450, family 1, subfamily a, polypeptide 2 Cyp1a2 0.758402 1.04 0.469265 1.15 
Cytochrome P450, family 1, subfamily b, polypeptide 1 Cyp1b1 0.627825   1.07 0.209534   -1.28 
Cytochrome P450, family 27, subfamily b, polypeptide 1 Cyp27b1 0.738395   -1.16 0.242247   -1.33 
Cytochrome P450, family 2, subfamily b, polypeptide 15 Cyp2b15 0.162908   1.17 0.447085   1.12 
Cytochrome P450, family 2, subfamily b, polypeptide 3 Cyp2b3 0.219644   1.24 0.447085   1.12 
Cytochrome P450, family 2, subfamily c, polypeptide 13 Cyp2c13 0.227206   1.25 0.447085   1.12 
Cytochrome P450, family 2, subfamily c, polypeptide 6 Cyp2c6 0.162908   1.17 0.447085   1.12 
Cytochrome P450, family 2, subfamily c, polypeptide 7 Cyp2c7 0.162908   1.17 0.447085   1.12 
Cytochrome P450, family 2, subfamily e, polypeptide 1 Cyp2e1 0.381847   1.41 0.373096   1.41 
Cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 
1 
Cyp3a23/
3a1 
0.802079 1.07 0.508695 1.18 
Cytochrome P450, family 4, subfamily b, polypeptide 1 Cyp4b1 0.516023   1.16 0.750040   1.2 
Epoxide hydrolase 1, microsomal Ephx1 0.027860*   1.79 0.005051*   3.3 
Fatty acid amide hydrolase Faah 0.380459   -1.25 0.662959   -1.06 
Fructose-1,6-bisphosphatase 1 Fbp1 0.466451   -1.15 0.871058   1.01 
Glutamate decarboxylase 1 Gad1 0.886822   -1.49 0.413211   1.39 
Glutamate decarboxylase 2 Gad2 0.665363   1.09 0.789988   1.41 
Glucokinase (hexokinase 4) regulator Gckr 0.088618†   -1.42 0.858440   -1.06 
Gamma-glutamyltransferase 1 Ggt1 0.752264   -1.17 0.004788*  3.04 
Glucose phosphate isomerase Gpi 0.294319   -1.31 0.038706*   -1.36 
Glutathione peroxidase 1 Gpx1 0.869443   -1.03 0.004771*   1.33 
Glutathione peroxidase 2 Gpx2 0.219087   2.31 0.018002*   4.21 
Glutathione peroxidase 3 Gpx3 0.729575   -1.21 0.737319   1.08 
Glutathione peroxidase 4 Gpx4 0.901330   1.01 0.680852   -1.04 
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Glutathione peroxidase 5 Gpx5 0.162908   1.17 0.447085   1.12 
Glutathione reductase Gsr 0.561476   -1.13 0.730703   -1.03 
Glutathione S-transferase A3 Gsta3 0.420991   1.2 0.016163*   1.53 
Glutathione S-transferase alpha 4 Gsta4 0.024743*   -1.17 0.665382   1.06 
Glutathione S-transferase mu 1 Gstm1 0.855854   -1.01 0.075047†   1.36 
Glutathione S-transferase mu 2 Gstm2 0.776357   -1.11 0.113875   1.15 
Glutathione S-transferase mu 3 Gstm3 0.390435   -1.13 0.080435   1.33 
Glutathione S-transferase mu 4 Gstm4 0.352415   -1.3 0.571792   1.04 
Glutathione S-transferase, mu 5 Gstm5 0.127434   -1.49 0.094276†   -1.12 
Glutathione S-transferase pi 1 Gstp1 0.134856   1.24 0.112341   1.23 
Glutathione S-transferase theta 1 Gstt1 0.200890   -1.52 0.179217   -1.16 
Hexokinase 2 Hk2 0.687386   -1.4 0.040470*   -2.25 
Hydroxysteroid (17-beta) dehydrogenase 1 Hsd17b1 0.324950   -2.24 0.125804   -2.02 
Hydroxysteroid (17-beta) dehydrogenase 2 Hsd17b2 0.736142   1.02 0.556826   -1.37 
Hydroxysteroid (17-beta) dehydrogenase 3 Hsd17b3 0.883893   -1.05 0.550401   -1.14 
Lactoperoxidase Lpo 0.796552   -1.03 0.024280*   5.74 
Myristoylated alanine rich protein kinase C substrate Marcks 0.118478   -1.97 0.238536   -1.95 
Microsomal glutathione S-transferase 1 Mgst1 0.061609†   1.5 0.653062   1.04 
Microsomal glutathione S-transferase 2 Mgst2 0.231552   1.11 0.292247   1.14 
Microsomal glutathione S-transferase 3 Mgst3 0.193045   -1.29 0.239300   1.12 
Myeloperoxidase Mpo 0.997143   -1.25 0.086698†   -1.95 
Metallothionein 3 Mt3 0.608582   1.05 0.005018*   1.63 
Methylenetetrahydrofolate reductase (NAD(P)H) Mthfr 0.124965   -1.82 0.270348   -1.31 
N-acetyltransferase 1 Nat1 0.905990   -1.06 0.142410   1.14 
Nitric oxide synthase 2, inducible Nos2 0.222886   -1.89 0.001160*   -3.48 
Nitric oxide synthase 3, endothelial cell Nos3 0.170235   -2.19 0.014383*  -1.82 
NAD(P)H dehydrogenase, quinone 1 Nqo1 0.007059*   1.65 0.022685*   1.55 
Pyruvate kinase, liver and RBC Pklr 0.505933   -1.34 0.669517   -1.02 
Pyruvate kinase, muscle Pkm2 0.715647   -1.29 0.111852   -1.42 
Paraoxonase 1 Pon1 0.678326   1.19 0.068923†   -2.41 
Paraoxonase 2 Pon2 0.617326   -1.16 0.242572   1.1 
Paraoxonase 3 Pon3 0.532167   1.1 0.013010*   1.5 
Swi/SNF related matrix associated, actin dependent regulator of 
chromatin, subfamily a-like 1 
Smarcal1 0.138214   -1.3 0.361878   -1.11 
Stannin Snn 0.613461   -1.16 0.031465†   -1.44 
Steroid-5-alpha-reductase, alpha polypeptide 1 Srd5a1 0.224372   -1.26 0.391807   -1.17 
Xanthine dehydrogenase Xdh 0.943939   -1.06 0.107604   1.4 
Actin, beta Actb 0.188799   -1.4 0.009471*   -1.26 
Beta-2 microglobulin B2m 0.008660*   -1.54 0.131953   -1.31 
Hypoxanthine phosphoribosyltransferase 1 Hprt1 0.447244   1.07 0.303827   1.04 
Lactate dehydrogenase A Ldha 0.847446   -1.17 0.039697*   -1.59 
Ribosomal protein, large, P1 Rplp1 0.452646   -1.07 0.322481   -1.03 
 
Table 1.  Effect of PM exposure on ovarian expression of drug metabolism genes.    
PND4 rat ovaries (n=3; 10 ovaries per pool) were treated with 1% DMSO (vehicle control) or 
PM (60 µM) for 2 or 4d.  Following RNA isolation, mRNA levels were quantified with an RT
2
 
Profiler PCR array.  Values represent fold-change ± SEM relative to a control value of 1, 
normalized to Hprt1 and Rplp1.  * = different from control, P < 0.05; 
†
= P < 0.10.  
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Figure 1.  Effect of PM on ovarian abundance of Ephx1, Gstm and Gstp mRNA and protein.  
PND4 rat ovaries (n=3; 10 ovaries per pool) were treated with 1% DMSO (vehicle control, CT) 
or PM (60 µM).  Following 2 or 4 d of culture, mRNA and protein were isolated and (A and D) 
Ephx1, (B and E) Gstm, and (C and F) Gstp, levels evaluated by quantitative RT-PCR or 
Western blot, respectively.  mRNA values represent fold-change ± SEM relative to a control 
value of 1, normalized to Gapdh.  Protein values represent signal intensity ± SEM normalized to 
Ponceau S. * = different from control, P < 0.05; 
# 
= P < 0.1. 
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Figure 2.  Impact of EPHX inhibition during PM exposure on follicle number.    
PND4 rat ovaries were cultured and treated on alternate days to 1% DMSO (vehicle control, 
CT), PM (60 µM), CHO (2 mM) or PM (60 µM) + CHO (2 mM).  Following 4 d of culture, 
follicles were classified and counted: (A) Primordial Follicles; (B) Small Primary Follicles; (C) 
Large Primary Follicles; (D) Secondary Follicles.  Values represent mean ± SE total follicles 
counted/ovary, n = 4-6. 
 
Different letters represent significant difference between treatments P < 
0.05. 
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Figure 3.  Impact of GSH supplementation during PM exposure on follicle number.    
PND4 rat ovaries were cultured and treated on alternate days to 1% DMSO (vehicle control, 
CT), PM (60 µM), GEE (2.5 mM) or PM (60 µM) + GEE (2.5 mM).  Following 4 d of culture, 
follicles were classified and counted: (A) Primordial Follicles; (B) Small Primary Follicles; (C) 
Large Primary Follicles; (D) Secondary Follicles.  Values represent mean ± SE total follicles 
counted/ovary, n = 4-6. 
 
Different letters represent significant difference between treatments P < 
0.05. * = P < 0.10 difference from CT. 
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Figure 4.  Impact of GSH depletion during PM exposure on follicle number.    
PND4 rat ovaries were cultured and treated on alternate days to 1% DMSO (vehicle control, 
CT), PM (60 µM), BSO (100 µM) or PM (60 µM) + BSO (100 µM).  Following 4 d of culture, 
follicles were classified and counted: (A) Primordial Follicles; (B) Small Primary Follicles; (C) 
Large Primary Follicles; (D) Secondary Follicles.  Values represent mean ± SE total follicles 
counted/ovary, n = 4-6. 
 
Different letters represent significant difference between treatments P < 
0.05. * = P < 0.10 difference from CT. 
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Figure 5.  Plate layout for evaluation of the impact of ovarian GSH levels on CEZ 
liberation.    
Each well contained one PND4 rat ovary that was treated  accordingly for 4 d to evaluate the 
following effects:  (A) Untreated – ovaries cultured in control media were exposed to the CEZ 
liberated from the adjacent PM + GEE, thus named Liberated (Lib.) PM + GEE; (B) PM + GEE 
– ovaries treated with PM and GEE to evaluate the effect of GEE (GSH supplementation) on 
PM-induced ovotoxicity; and (C) GEE – ovaries were treated with GEE and exposed to the CEZ 
liberated from the adjacent PM + GEE, thus named CEZ + GEE.  Control treated ovaries were 
maintained in a separate incubator.  
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Figure 6.  Impact of GSH supplementation on CEZ liberation and ovotoxicity.    
PND4 rat ovaries were cultured and treated as described in Figure 5.  Following 4 d of culture, 
follicles were classified and counted: (A) Primordial Follicles; (B) Small Primary Follicles; (C) 
Large Primary Follicles; (D) Secondary Follicles.  Values represent mean ± SE total follicles 
counted/ovary, n = 4-6. 
 
Different letter represent significant difference between treatments P < 
0.05. * = P < 0.10 difference from CT. 
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Figure 7.  Impact of GSH depletion on CEZ liberation and ovotoxicity.    
PND4 rat ovaries were cultured and treated as described in Figure 5.  Following 4 d of culture, 
follicles were classified and counted: (A) Primordial Follicles; (B) Small Primary Follicles; (C) 
Large Primary Follicles; (D) Secondary Follicles.  Values represent mean ± SE total follicles 
counted/ovary, n = 4-6. 
 
Different letter represent significant difference between treatments P < 
0.05. * = P < 0.10 difference from CT (a*) or PM (b*). 
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Abstract 
Phosphoramide mustard (PM) is an ovotoxic metabolite of the chemotherapeutic agent 
cyclophosphamide, and although PM-induced follicle depletion is observed, the mechanism 
driving this cell loss is unknown.  To gain insight into PM-induced ovotoxicity, a postnatal day 4 
(PND4) Fisher 344 rat whole ovary culture system was used.  Treatment of these cultured 
ovaries occurred on alternate days with vehicle control (1% DMSO) or PM (60 µM) for 2 or 4 d.  
Upon ovary collection, mRNA or protein were isolated and quantified by RT
2 
profiler PCR 
array, target-specific RT-PCR and/or Western blot.  Analysis determined altered mRNA levels of 
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genes involved in autophagy such as Beclin 1 (Becn1) following PM exposure.  Western blot 
analysis determined BECN1 protein levels to also be increased after 2 d of PM exposure 
suggesting the induction of autophagosome formation.  To confirm autophagy formation 
histologically, transmission election microscopy (TEM) was performed over a time course of PM 
exposure, and at time points prior to PM-induced follicle loss, both the presence of 
autophagosomes and the degradation of mitochondria were observed.  To investigate a functional 
role for PM-induced autophagy, ovaries were treated with PM under with either autophagy 
inhibition, via LY294002 (LY); or activation, via rapamycin.  Thus, ovaries were cultured with 
vehicle control (1% DMSO), PM (60 µM), LY (20 µM), rapamycin (1 µM), PM + LY or PM + 
rapamycin for 4 d.  LY had no effect on PM-induced ovotoxicity, while rapamycin treatment 
prevented PM-induced follicle loss.  These data identify that autophagy is involved in PM-
induced follicle loss, and that the mammalian target of rapamycin, mTOR, may be a gatekeeper 
during regulation of PM-induced ovotoxicity.   
 
Introduction 
 
The female ovarian reserve is established at birth and represents a finite number of 
follicles, which are comprised of the oocyte surrounded at initial stages of development by 
granulosa cells.  Throughout the lifespan of a woman, follicles gradually progress through 
development beginning at the primordial follicle stage and continuing through the primary and 
secondary follicle stages to eventually become surrounded by theca cells, form an antrum and 
ultimately be ovulated.  However, less than 1% percent of follicles will complete the cycle to be 
ovulated.  Any follicles that are not ovulated will die, thus resulting in over 99% of mammalian 
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follicles dying by the process of atresia (Hirshfield, 1991).  Once the ovarian reserve is depleted 
of follicles, ovarian failure, or menopause, occurs.  On average, the natural phenomenon of 
menopause occurs at the age of 51 (Jick and Porter, 1977), however, chemical exposures can 
deplete follicles leading to premature ovarian failure (POF).   
 Up until the last decade, apoptosis was accepted as the type of programmed cell death 
(PCD) occurring in ovarian follicles undergoing atresia (follicular death).  However, previous 
studies now suggest that autophagy may be an important process in follicles depletion, working 
independently or in tandem with apoptosis (Escobar et al., 2008; Rodrigues et al., 2009; Gannon 
et al., 2012).  Autophagy genes Beclin 1 (BECN1), autophagy-related 7 homolog (S. cerevisiae) 
(ATG7) and lysosome associated membrane protein (LAMP1) are involved in key steps of 
autophagosome and autolysosome assembly (Kim et al., 1999; Liang et al., 1999; Eskelinen, 
2006).  An autophagosome is the double-membraned structure that forms around the material 
targeted for destruction, transports that unwanted material, and merges with the lysosome for 
digestion forming the autolysosome (de Duve, 2005; Mizushima, 2007).   
 A study evaluating PCD at birth, a time of significant follicle loss, found in mice that at 
the time of parturition, autophagy is the active PCD pathway (Rodrigues et al., 2009).  Here, 
autophagy is thought to be the result of the nutrient deprivation experienced at birth due to the 
removal of the fetus from the placenta, a phenomenon that has also been observed in other 
tissues (Kuma et al., 2004; Rodrigues et al., 2009).  Nutrient deprivation is sensed by the key 
response element mammalian target of rapamycin (mTOR) leading to the induction of autophagy 
via initiation of the autophagosome-forming cascade (Schmelzle and Hall, 2000).  mTOR lies 
downstream of the phosphatidylinositol-3 kinase (PI3K) signaling pathway and the interaction of 
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these two pathways mediates cell survival and viability as well as negatively regulating 
autophagy (Jung et al., 2010).   
 In addition to the natural occurrence of autophagy in the ovary, chemical exposures, such 
as cigarette smoke, have been shown to induce autophagy-mediated follicular death in mice 
(Gannon et al., 2012; Gannon et al., 2013).  Compared to unexposed controls, cigarette smoke-
exposed mice had a reduced number of follicles, but did not have a higher level of terminal 
deoxynucleotide transferase dUTP nick end labeling (TUNEL), DNA laddering or caspase 
activity - all of which are classic signs of apoptosis (Tuttle et al., 2009).  However, cigarette 
smoke-exposed mice did have a higher number of autophagosomes in granulosa cells, increased 
BECN1 and LC3 protein levels and mitochondrial dysfunction (Gannon et al., 2013).  Also, 
through the use of a neonatal rat ovary culture method, single low exposures to 7,12-
dimethylbenz[a]anthracene (DMBA), a component of cigarette smoke, reduced follicle number 
and altered BECN1 mRNA and protein levels (Madden et al., 2014a).  Collectively, these studies 
suggest autophagy is an active process during ovarian response to xenobiotics. 
 The chemotherapy drug cyclophosphamide (CPA) exposure targets and depletes 
primordial follicles in mice (Plowchalk and Mattison, 1991; Desmeules and Devine, 2006) and 
antral (the developmental stage prior to ovulation) follicles in rats (Jarrell et al., 1991; Hoyer and 
Devine, 2002) at concentrations relevant to human exposures (Struck et al., 1987; Desmeules 
and Devine, 2006).  The results from these studies coincide with the human side effects, such as 
amenorrhea, premature menopause and infertility, reported by women and young girls who have 
undergone CPA treatment (Sanders et al., 1988; Suarez-Almazor et al., 2000). 
   CPA is a prodrug and must be metabolized in order to have anti-cancer effects.  Hepatic 
metabolism by cytochrome P450 (CYP) enzymes initiates the biotransformation of CPA, which 
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ultimately forms the active, anti-cancer and ovotoxic metabolite phosphoramide mustard (PM).  
Notably, PM can further biotransform to a volatile and ovotoxic metabolite, presumably 
chloroethylaziridine (CEZ), which also likely contributes to PM overall toxicity (Madden et al., 
2014b).  Previous studies suggest that oocytes are the main PM target, while in larger follicles, 
the granulosa cells are the targeted cell type (Desmeules and Devine, 2006).  Using a neonatal rat 
ovary culture method, this study also found that following PM exposure, the granulosa cells of 
primary follicles stained TUNEL positive following PM exposure (Desmeules and Devine, 
2006).  Interesting, caspase-3 staining in PM-exposed ovaries was not different from control and 
no primordial follicles stained positive for this apoptotic indicator (Desmeules and Devine, 
2006).  Additionally, a study investigating the effects of varying doses of CPA in vivo found no 
TUNEL or caspase-3 positive primordial follicle, despite finding a loss of primordial follicles 
induced by CPA (Kalich-Philosoph et al., 2013), which again, encourages the possibility that 
another PCD form is occurring, especially in the primordial follicles, in response to PM 
exposure.   
Therefore, in this study we hypothesized that autophagy is an active ovarian response 
following PM exposure and likely contributes to PM-induced follicle loss.  We evaluated mRNA 
and/or protein abundance of the autophagy related genes (Becn1, Atg7, LC3-II and Lamp) along 
with the presence of autophagosomes via transmission electron microscopy (TEM).  To further 
evaluate a functional role for autophagy in follicle death and survival, the mTOR targeted 
autophagy activator, rapamycin, and the PI3K targeted inhibition of autophagy, LY294002, were 
utilized in combination with PM to evaluate the effect on PM-induced follicle loss.      
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Materials and Methods 
Reagents:  
Bovine serum albumin (BSA), ascorbic acid, transferrin, 2-β-mercaptoethanol, 30% 
acrylamide/0.8% bisacrylamide, ammonium persulphate, glycerol, N’ N’ N’ N’-
tetramethylethylenediamine (TEMED), Tris base, Tris HCL, sodium chloride, Tween-20, 
phosphatase inhibitor, protease inhibitor and rapamycin were purchased from Sigma Aldrich Inc. 
(St. Louis, MO).  Dulbecco’s Modified Eagle Medium: nutrient mixture F-12 (Ham) 1x 
(DMEM/Ham’s F12), Albumax, penicillin (5000U/ml) Hank’s Balanced Salt Solution (without 
CaCl2, Mg Cl2, or MgSO4) were obtained from Invitrogen Co. (Grand Island, NY).  Millicell-
CM filter inserts and 48-well cell culture plates were obtained from Millipore (Billerica, MA) 
and Corning Inc. (Corning, NY), respectively.  RNeasy Mini kit, QIA Shredder kit, RNeasy Mini 
Elute kit, Quantitect ™ SYBR Green PCR kit, RT2 First Strand kit, RT2 SYBR Green 
Mastermix, and the Stress and Toxicity RT
2
 Profiler PCR arrays were purchased from Qiagen 
Inc. (Valencia, CA).  RNAlater was obtained from Ambion Inc. (Grand Island, NY).  2-(4-
morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) was purchased from A.G. 
Scientific, Inc. (San Diego, CA).  PM was obtained from the National Institutes of Health 
National Cancer Institute (Bethesda, MA).  All primers were obtained from the DNA facility of 
the Iowa State University office of biotechnology (Ames, IA).  Ponceau S was purchased from 
Fisher Scientific (Waltham, MA).  SignalFire™ ECL Reagent, anti-LAMP1, and the HRP-linked 
secondary anti-rabbit antibody was purchased from Cell Signaling Technology® (Danvers, MA).  
Anti-Becn1 antibody was purchased from Santa Cruz (Dallas, TX) and donkey anti-rabbit FITC 
labeled secondary antibody was obtained from Southern Biotech (Birmingham, AL).   
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Animals:  
The Iowa State University Institutional Animal Care and Use Committee’s approved all 
experimental procedures.  Fisher 344 (F344) rats were housed one per plastic cage and 
maintained in a controlled environment (22 ± 2ºC; 12h light/12h dark cycles).  The animals were 
provided a standard diet with ad libitum access to food and water, and allowed to give birth.   
 
In vitro ovarian cultures:   
Following euthanasia, ovaries were removed from female postnatal day (PND) 4 F344 rats 
(Devine et al., 2002).  Each ovary was removed, trimmed of oviduct and excess tissue, and 
placed onto a Millicell-CM membrane floating on 250 µl of previously 37ºC equilibrated 
DMEM/Ham’s F12 medium containing 1 mg/ml BSA, 1 mg/ml Albumax, 50 µg/ml ascorbic 
acid, 5 U/ml penicillin and 27.5 µg/ml transferrin per well in a 48-well plate.  To prevent 
dehydration, a drop of medium was placed on top of each ovary.  In order to eliminate CEZ as a 
confounding factor, any PM-treated ovaries were cultured separately from other treatments 
(Madden et al., 2014b) 
 
RNA isolation and quantitative real-time polymerase chain reaction (qRT-PCR):  
Following 2 or 4 d of in vitro culture, ovaries were stored in RNAlater at -80ºC.  Total RNA was 
isolated from ovaries (n=3; 10 ovaries per pool) using an RNeasy Mini kit according to the 
manufacturer’s instructions, concentrated via RNeasy Mini Elute kit and quantified with a 
NanoDrop (λ = 260/280 nm; ND 1000; Nanodrop Technologies Inc., Wilmington, DE).   
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RT
2
 PCR array 
According to the company-provided protocol, total RNA (250 ng) was reverse transcribed to 
cDNA using the RT
2
 first-strand kit and applied to the Stress and Toxicity Profiler PCR Array, 
which contains 96-wells, each well containing a specific primer set, thus each plate tested 96 
genes per one sample.  The performed PCR protocol was a 10 min hold at 95ºC and 40 cycles of 
denaturing at 95ºC for 15 s and a combined annealing and extension for 1 minute at 60ºC.  The 
genes of interest were normalized to the housekeeping genes recommended by company-
provided analysis software, hypoxanthine phosphoribosyltransferase (Hprt) and ribosomal 
protein, large, P1 (Rplp1).  The mRNA level of these two genes did not change across 
treatments.  The online SABiosciences RT² Profiler™ PCR Array Data Analysis quantified the 
changes in mRNA levels using the 2
-ΔΔCt 
method. 
 
Individual gene target RT-PCR 
Reverse transcription of total RNA (250 ng) to cDNA was performed using the Superscript III 
One-Step RT-PCR System (Invitrogen).  Using an Eppendorf mastercycler (Hauppauge, NY) 
and Quantitect ™ SYBR Green PCR kit (Qiagen Inc. Valencia, CA), the autophagy genes Atg7 
(forward: 5’-CTTCCTGGCCAAGGTGTTTA-3’; reverse: 5’-GTTGCTCAGACGGTCTCCTC-
3’) and Becn1 (forward: 5’-TAATGTGGGGAAGGGACAAG-3’; reverse: 5’-
AAATCCTTCCACATCTCAAACA-3’) were amplified.  The PCR protocol used was a 15 min 
hold at 95ºC and 40 cycles of denaturing at 95ºC for 15 s, annealing temperature of 58ºC, and 
extension at 72ºC for 15 s.  The genes of interest were normalized to the housekeeping gene 
Gapdh as no change in its mRNA levels were observed between treatments.  Changes in mRNA 
levels were quantified using the 2
-ΔΔCt 
method (Livak and Schmittgen, 2001; Pfaffl, 2001). 
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Protein isolation and Western blot analysis:  
PND4 ovaries (n=3; 10 ovaries per pool) were homogenized in 200 µl of ice-cold tissue lysis 
buffer and protein quantified using a standard BCA protocol on a 96-well assay plate.  Total 
protein (15 µg) was separated on a 10% SDS-PAGE and transferred to a nitrocellulose 
membrane.  Prior to 1 hr blocking in 5% milk, membranes were stained with Ponceau S to 
confirm equal protein loading.  The membrane was then incubated at 4 ºC with the Rabbit Anti-
BECN1 (1:250; Santa Cruz).  Following ~60 hrs of incubation, donkey anti-rabbit secondary 
antibody was applied and rocked with membrane for 1h at room temperature.  Autoradiograms 
were visualized on X-ray films in a dark room following 10 min incubation of membranes with 
1X SignalFire™ ECL reagent.  Densitometry of the appropriate sized bands was measured using 
Image Studio Lite Version 3.1 (LI-COR Biosciences, Lincoln, NE) which eliminates background 
noise.  Values were normalized Ponceau S staining. 
 
Immunofluorescence staining:  
Following treatment, ovaries were placed in 4% paraformaldehyde for 2 hours, washed and 
stored in 70% ethanol, paraffin embedded and serially sectioned (5 µM).  Two sections per ovary 
(n = 3) were deparaffinized, blocked with 5% BSA and incubated with anti-LAMP1 primary 
antibody (1:50 dilution) at 4°C overnight.  Secondary FITC-labelled antibody was applied for 1 
h, followed by incubation with the nuclear stain, Hoechst (30 minutes; 1:1000 dilution/5mg/ml; 
Invitrogen).  Slides were repeatedly rinsed with PBS, cover-slipped, and stored in the dark (4°C) 
until visualization.  Primary antibody was not added to immunonegative ovarian sections.  
Immunofluorescence was visualized on a Leica DMI300B fluorescent microscope at λ = 488 and 
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633 nm for FITC and Hoechst, respectively.  All images were captured using a 10× objective 
lens.  Protein staining was quantified using Image J software.  LAMP1 protein abundance was 
compared via quantification of signal intensity of foci (n=10) present in each section 
(n=2/ovary).   
 
Histological evaluation of autophagy-like morphology: 
For light and transmission electron microscopy (TEM), PND4 ovaries (n=5) were exposed on 
alternate days to PM (60 µM) and collected from culture after 1, 2, 3 or 4 days.  The ovaries 
were fixed with 2% glutaraldehyde (w/v) and 2% paraformaldehyde (w/v) in 0.1M sodium 
cacodylate buffer, pH 7.2, for at least 48 hrs at 4°C.  Samples were washed in buffer and then 
fixed in 1% osmium tetroxide in 0.1 M cacodylate buffer for 1 hr at room temperature  The 
samples were then dehydrated in a graded ethanol series, cleared with ultra-pure acetone, 
infiltrated and embedded using a modified EPON epoxy resin (Embed 812; Electron Microscopy 
Sciences, Ft. Washington, PA).  Resin blocks were polymerized for 48 hours at 70°C.  Thick and 
ultrathin sections were made using a Leica UC6 ultramicrotome (Leeds Precision Instruments, 
Minneapolis, MN).  Thick sections were stained with epoxy resin stain (Electron Microscopy 
Sciences, Ft. Washington, PA) and imaged with a Zeiss Axioplan II light microscope with a 
MRC AxioCam and Axiovision software (Carl Zeiss INC, Thornwood, NY).  Ultrathin sections 
were collected onto copper grids and images were captured using a JEM 2100 200kV scanning 
and transmission electron microscope (Japan Electron Optic Laboratories Inc., Peabody, MA). 
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Autophagy induction by rapamycin: 
Ovaries (n=6) were treated with one of: vehicle control media (1% DMSO); PM (60 µM); 
rapamycin (1 µM); or PM (60 µM) + rapamycin (1 µM) on alternate days for 4d.  The rapamycin 
concentration administered was adapted from a prior study (Wang et al., 2008a). 
 
Inhibition of autophagy by LY294002: 
For 4d, ovaries (n=4-6) were treated on alternate days to one of: vehicle control media (1% 
DMSO); PM (60 µM); LY294002 (20 µM); or PM (60 µM) + LY294002 (20 µM).  The 
concentration of LY294002 using the PND4 ovary culture method was previously determined to 
be effective in the ovarian culture system (Keating et al., 2009). 
 
Histological evaluation of follicle numbers:  
Following treatment, ovaries were placed in 4% paraformaldehyde for 2 hours, washed and 
stored in 70% ethanol, paraffin embedded, and serially sectioned (5 µM).  Every 6
th
 section was 
mounted and stained with hematoxylin and eosin.  Healthy oocyte-containing follicles were 
identified and counted in every 6
th
 section.  Unhealthy follicles were distinguished from healthy 
follicles by the appearance of pyknotic bodies and intense eosinophilic staining of oocytes.  
Healthy follicles were classified and enumerated according to Flaws et al., 1994.  Slides were 
blinded to prevent counting bias.   
 
Statistical analysis: 
Treatment comparisons for follicle count experiments were performed using Analysis of 
Variance (ANOVA).  Quantitative RT-PCR, Western blot and immunofluorescence staining data 
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were analyzed by t-test comparing treatment with control raw data at each individual time point.  
All statistical analysis was performed using Prism 5.04 software (GraphPad Software).  
Statistical significance was defined as P < 0.05 and a trend for a significant difference from 
control was designated at P < 0.1.   
 
Results 
Evaluation of changes in genes involved in stress and toxicity pathways following PM 
exposure 
A stress and toxicity RT
2
 Profiler PCR array was used to investigate the mRNA profile of PND4 
rat ovaries (n=3, 10 ovaries per pool) which had been exposed to PM (60 µM) for 2 and 4 days.  
As described in Table 1, following 2d of PM exposure, B2m mRNA levels decreased (P < 0.05), 
as well as a trend for a decrease (P < 0.10) in Tnfa and a trend for an increase in Hspa1b and 
Sqstml, relative to control treated ovaries.  After 4d of PM exposure, Bbc3, Cdkn1a, Cftr, Edn1, 
Gstp1, Nqo1, Tlr4, Tnfrsf1a, Txnrd1 mRNA levels increased (P < 0.05) compared to control, 
while decreases (P < 0.05) after 4d PM exposure were found in Casp1 and Il1b mRNA levels.  In 
addition, 4d PM exposure induced a trend (P < 0.10) for increased mRNA levels for the 
following genes: Cd40lg, Fas, Gadd45a and Mre11a as well as a trend (P < 0.10) for a decrease 
in levels of Adm, Epo, Mmp9, Tnf, and Vegfa.  The results of this experiment are summarized in 
Table 1.   
 
PM-induced mRNA expression changes of autophagy genes 
PND4 rat ovaries (n=3, 10 ovaries per pool) were cultured and collected after 2 and 4 days of 
PM (60 µM) exposure.  PM-induced changes in mRNA levels of the autophagy genes Atg7 and 
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Becn1 were quantified by qRT-PCR.  Following 2 days of PM exposure, compared to control, 
there was a trend (P < 0.10) for decreased Atg7 mRNA abundance but there was no impact of 
PM on Atg7 mRNA after 4 days of exposure (Fig. 1A).  There was no effect of PM on Becn1 
mRNA levels after 2 days of PM exposure; however, there was a trend (P < 0.10) for a slight 
increase in Becn1 after 4 days (Fig. 1B), relative to control.   
 
Effect of PM exposure on ovarian location and level of autophagy proteins  
To investigate post-transcriptional changes in autophagy proteins, BECN1 and LAMP1 protein 
levels activity was measured in PND4 rat ovaries following 2 and 4 days of PM (60 µM) 
exposure by protein isolation and Western blotting or fixed and sectioned for 
immunofluorescence (n=3, 2 sections per ovary), respectively.  Relative to control, an increase 
(P < 0.05) in BECN1 was found after 2d of PM exposure, but at 4 d, no difference between 
treatments in BECN1 levels was observed (Fig. 2).  At both time points, LAMP1 foci number 
was unaffected by PM exposure (Fig. 3); however, the size of the LAMP foci appear larger in 
PM-treated ovaries versus control.  
 
Investigation of autophagy by TEM 
In order to determine autophagosome formation and activity, PND4 ovaries were exposed to PM 
(60 µM) on alternate days and collected on days 1, 2, 3 and 4 of culture for TEM.  After 1 day, 
PM-exposed ovaries exhibited dark, electron dense structures in the oocyte cytoplasm of 
primordial follicles (Fig. 4C) and large double-membraned autophagosomes in the granulosa 
cells of the small primary follicles which appears to contain a mitochondria (Fig. 4C).  
Multilamellar bodies were seen in both control and PM-treated ovaries after 2d, with a greater 
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abundance apparent visually in PM-treated ovaries.  Some oocytes of small primary follicles 
following 2d of PM exposure appeared dead with global vacuolization (Fig. 4F) , while other 
small primary follicles had little sign of damage.  Similar to observations after 1d of PM 
exposure, the granulosa cells after 2d contained large double-membraned autophagosomes with 
unidentified structures engulfed suggesting a more advance state of digestion compared to 1d 
PM exposure (Fig. 4F).  After 3d of PM exposure, dead primordial follicles were evident by the 
lack of definition between the granulosa cell layer and the oocyte cytoplasm as well as small 
autophagosomes displacing the oocyte nucleus (Fig. 4G).  Like the earlier time points, the 
cytoplasm of granulosa cells continued to have large vacuolization, increasing in electron 
density.  Following 4d of PM exposure, in addition to apparent degradation, abnormal golgi 
apparatus were evident across follicle types (Fig. 4 and 5). 
 Large primary and secondary follicles, were evident after 3 and 4d, respectively, in 
control ovaries, however, these two follicle types were difficult to distinguish in PM-exposed 
ovaries because, although the oocyte had grown, the granulosa cell layer was minute, about 2 
µm, compared to the control, which was over 10 µm across (Fig. 5) .  Also, in contrast to control, 
the mitochondrial are much darker, electron-dense in the large follicle of PM-treated ovaries 
(Fig. 5C and D).  Analogous to the PM-treated primordial and small primary follicles, abnormal 
golgi apparatus and autophagosome were present in the oocyte cytoplasm and granulosa cells, 
respectively (Fig. 5C and D).  
 
Evaluation of a functional role for PM-induced autophagy  
To gain insight into the role of autophagy induced by PM exposure, PND4 ovaries (n= 5-6) were 
treated with vehicle control (1% DMSO), PM (60 µM), rapamycin (1 µM), PM (60 µM) + 
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rapamycin (1 µM), LY294002 (20 µM), or PM (60 µM) + LY294002 (20 µM) on alternate days 
for 4 d and then processed for histology.  As previously described (Madden et al., 2014), 
compared to control, there were reduced numbers of all follicle stages due to PM exposure (Fig. 
6).  Compared to control, rapamycin treatment alone only reduced (P < 0.05) secondary follicle 
number with no effect of treatment on any other follicle stage (Fig. 6D).  Rapamycin cultured 
with PM prevented PM-induced primordial and small primary follicle loss (Fig. 6A and B).  
Interestingly, PM + rapamycin treated ovaries had a strong trend for increased (P = 0.056) 
numbers of primordial follicles than control ovaries (Fig. 6A).  The addition of rapamycin did 
not impact the effects of PM on large primary and secondary, relative to control treated ovaries 
(Fig. 6C and D).       
 The addition of LY294002 resulted in an increased (P < 0.05) number of primordial 
follicles (Fig. 7A) and a trend (P < 0.10) for increased small primary follicles (Fig 7B), and a 
reduction (P < 0.05) in large primary and secondary follicles (Fig 7C and D), when compared to 
control ovaries.  The addition of LY294002 during PM exposure caused (P < 0.05) follicle 
depletion relative to control in all follicle developmental stages; however, this loss was not 
different from ovaries treated solely with PM (Fig. 7). 
 
Discussion 
PM is the ovotoxic and antineoplastic metabolite of the chemotherapy drug CPA 
(Plowchalk and Mattison, 1991; Desmeules and Devine, 2006).  CPA is used to treat a variety of 
cancers, but due it its ability to deplete primordial follicles (Plowchalk and Mattison, 1991), CPA 
increases a female patient’s risk of reduced fertility or POF (Bines et al., 1996), which is a major 
concern for the millions of female cancer survivors.  Although compromised fertility via follicle 
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depletion is well documented as a side effect of CPA, little is known about how this ovotoxicant 
elicits its detrimental effects to the ovary.   
A prior study, that used the same neonatal rat ovary culture system as in our experiments, 
investigated apoptosis as a PCD mechanism active during PM-induced follicle loss and found 
that granulosa cells of primary follicles were positively identified during TUNEL and cleaved 
caspase-3 staining following PM exposure (Desmeules and Devine, 2006).  However, the 
number of follicles positive for cleaved caspase-3 was not different from control and no 
primordial follicles stained positive for this classic apoptosis marker (Desmeules and Devine, 
2006).  In addition, the use of a caspase-3 inhibitor did not prevent PM-induced follicle loss 
leading the authors to conclude that PM-induced follicle loss occurs via a caspase-independent 
pathway (Desmeules and Devine, 2006).  
Autophagy, a caspase-independent PCD process, represents an alternative atretic route 
outside of  apoptosis.  There is mounting evidence in favor of the involvement of autophagy in 
both ovarian follicle death and survival.  For example, studies investigating the mechanisms 
responsible for follicle death at birth and puberty, times of large natural follicle loss, have found 
the classic markers of autophagy plentiful, with little to no signs of apoptosis (Rodrigues et al., 
2009; Tingen et al., 2009).  Furthermore, ovarian induction of autophagy genes was found in 
murine ovaries following exposure to cigarette smoke (Gannon et al., 2012; Gannon et al., 
2013).  Also, we have demonstrated altered mRNA levels of autophagy genes in neonatal rat 
ovaries exposed to low levels of  DMBA (Madden et al., 2014a), suggesting autophagy as a 
contributing factor to both the ovotoxicity of these compounds and the removal of damaged 
and/or dead follicles.   
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Interestingly, autophagy has also been suggested to act as a pro-survival mechanism in 
the ovary, particularly in the perinatal ovary and its establishment of the primordial follicle pool 
from the female germ cells (Gawriluk et al., 2011).  Specifically, PND1 Atg7
-/-
 knockout mice 
had no apparent germ cells and Becn1
+/-
 had less than half the number of germ cells compared to 
control, thus supporting the functional requirement of these autophagy proteins for normal 
follicular development to occur and the consideration of autophagy as more than just a PCD 
process. 
The ovarian culture method is perfectly suited to the study of autophagy involvement in 
ovotoxicity, since there is lack of the functional circulatory system by which immune cells could 
remove such debris.  The lack of a concomitant increase in unhealthy or dead follicles mirroring 
the loss of healthy follicles after PM exposure, supports that there is some mechanism in place 
for this removal.  We observed markers indicating that autophagy is an active ovarian process 
following PM exposure.  The increase observed in the mRNA and protein level of Becn1, an 
early initiator of the autophagosome formation, is suggestive that autophagy is occurring, but 
additional gene expression alternations were observed in support of this hypothesis.  For 
example, relative to control, a large increase was found in Bcl-2 binding component 3 (PUMA), 
which has been shown to be involved in mitochondria-specific autophagy.  In addition, a striking 
increase in cyclin-dependent kinase inhibitor 1A (p21) was found in PM-exposed ovaries 
compared to control, which has also been linked to the induction of autophagy (Chen et al., 
2014).  In congruence, a decrease in mRNA level was found in caspase-1 after PM exposure, 
which is in agreement with the previous study reporting PM-induced follicle depletion is 
caspase-independent (Desmeules and Devine, 2006). 
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 Ovarian histology was examined in fine detail using TEM following a time course of PM 
exposure.  Since larger primary and secondary follicles develop after approximately 3-4 days in 
culture, determination of the impacts of PM on all stage follicles (primordial, small primary, 
large primary and secondary) was possible.  In small preantral (primordial and small primary) 
follicles, electron dense structures along with engulfed mitochondria in double-membraned 
structures was noted.  As the time of exposure progressed, vacuolization of oocytes was observed 
as well as abnormal golgi apparatus were apparent.  In large preantral follicles (large primary and 
secondary), many of the same morphological alterations were seen.  A major observation 
incompatible with follicle viability and growth is reduction in the width of the granulosa cell 
layer, from about 2 to 10 µM in width.  These data are in agreement with the gap between the 
oocyte and granulosa cell that we have previously reported (Madden et al., 2014).  More 
importantly, these PM-induced changes in the cellular components are observed at time points 
prior to the observation of follicle loss (day 4; Madden et al., 2014), supporting that they are 
ovotoxic changes that occur due to PM exposure and contribute to ovotoxicity.  Similarly, DNA 
double-stranded breaks by PM were detected prior to follicle loss (Petrillo et al., 2011).   
 Our findings coincide with a previous in vivo study, which found ovarian autophagy 
induced in response to whole-body cigarette exposure (Gannon et al., 2012; Gannon et al., 
2013).  Similarly, the majority of autophagosomes were observed in the granulosa cells and these 
structures appeared to also contain mitochondria (Gannon et al., 2012).  Additionally, an 
increase in BECN1 protein level was observed.  Collectively, these studies are among the first to 
report that autophagy is an active ovarian process that can be initiated in response to xenobiotic 
exposures.    
96 
 
 
Our evidence collected to this point strongly supported autophagy as an ovotoxic 
mechanism induced by PM, thus, a functional role for PM-induced autophagy was investigated 
using chemical manipulation of pathways reported in the literature to regulate autophagy (Holen 
et al., 1993; Blommaart et al., 1997; Petiot et al., 2000; Codogno and Meijer, 2005; Wang et al., 
2008b).  By administering PM in combination with LY294002, which inhibition autophagy via  
the PI3K pathway (Holen et al., 1993; Blommaart et al., 1997; Petiot et al., 2000), we 
hypothesized that if autophagy was prevented, that PM-induced follicle depletion would be at a 
higher level than in ovaries treated with PM alone.  Surprisingly, there was no impact of the 
LY294002 treatment on PM-induced follicle loss.  Interestingly, this result underscores the 
difference in mechanisms of ovotoxicity induced by chemical exposure.  Increased and 
decreased primordial follicle loss was observed in ovaries treated with DMBA or 4-
vinylcyclohexene diepoxide (VCD), respectively, during LY294002 treatment, relative to 
DMBA and VCD alone (Keating et al., 2009).   
Our next step was to activate autophagy via the use of rapamycin, which inhibits mTOR, 
a negative regulator of autophagy (Chen et al., 1995; Choi et al., 1996; Jung et al., 2010).  We 
expected that if autophagy is an ovotoxic mechanism induced by PM, accelerated PM-induced 
follicle loss would be evident.  In fact, the opposite was the case; PM-induced follicle loss was 
prevented in primordial and small primary follicles in the PM + rapamycin treatment.  mTOR is 
a downstream component of PI3K signaling and is activated and inhibited through 
phosphorylation at different sites (Cheng et al., 2004).  If PM is working through mTOR to 
induce autophagy, it is unsurprising that no impact of PM during PI3K inhibition was noted, 
since mTOR was likely unavailable to PM in this experimental paradigm.  It was interesting that 
rapamycin treatment prevented PM-induced follicle loss, and while this effect could be through 
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autophagy induction, examining autophagy marker induction during rapamycin and PM 
exposure will be a worthwhile next step for future experiments.    
The PI3K and mTOR pathways have gained recent attention in ovarian physiology and 
toxicology, as two pathways suggested to play a key role in follicle activation and influence 
ovotoxicity (Keating et al., 2009; Adhikari et al., 2010; Sobinoff et al., 2011).  An in vivo study 
found in mice that CPA increased  phosphorylation of proteins in the PI3K pathway, including 
mTOR and when the PI3K pathway was perturbed via the drug AS101, CPA-induced follicle 
loss was reduced (Kalich-Philosoph et al., 2013).  However, how AS101 impacts the PI3K 
pathway appears unknown, but similar to this study, manipulation of this pathway, mTOR 
specifically in this study, show promising results as a potential therapeutic to alleviate CPA/PM-
induced infertility.  
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Figures 
  2d mRNA 4d mRNA 
Gene Name Symbol P-value 
Fold 
Change P-value 
Fold 
Change 
Adrenomedullin Adm 0.419797   -1.11 0.054799†   -2.44 
Aquaporin 1 Aqp1 0.438229   -1.92 0.836907   1.02 
Aquaporin 2 (collecting duct) Aqp2 0.628950   -1.41 0.867642   -1.09 
Aquaporin 4 Aqp4 0.409614   1.9 0.480284   1.27 
Aryl hydrocarbon receptor nuclear translocator Arnt 0.402638   1.98 0.912393   -1.03 
Activating transcription factor 4 (tax-responsive enhancer 
element B67) 
Atf4 0.388710 2.31 0.572265 -1.16 
Activating transcription factor 6 Atf6 0.366526   2.26 0.497833   1.17 
ATG12 autophagy related 12 homolog (S. cerevisiae) Atg12 0.196181   2.46 0.222277   1.23 
ATG7 autophagy related 7 homolog (S. cerevisiae) Atg7 0.232411   2.06 0.229800   1.4 
Ataxia telangiectasia mutated homolog (human) Atm 0.310347   1.87 0.171512   1.44 
Bcl-2 binding component 3 Bbc3 0.121654   7.5 0.024119*   5.22 
Beclin 1, autophagy related Becn1 0.210899   2.73 0.314192   1.29 
BH3 interacting domain death agonist Bid 0.467470   1.41 0.854024   -1.05 
BCL2/adenovirus E1B interacting protein 3-like Bnip3l 0.420711   1.58 0.218922   1.15 
Calreticulin Calr 0.476559   1.18 0.740587   1.03 
Carbonic anhydrase 9 Car9 0.249993   2.84 0.147251   1.4 
Caspase 1 Casp1 0.454259   1.36 0.021000* -1.53 
Caspase 7 Casp7 0.225881   2.18 0.345033   1.16 
Chemokine (C-C motif) ligand 12 Ccl12 0.966183   -1.33 0.110543   -1.84 
CD40 ligand Cd40lg 0.151793   3.04 0.079118†   1.28 
Cyclin-dependent kinase inhibitor 1A Cdkn1a 0.103088   21.76 0.009860*   15.04 
Cystic fibrosis transmembrane conductance regulator 
homolog (human) 
Cftr 0.121441 5.79 0.038517* 2.8 
CHK1 checkpoint homolog (S. pombe) Chek1 0.195285   3.35 0.219069   1.35 
CHK2 checkpoint homolog (S. pombe) Chek2 0.184901   4 0.134936   1.74 
C-reactive protein, pentraxin-related Crp 0.306373   11.03 0.150496   1.78 
Damage specific DNA binding protein 2 Ddb2 0.234869   2.32 0.433278   1.09 
DNA-damage inducible transcript 3 Ddit3 0.253815   2.18 0.677588   1.06 
DnaJ (Hsp40) homolog, subfamily C, member 3 Dnajc3 0.162845   5.36 0.279235   1.16 
Endothelin 1 Edn1 0.085487   4.46 0.007401*   1.48 
Erythropoietin Epo 0.420016   2.1 0.077783†   -1.86 
Fas (TNF receptor superfamily, member 6) Fas 0.152999   4.34 0.091059†   1.65 
Ferritin, heavy polypeptide 1 Fth1 0.201300   5.13 0.287588   1.21 
Growth arrest and DNA-damage-inducible, alpha Gadd45a 0.117923 6.36 0.056880† 2.23 
Growth arrest and DNA-damage-inducible, gamma Gadd45g 0.165395   3.96 0.327235   1.28 
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Glutamate-cysteine ligase, catalytic subunit Gclc 0.213655   7.21 0.161268   1.4 
Glutamate cysteine ligase, modifier subunit Gclm 0.200845   3.93 0.235398   1.45 
Growth factor receptor bound protein 2 Grb2 0.129836   4.41 0.296947   1.12 
Glutathione reductase Gsr 0.157221   3.58 0.192857   1.14 
Glutathione S-transferase pi 1 Gstp1 0.169424   5.27 0.002306*   1.41 
Heme oxygenase (decycling) 1 Hmox1 0.230743   5.25 0.586164   -1.15 
Heat shock protein 90, alpha (cytosolic), class A member 1 Hsp90aa1 0.135410 3.66 0.206438 1.16 
Heat shock protein 90, beta, member 1 Hsp90b1 0.219337 3.58 0.449016 1.13 
Heat shock 70kD protein 1B (mapped) Hspa1b 0.078083† 7.89 0.167280 2.15 
Heat shock protein 4 Hspa4 0.162369   4.05 0.628763   1.06 
Heat shock protein 4-like Hspa4l 0.247055   12.07 0.113168   1.67 
Heat shock protein 5 Hspa5 0.156053   3.32 0.493379   1.11 
HUS1 checkpoint homolog (S. pombe) Hus1 0.125403   4.87 0.386687   1.29 
Interferon gamma Ifng 0.112426   5.94 0.298985   1.52 
Interleukin 1 alpha Il1a 0.475107   1.33 0.356756   -1.23 
Interleukin 1 beta Il1b 0.535699   1.21 0.039169*   -1.93 
Interleukin 6 Il6 0.377604   3.52 0.290754   -1.9 
Lactate dehydrogenase A Ldha 0.209343   4.15 0.163127   -1.28 
Myeloid cell leukemia sequence 1 Mcl1 0.136931   4.2 0.103449   1.42 
Matrix metallopeptidase 9 Mmp9 0.649328   1.17 0.064778†   -2.58 
MRE11 meiotic recombination 11 homolog A (S. cerevisiae) Mre11a 0.237973   3.22 0.095880†   1.37 
Nibrin Nbn 0.207718   2.99 0.486507   1.09 
Nuclear factor of activated T-cells 5 Nfat5 0.104889   5.86 0.112377   1.38 
NAD(P)H dehydrogenase, quinone 1 Nqo1 0.190228   5.66 0.034212*   2.43 
Poly (ADP-ribose) polymerase 1 Parp1 0.151388   4.63 0.351783   1.26 
Poly (ADP-ribose) polymerase 2 Parp2 0.152741   4.12 0.360298   1.27 
Peroxiredoxin 1 Prdx1 0.290861   1.75 0.701133   -1.42 
Poliovirus receptor Pvr 0.220251   2.07 0.388302   1.21 
RAD17 homolog (S. pombe) Rad17 0.221535   2.36 0.472564   1.09 
RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae) Rad51 0.194399   2.5 0.104578   1.41 
RAD9 homolog (S. pombe) Rad9 0.227146   3.45 0.158361   1.15 
Receptor (TNFRSF)-interacting serine-threonine kinase 1 Ripk1 0.366649   2.08 0.396183   1.18 
Receptor-interacting serine-threonine kinase 3 Ripk3 0.173003   2.08 0.120046   -1.59 
Serpin peptidase inhibitor, clade E, member 1 Serpine1 0.332730   2.09 0.902335   -1.11 
Solute carrier family 2 (facilitated glucose transporter), 
member 1 
Slc2a1 0.165728 4.15 0.513878 -1.25 
Solute carrier family 5 (sodium/myo-inositol cotransporter), 
member 3 
Slc5a3 0.128854 5.79 0.110675 1.69 
Solute carrier family 9 (sodium/hydrogen exchanger), 
member 3 
Slc9a3 0.265134 4.73 0.502139 1.2 
Sequestosome 1 Sqstm1 0.092462† 6.93 0.478914 1.17 
Toll-like receptor 4 Tlr4 0.642777   -1.45 0.023985*   1.21 
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Tumor necrosis factor (TNF superfamily, member 2) Tnf 0.067945†   -2.22 0.092015†   -1.47 
Tumor necrosis factor receptor superfamily, member 10b Tnfrsf10b 0.463041   -1.19 0.205793   -1.11 
Tumor necrosis factor receptor superfamily, member 1a Tnfrsf1a 0.312884   2.15 0.035641*  1.25 
Tumor protein p53 Tp53 0.179527   2.17 0.219701   -1.07 
Thioredoxin 1 Txn1 0.399887   1.56 0.320947   1.08 
Thioredoxin-like 4B Txnl4b 0.359633   1.82 0.205090   1.3 
Thioredoxin reductase 1 Txnrd1 0.385092   1.71 0.029960*   1.32 
Unc-51 like kinase 1 (C. elegans) Ulk1 0.319923   2.66 0.293571   1.23 
Vascular endothelial growth factor A Vegfa 0.221746   2.14 0.052465†   -1.81 
X-box binding protein 1 Xbp1 0.298901   2.4 0.498726   1.16 
Xeroderma pigmentosum, complementation group C Xpc 0.120776   7.93 0.510219   1.16 
Actin, beta Actb 0.474897   -1.9 0.150776   -1.18 
Beta-2 microglobulin B2m 0.018168* -2.68 0.123497 -1.23 
Hypoxanthine phosphoribosyltransferase 1 Hprt1 0.202150   -1.22 0.149469   1.13 
Lactate dehydrogenase A Ldha 0.663564   -1.06 0.170170   -1.26 
Ribosomal protein, large, P1 Rplp1 0.218626   1.22 0.166232   -1.1 
 
Table 1.  Effect of PM exposure on ovarian expression of stress and toxicity genes.    
PND4 rat ovaries were treated with 1% DMSO (vehicle control) or PM (60 µM) for 2 or 4 d.  
Following RNA isolation, mRNA levels were quantified with an RT
2
 Profiler PCR array.  Values 
represent fold-change to a control value of 1, normalized to Hprt1 and Rplp1.  * = different from 
control, P < 0.05; 
†
= P < 0.1 
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Figure 1.  Effect of PM on ovarian mRNA abundance of Atg7 and Becn1.  
PND4 rat ovaries (n = 3; 10 ovaries per pool) were treated with 1% DMSO (vehicle control; CT) 
or PM (60 µM).  Following 2 or 4 d of culture, mRNA was isolated and (A) Atg7 and (B) Becn1 
levels evaluated by quantitative RT-PCR.  mRNA values represent fold-change ± SEM relative 
to a control value of 1, normalized to Gapdh. # 
 
= P < 0.1 difference from CT. 
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Figure 2.  Effect of PM on ovarian abundance of BECN1 protein.  
PND4 rat ovaries (n = 3; 10 ovaries per pool) were treated with 1% DMSO (vehicle control; CT) 
or PM (60 µM).  Following 2 or 4 d of culture, protein levels of BECN1 were evaluated by (A) 
Representative Western blot of 2 d normalized to Ponceau S and (B) data quantification.  Values 
represent signal intensity ± SEM. # 
 
= P < 0.1 different from control. 
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Figure 3.  Localization and effect of PM on ovarian LAMP1 protein.  
PND4 rat ovaries (n = 3; 2 sections per ovary) were treated with 1% DMSO (vehicle control;CT) 
or PM (60 µM).  Following 2 or 4 d of culture, ovaries were fixed in formalin, and 
immunofluorescence staining was performed using a primary antibody directed against LAMP1: 
(A) 2d CT; (B) 2d LAMP; (C) 4d CT and (D) 4d LAMP1.  LAMP1 is represented in red and the 
Hoechst nuclear stain is in blue.  (E) Quantification of the number of LAMP1 foci was 
performed. 
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Figure 4. Histological evaluation by 
TEM in small preantral follicles 
following PM exposure.  
PND4 rat ovaries were treated with 
1% DMSO (vehicle control, CT) or 
PM (60 µM).  Following 1, 2, 3 and 4 
d of culture, ovaries were fixed and 
processed for TEM (A) 1d CT 
primordial follicle; (B) 1d CT small 
primary follicle; (C) 1d PM 
primordial (D) 1d PM small primary 
(E) 2d PM primordial (F) 2d PM 
small primary (G) 3d primordial (H) 
3d small primary (I) 4d primordial (J) 
4d small primary; Hollow arrow = 
autophagosomes; G = abnormal golgi 
apparatus; Thin black arrow = double 
membrane; Thin dashed black arrow 
= electron dense structures; Solid 
thick black arrow = multilamellar 
structures; Arrow head = global 
vacuolization of oocyte. 
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Figure 5.  Detection of autophagosomes by TEM in large preantral follicles following PM 
exposure.  
PND4 rat ovaries were treated with 1% DMSO (vehicle control, CT) or PM (60 µM).  Following 
1, 2, 3 and 4 d of culture, ovaries were fixed and processed for TEM (A) 3d CT; (B) 4d CT; (C) 
3d PM and (D) 4d PM.  Black double-ended arrows indicate the width of the granulosa cell 
layer; Hollow arrows = autophagosomes; G = abnormal golgi apparatus 
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Figure 6.  Effect of autophagy induction via rapamycin (Rapa) during PM exposure on 
follicle number.    
PND4 rat ovaries were cultured and treated on alternate days with 1% DMSO (vehicle control, 
CT), PM (60 µM), Rapa (1 µM) or PM (60 µM) + Rapa (1 µM).  Following 4 d of culture, 
follicles were classified and counted: (A) Primordial Follicles; (B) Small Primary Follicles; (C) 
Large Primary Follicles; (D) Secondary Follicles.  Values represent mean ± SE total follicles 
counted/ovary, n = 4-6. 
 
Different letters represent significant difference between treatments P < 
0.05. * = P < 0.10 difference from CT. 
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Figure 7.  Effect of autophagy inhibition via LY294002 (LY) during PM exposure on 
follicle number.    
PND4 rat ovaries were cultured and treated on alternate days with 1% DMSO (vehicle control, 
CT), PM (60 µM), LY (20 µM) or PM (60 µM) + LY (20 µM).  Following 4 d of culture, 
follicles were classified and counted: (A) Primordial Follicles; (B) Small Primary Follicles; (C) 
Large Primary Follicles; (D) Secondary Follicles.  Values represent mean ± SE total follicles 
counted/ovary, n = 4-6. 
 
Different letters represent significant difference between treatments P < 
0.05. * = P < 0.10 difference CT. 
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Abstract 
Chronic exposure to the polycyclic aromatic hydrocarbon 7,12-
dimethylbenz[a]anthracene (DMBA), generated during combustion of organic matter including 
cigarette smoke, depletes all ovarian follicle types in the mouse and rat, and in vitro models 
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mimic this effect.  To investigate the mechanisms involved in follicular depletion during acute 
DMBA exposure, two concentrations of DMBA at which follicle depletion has (75 nM) and has 
not (12.5 nM) been observed were investigated.  Postnatal day four F344 rat ovaries were 
maintained in culture for four days before a single exposure to vehicle control (1% DMSO; CT) 
or DMBA (12 nM; low-concentration or 75 nM; high-concentration).  After four or eight 
additional days of culture, DMBA-induced follicle depletion was evaluated via follicle 
enumeration.  Relative to control, DMBA did not affect follicle numbers after 4 days of 
exposure, but induced large primary follicle loss at both concentrations after 8 days; while, the 
low-concentration DMBA also caused secondary follicle depletion.  Neither concentration 
affected primordial or small primary follicle number.  RNA was isolated and quantitative RT-
PCR performed prior to follicle loss to measure mRNA levels of genes involved in xenobiotic 
metabolism (Cyp2e1, Gstmu, Gstpi, Ephx1), autophagy (Atg7, Becn1), oxidative stress response 
(Sod1, Sod2) and the phosphatidylinositol 3-kinase (PI3K) pathway (Kitlg, cKit, Akt1) 1, 2 and 
4 days after exposure.  With the exception of Atg7 and cKit, DMBA increased (P < 0.05) 
expression of all genes investigated.  Also, BECN1 and pAKTThr308 protein levels were 
increased while cKIT was decreased by DMBA exposure.  Taken together, these results suggest 
an increase in DMBA bioactivation, add to the mechanistic understanding of DMBA-induced 
ovotoxicity and raise concern regarding female low concentration DMBA exposures.   
 
Introduction 
The ovary contains a finite number of oocyte-containing follicles. Appropriate maturation 
and survival through the primordial, small primary, large primary, secondary, and antral 
follicular stages is essential for both conception and female health.  The primordial is most 
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immature follicular stage, in which the oocyte remains arrested in meiosis and waits for an 
appropriate signal to enter into the growing follicular pool toward ovulation.  Once the ovarian 
primordial follicular reserve is depleted, ovarian failure occurs, rendering the female both 
infertile and at an increased risk for development of a variety of health conditions including 
osteoporosis and heart disease (Greendale et al., 1999).   
Follicles are vulnerable to toxic exposures at all developmental stages.  7,12-
dimethylbenz[a]anthracene (DMBA), a polycyclic aromatic hydrocarbon (PAH), is produced 
from the burning of organic material (Gelboin, 1980), thus cigarette smoke is an exposure 
source.  DMBA depletes all ovarian follicle types in mice and rats (Mattison and Schulman, 
1980) and is the most ovotoxic of three PAH cigarette smoke-components (DMBA, 3-
methylcholanthrene and benzo[a]pyrene (Borman et al., 2000).  An acute high-concentration 
exposure to DMBA in vivo destroyed primordial oocytes in rats and mice (Mattison, 1979; 
Mattison and Thorgeirsson, 1979), and use of an ovary culture system has demonstrated that 
repeated exposures of DMBA to F344 rat ovaries caused primordial follicle loss at 
concentrations of 75 nM and higher (Igawa et al., 2009).  In support of the ovotoxicity of DMBA 
(and other cigarette smoke components), ovarian failure onset is accelerated in female cigarette 
smokers (Jick and Porter, 1977).        
In order for ovotoxicity to ensue, DMBA must be bioactivated to an ovotoxic metabolite; 
DMBA-3,4-diol, 1,2-epoxide (Miyata et al., 1999; Igawa et al., 2009), by a number of enzymes 
including microsomal epoxide hydrolase (Ephx1).  Using the in vitro postnatal day (PND) 4 
ovarian culture system, competitive inhibition of EPHX1 by cyclohexene oxide reduced DMBA-
induced follicle loss in ovaries from mice (1 μM DMBA; Rajapaksa et al., 2007) and rats (1 μM 
DMBA; Igawa et al., 2009).  Furthermore, mRNA levels of Ephx1 increased after 2 days of 
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DMBA exposure, prior to follicle loss which occurs after 4 days, relative to control (Rajapaksa et 
al., 2007; Igawa et al., 2009).  Additionally, cytochrome P450 isoform 2E1 (Cyp2e1)-null mice 
had increased sensitivity to DMBA-induced primordial and small primary follicle loss (Keating 
et al., 2008).  This was at least in part due to increased Ephx1 levels in the Cyp2e1-null ovaries.  
Thus, the action of ovarian EPHX1 is critical for DMBA to impart its ovotoxicant effects, and 
Cyp2e1 and Ephx1 regulation are in some way interrelated (Keating et al., 2008).   
Previous studies have suggested that the phosphatidylinositol 3-kinase (PI3K) pathway 
plays a role in Ephx1 expression regulation (Kim et al., 2003; Bhattacharya et al., 2012).  
Specifically, PI3K inhibition using LY294002 in cultured F344 rat ovaries resulted in increased 
Ephx1 mRNA and protein expression (Bhattacharya et al., 2012), while decreased EPHX1 was 
observed following PI3K inhibition in rat hepatocytes (Kim et al., 2003).  Despite these tissue-
specific responses, a link between Ephx1 gene expression and the PI3K pathway is supported.   
In addition to its role in xenobiotic biotransformation via Ephx1 regulation, the PI3K 
pathway is vital for follicle survival and recruitment, particularly pre-antral follicles (Yoshida et 
al., 1997; Parrott and Skinner, 1999; Castrillon et al., 2003; Keating et al., 2009).  Initiation of 
the PI3K signaling pathway occurs once the granulosa-derived signaling molecule Kit ligand 
(KITLG) binds the oocyte-expressed stem cell receptor (cKIT; Ismail et al., 1996).  Following 
KITLG-cKIT interaction, the PI3K signaling cascade is activated leading to phosphorylation of 
the downstream effector molecule protein kinase B (AKT) and subsequently the forkhead 
transcription factor 3a (FOXO3a), both important for control of primordial follicle survival and 
recruitment, respectively (Castrillon et al., 2003; Reddy et al., 2005; Liu et al., 2006; John et al., 
2008).  Foxo3a-null mice suffer from follicular depletion and ovarian failure as a result of global 
follicle activation (Castrillon et al., 2003), while oocyte-specific FOXO3a overexpression 
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restricts primordial follicles from entering the recruitment pool, also rendering the female 
infertile (Liu et al., 2006).   
The ovarian response to oxidative stress is also important for follicle viability.  Reactive 
oxygen species (ROS) have been shown to increase prior to DMBA-induced follicle loss in vitro, 
suggesting that DMBA exposure (0.1-100 µM) induces oxidative stress within the ovary (Tsai-
Turton et al., 2007).  Co-treatment with DMBA (10 µM) and glutathione (GSH; which detoxifies 
ROS) alleviated DMBA-induced follicle loss (Tsai-Turton et al., 2007), further supporting that 
DMBA induces ROS generation.  Reactive xenobiotics can also be detoxified through GSH 
conjugation catalyzed by the glutathione S-transferase (GST) family of enzymes (Reddy et al., 
1983).  GST isoform pi (Gstp) mRNA and protein increase following DMBA exposure in the 
cultured neonatal F344 rat ovary prior to the onset of follicle loss (Bhattacharya and Keating, 
2012).  Furthermore, mice that are deficient in GSTPI have increased levels of DMBA-induced 
skin tumors (Henderson et al., 1998), indicating that GSTP-catalyzed GSH conjugation to 
DMBA is a potential detoxification event.  
In addition to ROS alleviation by GSH, superoxide dismutases (SOD1 – cytoplasmic; 
SOD2 - mitochondrial) can act directly on superoxide anion radicals to form water and hydrogen 
peroxide.  Studies have shown that Sod1-null mice exhibit reduced fertility (Ho et al., 1998; 
Matzuk et al., 1998), while although Sod2-deficient mice die pre-pubertally, when SOD-
deficient ovaries are transplanted to wild-type mice, reproductive abnormalities are not observed 
(Matzuk et al., 1998).   
As an alternative to apoptosis (Morita and Tilly, 1999; Hu et al., 2001), another form of 
programmed cell death, autophagy, may contribute to follicle depletion.  When activated, 
autophagy induces the formation of an autophagosome, which, once fused with the lysosome, 
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can consume internal components of a cell (Levine and Klionsky, 2004).  Several proteins are 
involved in the process of autophagy including Autophagy-related protein 7 (ATG7) and Beclin-
1 (BECN1; Kim et al., 1999; Liang et al., 1999).  ATG7 and BECN1 are of particular interest in 
the ovary due to previous evidence suggesting their involvement in autophagy for female germ 
cell survival (Gawriluk et al., 2011).  Further evidence supporting involvement of autophagy 
during DMBA-induced ovotoxicity has come from work demonstrating that cigarette smoke 
exposure (a source of DMBA) induced autophagy in the ovaries of exposed mice (Gannon et al., 
2012; 2013). Thus autophagy could potentially be involved during DMBA-induced follicle loss.    
It is difficult to estimate human DMBA ovarian exposure due to differences in hepatic 
bioactivation between individuals.  For this reason, the ovotoxic effects of repeated DMBA 
exposures have been investigated using the PND4 in vitro ovary culture system at a 
concentration (1 µM) that causes approximately 50% primordial follicle loss after 4 days 
(Rajapaksa et al., 2007; Igawa et al., 2009).  Additionally, these exposures have been previously 
administered from the onset of culture when the ovary is largely comprised of primordial 
follicles.  The current study was designed to delay exposure to DMBA until after 4 days of 
culture in order to determine the impact of DMBA exposure on large primary and secondary 
follicles.  Also, single DMBA exposures were used to determine the impact of low concentration 
acute exposures to DMBA, similar to that of passive cigarette smoke exposure, on ovarian 
function.  The ovarian response to acute DMBA exposure was examined by quantifying follicle 
numbers and measuring the mRNA levels of genes involved in 1) xenobiotic biotransformation -  
Cyp2e1, Ephx1, Gstpi and Gstmu; 2) PI3K signaling - Akt1, cKit and Kitlg; 3) the oxidative 
stress response - Sod1 and Sod2; and 4) autophagy -  Atg7 and Becn1.  Also, levels of EPHX1, 
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BECN1, cKIT and pAKTThr308 in ovaries treated with control, low (12.5 nM) or high (75 nM) 
DMBA were evaluated.  
 
Materials and Methods 
Reagents:  
7,12-dimethylbenz[a]anthracene (DMBA), bovine serum albumin (BSA), ascorbic acid, 
transferrin, 2-β-mercaptoethanol, 30% acrylamide/0.8% bisacrylamide, ammonium persulphate, 
glycerol, N’ N’ N’ N’-Tetrathylethylenediamine (TEMED), Tris base, Tris HCL, sodium 
chloride, Tween-20 were purchased from Sigma Aldrich Inc. (St. Louis, MO).  Dulbecco’s 
Modified Eagle Medium: nutrient mixture F-12 (Ham) 1x (DMEM/Ham’s F12), Albumax, 
penicillin (5000U/ml) Hank’s Balanced Salt Solution (without CaCl2, MgCl2, or MgSO4) were 
obtained from Invitrogen Co. (Grand Island, NY).  Millicell-CM filter inserts and 48-well cell 
culture plates were obtained from Millipore (Billerica, MA) and Corning Inc. (Corning, NY), 
respectively.  RNeasy Mini kit, QIA Shredder kit, RNeasy Mini Elute kit, and Quantitect ™ 
SYBR Green PCR kit were purchased from Qiagen Inc. (Valencia, CA).  RNAlater was obtained 
from Ambion Inc. (Grand Island, NY).  With the exception of cKit  and Kitlg which were 
obtained from Integrated DNA Technologies (Coralville, IA), all primers were obtained from the 
DNA facility of the Iowa State University office of biotechnology (Ames, IA).  Anti-EPHX1 
antibody was from Detroit R&D (Detroit, MI).  Anti-pAKT
Thr308
 was purchased from Abcam 
Technology (Cambridge, MA) and Cell Signaling Technology (Danvers, MA).  Anti-BECN1 
and anti-cKIT were obtained from Santa Cruz (Dallas, TX) and Cell Signaling Technology 
(Danvers, MA), respectively. 
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Animals:  
Fisher 344 (F344) rats (approximately 6 months of age) were housed in plastic cages and 
maintained in a controlled environment (22 ± 2ºC; 12h light/12h dark cycles).  The animals were 
provided a standard diet with ad libitum access to food and water, and housed with a proven 
male for 5 days (two females per male).  Approximately 2-3 days before parturition date, females 
were separated and housed one per cage and allowed to give birth.  The University of Arizona 
and Iowa State University Institutional Animal Care and Use Committee’s approved all 
experimental procedures.   
 
In vitro ovarian cultures:   
Ovaries were collected from female PND4 F344 rats and cultured as described by Devine et al., 
2002.  The PND4 rat pups were euthanized by CO2 inhalation followed by decapitation.  Ovaries 
were removed, trimmed of oviduct and other excess tissue, and placed onto a Millicell-CM 
membrane floating on 250 µl of previously 37ºC equilibrated DMEM/Ham’s F12 medium 
containing 1 mg/ml BSA, 1 mg/ml Albumax, 50 µg/ml ascorbic acid, 5 U/ml penicillin and 27.5 
µg/ml transferrin per well in a 48-well plate.  A drop of medium was placed on top of each ovary 
to prevent dehydration.  Ovaries were cultured at 37ºC and 5% CO2 for 4 days, then treated with 
vehicle control media (1% DMSO), low DMBA (12.5 nM) or high DMBA (75 nM) for an 
additional 1, 2, 4 or 8 days.  This time of exposure ensured that large primary and secondary 
ovarian follicles were present at time of treatment. 
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Histological evaluation of follicle numbers: 
 Following 4 or 8 days of culture, ovaries were placed in 4% paraformaldehyde for 2 hours, 
washed and stored in 70% ethanol, paraffin embedded, and serially sectioned (5 µM).  Every 6
th
 
section was mounted and stained with hematoxylin and eosin.  Healthy oocyte-containing 
follicles were identified and counted in every 6
th
 section.  Follicles were considered primordial if 
they contained an oocyte surrounded with a single layer of squamous-shaped granulosa cells; 
small primary if they contained an oocyte surrounded by ≤ 10 cuboidal-shaped granulosa cells; 
large primary if they contained an oocyte surrounded by  10 cuboidal shaped-granulosa cells; 
and secondary if they contained an oocyte surrounded by multiple layers of granulosa cells.  
Unhealthy/atretic follicles were distinguished from healthy follicles by the appearance of 
pyknotic bodies and intense eosinophilic staining of oocytes.  Healthy follicles were classified 
and enumerated according to Flaws et al., 1994.  Slides were blinded to prevent counting bias.   
 
RNA isolation and polymerase chain reaction (PCR):  
Following 1, 2 or 4 days post-treatment, ovaries were stored in RNAlater at -80ºC.  Total RNA 
was isolated from ovaries (n=3; 6 ovaries per pool) using an RNeasy Mini kit according to the 
manufacturer’s instructions.  RNA was eluted in 14 µl of RNase-free water and concentration 
quantified using a NanoDrop (λ = 260/280 nm; ND 1000; Nanodrop Technologies Inc., 
Wilmington, DE).  Total RNA (150 ng) was reverse transcribed to cDNA using the Superscript 
III One-Step RT-PCR System.  Genes of interest were amplified using an Eppendorf 
mastercycler (Hauppauge, NY) using a Quantitect ™ SYBR Green PCR kit (Qiagen Inc. 
Valencia, CA).  The primers used are listed in Table 1.  The PCR conditions used were a 15 min 
hold at 95ºC and 40 cycles of denaturing at 95ºC for 15 s, annealing  at 58 ºC for 15 s, and 
121 
 
 
extension at 72ºC for 20 s.  Changes in gene expression were quantified using the 2
-ΔΔCt 
method 
(Livak and Schmittgen, 2001; Pfaffl, 2001).  It should be noted that DMBA exposure impacted 
expression of a number of housekeeping genes (β-actin, cyclophilin B, and hypoxanthine 
phosphoribosyltransferase 1, data not shown), with the exception of Gapdh and 18S rRNA.  
Gapdh was chosen as the housekeeping gene.    
 
Immunofluorescence staining: 
Following treatment, ovaries were placed in 4% paraformaldehyde for 2 hours, washed and 
stored in 70% ethanol, paraffin embedded and serially sectioned (5 µM).  Two sections per ovary 
(n = 3) were deparaffinized and incubated with primary antibodies (1:50 dilution) directed 
against EPHX1, pAKT
Thr308
, BECN1 or cKIT at 4°C overnight.  The blocking solution used was 
5% BSA.  Secondary FITC antibody was applied for 1 h, followed by Hoechst (30 minutes; 
5mg/ml).  Slides were repeatedly rinsed with PBS, cover-slipped, and stored in the dark (4°C) 
until visualization.  Primary antibody was not added to immunonegative ovarian sections.  
Immunofluorescence was visualized on a Leica DMI300B fluorescent microscope at λ = 488 and 
633 nm for FITC and Hoechst, respectively.  All images were captured using a 10× objective 
lens.  Protein staining was quantified using ImageJ software by circling the follicle under 
analysis and measuring integrated density.  An identical measurement area was maintained 
between follicles of a particular stage.  Integrated density of EPHX1, pAKT, and cKIT protein 
staining was measured in ten small (primordial and small primary) follicles and five large (large 
primary and secondary) follicles per section.  The average number of follicles analyzed per ovary 
was 20 small and 10 large.  BECN1 protein abundance was evaluated via quantification of the 
total number of foci present in each section.  Statistical analysis was performed by comparison 
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between control and treatment on day of staining.  When statistical difference was observed for 
all three staining repetitions, an effect of treatment on the protein of interest was concluded.  For 
ease of presentation, control treatment is presented as 100% and the DMBA treatments are 
expressed as a percentage of control.  Statistical difference is from the raw data.   
 
Statistical analysis: 
Comparisons were made between treatments for follicle count experiments using Analysis of 
Variance (ANOVA).  Quantitative RT-PCR and immunofluorescence staining data were 
analyzed by t-test comparing treatment with control raw data at each individual time-point.  All 
statistical analyses were performed using Prism 5.04 software (GraphPad Software).  Statistical 
significance was defined as P < 0.05.   
 
Results 
Effect of acute DMBA exposure on ovarian histology and follicle number 
To investigate the effects of acute low and high DMBA exposures on follicle viability and 
ovarian morphology, PND4 ovaries were exposed once after 4 days of culture and the ovaries 
were maintained for an additional 4 (Figure 1A - D) or 8 (Figure 2A - H) days.  There was no 
impact of a single exposure to DMBA at either concentration on primordial, small primary or 
large primary follicles after 4 days in culture.  Interestingly, there were increased (P < 0.05) 
secondary follicle number at the low DMBA concentration.  Additionally, DMBA did not induce 
primordial or small primary follicle loss at either concentration 8d after exposure (Figure 2A-
1F).  Both DMBA concentrations induced large primary follicle loss (P < 0.05; Figure 2G).  
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Interestingly, only the low DMBA concentration induced secondary follicle loss (P < 0.05; 
Figure 2H).   
 In addition to follicle depletion, DMBA single exposure caused morphological alterations 
in both large primary and secondary follicles.  Shrunken, eosinophilic oocytes resulting from an 
apparent loss of connection between the oocyte and granulosa cells occurred at both 
concentrations.  Intense eosinophilic staining of follicles also indicated significantly more atretic 
follicles in ovaries exposed to DMBA (Figure 2D). 
 
Effect of acute DMBA exposures on mRNA expression 
Temporal pattern of single DMBA exposure on expression of genes involved in chemical 
metabolism 
Cyp2e1 mRNA was increased (P < 0.05) by both DMBA treatments after 4d of exposure, and 
there was a trend (P < 0.1) for an increase after 2d.  Interestingly, the low DMBA exposure 
induced a greater increased in Cyp2e1 at the 4d time point (Figure 3A).  Gstpi was increased (P 
< 0.05) in a temporal and concentration dependent pattern by the high and low DMBA exposures 
increasing Gstpi mRNA level after 1d and 4d, respectively (Figure 3B).  There was no impact of 
DMBA exposure on Gstmu mRNA until 4d in the low exposure when Gstmu was increased (P < 
0.05; Figure 3C).  Ephx1 mRNA was increased (P < 0.05) by low DMBA after 4d, with a trend 
(P < 0.1) for a lesser increase at the high DMBA concentration after 2d of exposure (Figure 3D).   
   
Induction of genes involved in oxidative stress response by DMBA exposure 
Both DMBA exposures increased (P < 0.05) Sod1 mRNA after 2d, however, this increase was 
returned to control levels after 4d in the high DMBA exposure, while there was a trend (P < 0.1) 
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for increased Sod1 to be maintained after 4d at the low DMBA exposure (Figure 4A).  Sod2 was 
increased at the high DMBA exposure after 2d, and there was a trend for an increase in Sod2 by 
the low DMBA (P = 0.1) after 2d (Figure 4B).   
 
Induction of autophagy genes by single DMBA exposure 
There was no impact of high DMBA exposure on Atg7 mRNA expression, however, the low 
concentration tended (P < 0.1) to reduce Atg7 mRNA after 2d with a further decrease (P < 0.05) 
after 4d (Figure 5A).  Becn1 mRNA was increased by low DMBA after 2d (P < 0.1) and 4d (P < 
0.05) while high DMBA tended to increase Becn1 after 2d with a return to basal levels after 4d 
(Figure 5B).      
 
Impact of DMBA exposure on PI3K gene expression 
There was a temporal concentration dependent pattern of Kitlg induction with the high DMBA 
exposure increasing Kitlg after 2d, while the low DMBA exposure lagged and induced Kitlg 
mRNA after 4d.  There was also a trend for induced Kitlg after 2d in the low DMBA exposure 
(Figure 6A).  Neither concentration of DMBA affected cKit mRNA level (Figure 6B), while 
there was also a temporal concentration dependent pattern of Akt1 mRNA induction (Figure 6C).  
The high DMBA exposure induced increased (P < 0.05) Akt1 mRNA after 1d, was at control 
levels after 2d but increased (P < 0.05) again after 4d of exposure.  At the low DMBA 
concentration, Akt1 was increased (P < 0.05) after 2 and 4d of exposure (Figure 6C).          
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Effect of acute DMBA exposure on protein localization and level 
EPHX1 protein was localized to the oocyte cytoplasm and interstitial tissue.  No impact of 
DMBA exposure on EPHX1 protein was observed in the oocyte cytoplasm or in the ovary as a 
whole at either DMBA concentration (Figure 7A-D).  BECN1 protein appeared as punctate foci 
localized mainly in the granulosa cell layer.  A greater number of BECN positive foci were 
observed in ovaries treated with 12.5 nM DMBA, relative to control or 75 nM DMBA treated 
ovaries (Figure 7E-H).  cKIT was localized to the oocyte cytoplasmic membrane of primordial 
and small primary follicles.  There was a trend for decreased cKIT protein concentration in 75 
nM DMBA treated ovaries but no impact of 12.5 nM DMBA related to control treated ovaries 
(Figure 7I-L).  Finally, pAKT
Thr308
 was present in the oocyte cytoplasm of follicles of all stages.  
Quantification of pAKT
Thr308 
demonstrated higher levels (P < 0.05) in the oocytes of small and 
large follicles exposed to 12.5 nM DMBA relative to control and in the large follicles in 75 nM 
DMBA-treated ovaries (Figure 7M-P).          
         
Discussion 
DMBA is an ovotoxicant that causes follicle depletion, ultimately resulting in ovarian 
failure (Keating et al., 2008; Igawa et al., 2009; Nteeba et al., 2014).  This study was designed to 
focus on effects of DMBA on large primary and secondary follicles by allowing these follicles to 
develop in culture before DMBA exposure.  Previously, follicle loss was observed after 
continuous exposure (alternate days) to 75 nM DMBA but not 12.5 nM (Igawa et al., 2009).  
Relative to control, we observed that a single concentration of DMBA at either concentration did 
not deplete primordial or small primary follicles at either timepoint examined, while both DMBA 
concentrations depleted large primary follicles.  The low DMBA concentration caused loss of 
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secondary follicles also.  These data support that even low level acute DMBA exposures can 
affect and deplete the number of large primary and secondary follicles, potentially causing 
temporary infertility in exposed females.  While previous studies have shown that all stage 
follicles are depleted by DMBA (Rajapaksa et al., 2007; Igawa et al., 2009), our data may 
suggest that the larger follicles could be the initial targets of DMBA, and that depletion of 
smaller follicles stages may be a consequence of loss of larger follicles, that is, increased 
recruitment from the pool of smaller follicles may occur to replace the larger follicles that have 
been lost.  Alternatively, it may be that higher DMBA concentrations can directly deplete the 
primordial and small primary follicle pools, as has been observed previously (Igawa et al., 2009).  
Taken together, these data support that acute, low-level DMBA exposure represents a valid 
female health concern and warrants attention. 
  It was both interesting and surprising that there appeared to be a difference in depletion 
of the large primary and secondary follicles between low and high DMBA exposures, which led 
to the hypothesis that DMBA may induce concentration-dependent differential ovarian gene 
expression in the neonatal rat ovary.  Over a time course of DMBA exposure, we discovered that 
both concentrations increased Cyp2e1 mRNA level, and this was highest at the low DMBA 
concentration.  Though there is little data in the literature to suggest that CYP 2E1 is involved in 
DMBA biotransformation, our data showing that ovarian Cyp2e1 mRNA level increases in 
response to DMBA exposure suggests that this gene is responsive to DMBA exposure and may 
support a role for CYP2E1 in DMBA metabolism. In support of this possibility, Cyp2e1-null 
mice exposed to DMBA (0.5µM and higher) exhibited greater primordial and small primary 
follicle loss relative to controls (Keating et al., 2008).  
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The GST family of enzymes mediate xenobiotic metabolism by conjugating GSH to 
compounds, promoting excretion from the body (Reddy et al., 1983).  In cultured rat pre-
ovulatory follicles, co-treatment with GSH during DMBA exposure lessened follicle apoptosis 
(Tsai-Turton et al., 2007) suggesting the possible involvement of GST enzymes in catalyzing 
detoxification of DMBA.  Gstpi has previously been identified to be involved in the ovarian 
response to DMBA exposure in neonatal rat ovaries (Bhattacharya and Keating, 2012), and adult 
mice exposed to DMBA (Nteeba et al., 2014).  Gstpi-null mice are also more sensitive to 
DMBA-induced skin tumors (Henderson et al., 1998).  GSTMU has also been demonstrated to 
be increased in response to DMBA in the ovaries from obese adult mice (Nteeba et al., 2014).  In 
addition to the role of GSTPI and GSTMU in catalyzing GSH conjugation to xenobiotics, they 
can also play a role in inhibiting the pro-apoptotic proteins c-Jun N-terminal Kinase (JNK) 
(Keating et al., 2010; Bhattacharya and Keating, 2012) and apoptosis signal-regulating kinase 1 
(ASK1) (Bhattacharya et al., 2013).   
The current study determined that Gstmu is increased by the low DMBA exposure, with 
no impact of a higher exposure.  Gstpi follows a temporal and concentration dependent pattern of 
increase with an increase in the high DMBA after 1d, but low DMBA after 4d.  These data 
demonstrate that even low-level exposures activate the ovarian response to xenobiotic exposure, 
and underscore the importance of the timepoint examined in terms of an ovarian response to an 
ovotoxic exposure.  GSTMU and GSTPI are thus likely involved in ovarian DMBA 
biotransformation, however, it remains unclear which role (regulation of detoxification or 
apoptosis) of GSTPI and GSTMU predominates during ovarian DMBA exposure.  However, it is 
clear that these data are in agreement with those previously demonstrated in cultured rat pre-
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ovulatory follicles, though the DMBA concentrations used in that study were higher than our 
treatments (Tsai-Turton et al., 2007).     
EPHX1 is increased in response to ovarian DMBA exposure and bioactivates DMBA to 
the ovotoxic metabolite DMBA-3,4-diol, 1,2-epoxide (Rajapaksa et al., 2007; Igawa et al., 2009; 
Nteeba et al., 2014).  Interestingly, although a trend for an increase in Ephx1 mRNA at the 75 
nM DMBA concentration was observed, the low DMBA had a greater increase in Ephx1 after 4d 
of exposure.  This could potentially result in increased bioactivation of DMBA to the more 
ovotoxic metabolite.     Although increased EPHX1 protein was not observed in the current study 
it is possible that basal EPHX1 is depleted by low concentrations of DMBA at a higher rate than 
high DMBA, and that this potentially results in increased Ephx1 mRNA as a feedback 
mechanism, though this has not previously been reported for Ephx1.  If this is the case, ovaries 
treated with low DMBA could therefore be exposed to higher amounts of the ovotoxic DMBA 
metabolite, while lack of any increase in Ephx1 mRNA in the high DMBA-treated ovaries may 
indicate less biotransformation of DMBA to the active form above the normal ovarian level due 
to basal EPHX1 contribution.   
 Oxidative stress contributes to DMBA-induced follicular apoptosis likely through 
formation of ROS (Tsai-Turton et al., 2007), and Sod1 and Sod2 play essential roles in the 
detoxification of ROS.  Sod1 was increased by low DMBA after 2d with a trend for an increase 
after 4d of exposure, and after 4d by the high DMBA.  Interestingly, Sod2 was increased by high 
DMBA with only a trend for an increase by low DMBA exposure at the same timepoint.  These 
data suggest that ROS are formed following DMBA treatment and the ovary induces an 
oxidative stress response to combat the harmful oxygen molecules.  Previous studies have shown 
that large pre-antral and antral follicles are particularly sensitive to ROS, in contrast to 
129 
 
 
primordial and small primary follicles which are more resistant, thus an increase in ROS at the 
low DMBA exposure may partially explain the loss of secondary follicles (Devine et al., 2002; 
Tsai-Turton et al., 2007).  These findings provide additional evidence that DMBA induces 
production of ROS in the ovary, and that oxidative stress may play a role in DMBA-induced 
follicle depletion. 
 Cigarette smoke exposure increases expression of genes involved in the autophagy 
response in mouse ovaries (Gannon et al., 2012).  We observed that, in the cultured rat ovary, 
compared to control, Atg7 is decreased by low but not high DMBA exposure.   Becn1 mRNA 
levels increased after both treatments, again demonstrating temporal pattern of elevation which 
peaks in the high before the low DMBA.  In addition, increases in BECN1 foci were observed at 
the low DMBA exposure.  Autophagy may be activated as a means of follicle depletion and 
involved in DMBA-induced follicle loss, consistent with data in cigarette-smoke exposed mouse 
ovaries (Gannon et al., 2012).  These results add to the growing number of studies generating 
evidence for ovarian autophagy playing an active role in follicle depletion.  
 PI3K signaling is essential for primordial and small primary follicle viability, regulation 
of follicular recruitment into the growing pool (Yoshida et al., 1997; Parrott and Skinner, 1999; 
Castrillon et al., 2003) and for regulation of ovarian xenobiotic metabolism gene expression 
(Bhattacharya and Keating, 2012).  The key components of this signaling pathway investigated 
in this study were the granulosa expressed ligand, Kitlg; the oocyte receptor, cKit; and the 
signaling molecule, Akt1.  It is worth noting that the earliest observed mRNA change in this 
study was that of Akt1.  Low DMBA exposure increased mRNA levels of Kitlg and Akt1 while 
high DMBA exposure also increased Kitlg, earlier than the low treatment, and increased Akt1 
also at an earlier timepoint.  Interestingly, no impact of either DMBA exposure on cKit was 
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observed.  However, cKIT protein was reduced, but the proxy molecule for PI3K activation, 
pAKTThr308 was increased by both DMBA concentrations, supporting increased PI3K 
activation.  This increase in the PI3K pathway could partially explain why the primordial and 
small primary follicles were protected from DMBA exposure.  PI3K inhibition increases 
DMBA-induced primordial and small primary follicle loss (Keating et al., 2009), thus our data 
supports that finding because the induction of the PI3K pathway observed may have prevented 
primordial and primary follicle loss.  
 The data herein support that acute low-level exposure to DMBA is a concern for female 
fertility due to depletion of large primary and secondary follicles, and is consistent with the 
reduced fecundity experienced by many female smokers (Baird and Wilcox, 1985; Alderete et 
al., 1995).  While large primary were depleted by both DMBA exposures, and secondary 
follicles lost only during the low exposure, it is worth considering that the numbers within these 
follicle classes are low, thus small changes can appear significantly different, thus, we consider it 
premature to assume that differential follicle loss occurred.  Undoubtedly however, low 
concentrations of DMBA depleted large ovarian preantral follicles.  Also, genes involved in 
xenobiotic biotransformation, the oxidative stress response, autophagy and PI3K signaling are 
activated as part of the ovarian response to DMBA exposure.  
 
 
 
 
 
 
 
 
131 
 
 
Figures 
 
Primers used in real-time PCR 
Gene Forward (5'-3') Reverse (5'-3') 
Ephx1 GGCTCAAAGCCATCAGGCA CCTCCAGAAGGACACCACTTT 
GSTp GGCATCTGAAGCCTTTTGAG  GAGCCACATAGGCAGAGAGC 
GSTm TTCAAGCTGGGCCTGGAC  CAGGATGGCATTGCTCTG 
Cyp2e1 CGTGTGTGTGTTGGAGAAGG TACTGCCAAAGCCAACTGTG 
Sod1 GGAGAGCATTCCATCATTGG CAATCACACCACAAGCCAAG 
Sod2 GCCTTTGTGAATTTGCCTTT CTGACCACAGCCTTTTTGGT 
Atg7 CTTCCTGGCCAAGGTGTTTA GTTGCTCAGACGGTCTCCTC 
Becn1 TAATGTGGGGAAGGGACAAG AAATCCTTCCACATCTCAAACA 
Kitlg GGCCTACAATGGACAGCAAT TCAACTGCCCTTGTAAGACTT 
cKit CTTTTGCGCAAGCTTTTGT ATCCCCCGCTCCAAAGTAT 
Akt1 ACCTCTGAGACCGACCGACACCAG ACTTTCCCCAGTTCTCCT 
Gapdh GGATGGAATTGTGAGGGAGA GTGGACCTCATGGCCTACAT 
 
Table 1.  RT-PCR primer sequences. 
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Figure 1.  Impact of single DMBA exposure on follicle morphology and number.    
PND4 rat ovaries were cultured for 4 d in control media and thereafter exposed once to 1% 
DMSO (vehicle control) or 12.5 nM DMBA or 75 nM DMBA.  Following four additional days 
of culture, follicles were classified and counted: (A) Primordial Follicles; (B) Small Primary 
Follicles; (C) Large Primary Follicles; (D) Secondary Follicles.  Values represent mean ± SE 
total follicles counted/ovary, n=5. 
# 
= P < 0.1. 
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Figure 2.  Effect of single DMBA exposure on follicle morphology and number.    
PND4 rat ovaries were cultured for 4 d in control media and thereafter exposed once to (A) 1% 
DMSO (vehicle control) or (B) 12.5 nM DMBA or (C) 75 nM DMBA.  D depicts DMBA-
induced shrunken oocytes indicated by the open arrow.  Following eight additional days of 
culture, follicles were classified and counted: (E) Primordial Follicles; (F) Small Primary 
Follicles; (G) Large Primary Follicles; (H) Secondary Follicles.  Values (E-H) represent mean ± 
SE total follicles counted/ovary, n=5; * = different from control in each follicle type, P < 0.05. 
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Figure 3.  Effect of DMBA on ovarian expression of chemical biotransformation genes.  
PND4 rat ovaries were cultured for 4 d in control media and thereafter exposed to a single 1% 
DMSO (vehicle control) or DMBA (12.5 nM or 75 nM).  Following 1, 2 or 4 additional days of 
culture, mRNA was isolated and (A) Cyp2e1, (B) Gstp, (C) Gstm, and (D) Ephx1 levels 
evaluated by quantitative RT-PCR.  Values represent fold-change ± SEM relative to a control 
value of 1, normalized to Gapdh.   * = different from control, P < 0.05; 
# 
= P < 0.1. 
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Figure 4.  Effect of DMBA on ovarian expression of reactive oxygen species metabolism 
genes.  
PND4 rat ovaries were cultured for 4 d in control media and thereafter exposed to a single 1% 
DMSO (vehicle control) or DMBA (12.5 nM or 75 nM).  Following 1, 2 or 4 additional days of 
culture, mRNA was isolated and (A) Sod1 or (B) Sod2 levels evaluated by quantitative RT-PCR.  
Values represent fold-change ± SEM relative to a control value of 1, normalized to Gapdh.   * = 
different from control, P < 0.05; 
# 
= P < 0.1. 
## 
= P = 0.1. 
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Figure 5.  Effect of DMBA on ovarian expression of autophagy genes.  
PND4 rat ovaries were cultured for 4 d in control media and thereafter exposed to a single 1% 
DMSO (vehicle control) or DMBA (12.5 nM or 75 nM).  Following 1, 2 or 4 additional days of 
culture, mRNA was isolated and (A) Atg7 or (B) Becn1 levels evaluated by quantitative RT-
PCR.  Values represent fold-change ± SEM relative to a control value of 1, normalized to 
Gapdh.   * = different from control, P < 0.05; 
# 
= P < 0.1. 
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Figure 6.  Effect of DMBA on ovarian expression of autophagy genes.  
PND4 rat ovaries were cultured for 4 d in control media and thereafter exposed to a single 1% 
DMSO (vehicle control) or DMBA (12.5 nM or 75 nM).  Following 1, 2 or 4 additional days of 
culture, mRNA was isolated and (A) Kitlg or (B) cKit or (C) Akt1 levels evaluated by 
quantitative RT-PCR.  Values represent fold-change ± SEM relative to a control value of 1, 
normalized to Gapdh.   * = different from control, P < 0.05; 
# 
= P < 0.1. 
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Figure 7.  Localization and effect of DMBA on ovarian EPHX1, BECN1, cKIT or 
pAKT
Thr308
 protein.  
PND4 rat ovaries were cultured for 4 d in control media and thereafter exposed to a single (A) 
1% DMSO (vehicle control) (B) 12.5 nM DMBA or (C) 75 nM DMBA.  Following four 
additional days of culture, ovaries were fixed in formalin, and immunofluorescence staining was 
performed using a primary antibody directed against (A-C) EPHX1, (E-G) BECN1, (I-K) cKIT 
or pAKT
Thr308
.  EPHX1 is represented in green and the Hoechst nuclear stain is in blue.  BECN1, 
cKIT and pAKT
Thr308
 are represented in red and the Hoechst nuclear stain is in green. 
Quantification of (D) EPHX1, (H) BECN1, (L) cKIT or (P) pAKT
Thr308
 was performed and * = 
different from control, P < 0.05; 
# 
= P < 0.1. 
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Chapter 6.  DISSERTATION CONCLUSION 
 
As described in this dissertation, the ovarian follicle reserve is essential to sustain 
fertility throughout the lifespan of a woman.  When this vital pool is compromised by 
ovotoxicants such as PM or DMBA, the effects of these chemicals are apparent both at the 
molecular level as described herein, but also systemically by affecting a woman’s ability to 
conceive, her overall health and potentially even her quality of life, since many negative 
health associations are increased post-menopause.  Although infertility affects millions of 
women around the world, there is much to learn about ovarian physiology and toxicology, 
thus, the goal of this dissertation was to help close some of these knowledge gaps by gaining 
an understanding of how ovotoxic compounds contribute to infertility and characterizing the 
ovarian protective response to such exposures.  
 
Volatile Ovotoxic Compound 
Despite PM’s recognition as the cancer-fighting and follicle-killing metabolite of the 
chemotherapy drug CPA (Plowchalk and Mattison, 1991; Desmeules and Devine, 2006), 
little is known about the mechanisms that are activated upon ovarian exposure to PM.  In our 
endeavor to understand the mechanism(s) of PM-induced follicle depletion, we discovered 
that PM partitions to a volatile and ovotoxic compound, which we assume to be CEZ.  
Although the generation of CEZ is known to occur in vitro and has been demonstrated in 
other tissues, we were first to characterize its ovotoxicity.  We found that CEZ and PM each 
induced follicle loss after 4 days in the neonatal rat ovary and that CEZ appears to primarily 
target the primordial follicle pool (Madden et al., 2014).  The generation of CEZ was 
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confirmed to be a spontaneous reaction, independent of ovarian metabolism (Madden et al., 
2014).  
Upon discovery of the generation of CEZ occurring in our culture system, separate 
incubators and separate incubation times per experiment were employed to eliminate 
contamination and improve exposure consistencies across treatments.  To reduce risk of our 
own exposure, the incubator containing PM or CEZ treatments was maintained in a fume 
hood.  Although literature strongly supports CEZ as the volatile compound generated in our 
system, attempts were made to capture and confirm that CEZ was, in fact, our volatile 
compound of interest.  Despite our efforts, we were unable to confirm this, as many questions 
still remain at to how much of PM is converted to CEZ in our system, when is this 
conversion occurring, how long does it persist, and without a standard CEZ to compare to, 
this was an uphill battle.   
In agreement with previous reports, we too concluded that, “the chemistry of PM is 
complex and very condition-dependent” (Shulman-Roskes et al., 1998).  Regardless of its 
challenges, the potential impact of the generation of CEZ and its ovotoxicity is substantial.  
Potentially, CEZ, not PM, is the active metabolite of CPA, which would help explain some 
of the confusion in the field as to how PM elicits it toxic effects while having a very short 
half-life and poor membrane permeability (Shulman-Roskes et al., 1998).  Additionally, CEZ 
generation was originally observed in rat exhalants who had received CPA (Rauen and 
Norpoth, 1968), thus anyone receiving CPA may be expiring CEZ from their lungs and 
exposing those in close proximity such as doctors, nurses and family members to this 
ovotoxicant.  Taken together, our data and the reports of others suggest that CEZ is a 
145 
 
 
chemical requiring further investigation to understand its role in ovotoxicity as well as 
chemotherapy.   
 
Phosphoramide Mustard (PM) 
With the appreciation that our PM treatments also include the effects of CEZ, we 
moved forward to investigate the mechanism underlying PM-induced infertility using the 
neonatal rat ovary culture system previously described.  This system is advantageous for 
these studies since hepatic biotransformation contributions are removed, allowing direct 
ovarian exposure to be studied.    
 
Metabolism:  PM exposure altered the mRNA and protein levels of the key xenobiotic 
metabolism genes EPHX1, GSTM, and GSTP, thus suggesting their involvement in the 
ovarian response to PM.  By competitively inhibiting EPHX1, we found that this enzyme 
likely contributes to the detoxification of PM and/or CEZ.  Manipulation of GSH levels 
demonstrated that increasing GSH levels in the ovary reduces PM-induced follicle loss and 
decreasing the GSH levels has no impact on PM ovotoxicity.  In this experiment, the addition 
or depletion of GSH alone reduced follicle number and promoted further questions, not 
answered by current literature, regarding the GSH levels present in neonatal rat ovary, 
particularly in the small preantral follicles.  Additionally, our work has identified novel genes 
to be altered during PM exposure through use of a PCR array.  This work therefore has 
opened up many avenues for further exploration. 
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Autophagy: PM-induced follicle loss has been previously reported (Plowchalk and Mattison, 
1991; Desmeules and Devine, 2006) and was confirmed in our neonatal rat ovary culture 
system (Madden et al., 2014), but the PCD mechanism driving PM follicle depletion is 
unknown.  PM-treated ovaries do not have an increased in atretic (unhealthy) follicles to 
mirror loss of the healthy population, suggesting rapid clearance of these follicles is 
occurring (Madden, unpublished), thus autophagy was hypothesized to be a PCD mechanism 
activated by PM.  
 Increased mRNA levels of PUMA, p21 and Becn1, and decrease in Caspase-1, 
provided encouragement that autophagy could be occurring following PM exposure, which 
was furthered by also finding an increase in BECN1 protein level.  Our hypothesis was 
confirmed via visualization by TEM of the formation of autophagosomes and within these 
structures seeing the digestion of organelles such as mitochondria.  To gain an understanding 
for the functional role of PM-induced autophagy, LY294002 was used to inhibit autophagy 
via inhibition of the PI3K pathway and rapamycin was used to activate autophagy by 
inhibiting mTOR.  LY294002 had no impact on the ovotoxicity of PM, while rapamycin 
prevented PM-induced follicle loss.  While it appears that PM-induced activation of 
autophagy is occurring, however, we appreciate that  the pathways manipulated are complex 
and this area is a noteworthy one for  further investigation to understand the mechanism 
preventing PM follicle depletion. 
 
7,12-dimethylbenz[a]anthracene (DMBA) 
In contrast to PM, DMBA ovotoxicity has been focus of many studies and although 
its bioactivation is well characterized, its detoxification and mechanism of follicle destruction 
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remain unclear.  Therefore, the focus of our study was to investigate the effect of DMBA on 
the larger preantral follicles by allowing PND4 rat ovaries to develop over 4 d in culture 
before receiving a single exposure to 12.5 nM or 75 nM DMBA, which are both considered 
as low-dose exposures relative to prior studies, and may mimic those received through 
passive cigarette smoke exposure.  Our results indicated that these acute low-dose DMBA 
exposures still invoked an ovarian response, resulting in follicle loss of large primary (12.5 
nM and 75 nM) and secondary (12.5 nM) follicles as well as altered mRNA levels of 
numerous genes including those involved in xenobiotic metabolism, autophagy, the PI3K 
pathway and the oxidative stress response.  Of note, while most of the studies outlined in this 
dissertation and in the literature examine the effects of repetitive ovotoxicant exposures, this 
DMBA study sheds light on the value of low-level and acute exposure studies.   
 
Future Areas of Interest 
Each of the PM studies described in this dissertation are the initial steps towards 
understanding how CPA-induced infertility occurs.  Additional research is required to 
confirm CEZ as the volatile, ovotoxic compound, which in itself will require investigation in 
order to gain an understanding for the kinetics of this reaction.  Our results suggest that 
EPHX1 likely plays a key role in the metabolism of PM or, as we hypothesize, in the 
detoxification of CEZ.  The EPHX1 inhibitory experiment could be expanded to include 
treatments similar to that of the GSH experiment, so that the ovaries exposed to the volatile 
compound are also treated with the EPHX1 inhibitor.  Another interesting avenue would be 
to investigate the effect of CPA and its metabolite using an EPHX1 knockout mouse in 
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comparison to wild type.  This experiment would provide the opportunity to investigate 
pharmokinetic, biological and morphological differences between treatment and genotypes.   
Another future area of interest includes the investigation of the level of GSH in the 
primordial and small primary follicle, which the neonatal rat ovary will provide a great 
model to understand this because at 4 days of age, the rat ovary only consists of these small 
follicles.  There is no information in the literature regarding these levels, thus, considering 
the importance of GSH conjugation in many physiological functions, understanding the level 
of GSH in these early follicle types could have a large impact in reproductive toxicology as it 
is largely assumed that GSH conjugation is occurring to detoxify ovotoxicants and protect 
this value pool of follicles.  Furthermore, generation of GSH conjugated PM compounds 
would also further our knowledge on the ovotoxicity (increased or decreased) that GSH 
conjugation imparts. 
An avenue for further exploration that has been generated by these studies is to 
understand the action of autophagy following ovotoxicant exposures like PM and DMBA.  
For PM, in particular, follicle loss was prevented by using a clinically available compound, 
rapamycin to activate autophagy via inhibition of mTOR, while inhibition of the upstream 
PI3K pathway with LY294002 did not impact PM follicle depletion.  Performing these same 
studies during DMBA exposure would aid in understanding if autophagy is a common 
phenomenon induced by ovotoxicants.  Additional molecular studies using rapamycin and 
LY294002 will need to be done to understand the impact of these pathway manipulations on 
gene expression up- and downstream of the target pathway.  
Lastly, while the PND4 rat ovary culture method used is a great model to understand 
the direct impact of chemicals on the ovary as well as enable us to manipulate pathways, 
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validation of these results in vivo will be a critical step to fully understand CPA-induced 
fertility.  
 
Dissertation Summary 
Ovotoxicants, such as DMBA and PM, elicit an ovarian response that includes 
activation of xenobiotic metabolism, autophagy and alteredPI3K signaling in order to 
maintain a balance between pro-survival and pro-death all with the main goal of ensuring 
quality oocytes for the production of the next generation.  For PM, EPHX1 and mTOR are 
good candidate proteins for further investigation as both were shown in our model to have a 
determining role in the ovotoxicity of PM.  In addition, the potential involvement of CEZ in 
the ovotoxic, and presumably antineoplastic, effects of CPA is of great interest and concern.  
Unfortunately, much is left to be learned in this field before fertility preservation techniques 
are able to provide the promise of fertility following chemotherapy or other harmful 
exposures.   
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 APPENDIX 
  30 µM PM 60 µM PM  
Gene Name Symbol P-value 
Fold 
Change P-value 
Fold 
Change 
ATP citrate lyase Acly 0.954085   0.04 0.260582   -0.25 
Aconitase 1, soluble Aco1 0.361035   0.36 0.151053   -0.45 
Aconitase 2, mitochondrial Aco2 0.440342   0.32 0.373738   -0.19 
Amylo-1,6-glucosidase, 4-alpha-glucanotransferase Agl 0.215581   0.41 0.400170   -0.21 
Aldolase A, fructose-bisphosphate Aldoa 0.543220   0.12 0.816814   0.05 
Aldolase B, fructose-bisphosphate Aldob 0.231024   -0.74 0.334998   0.8 
Aldolase C, fructose-bisphosphate Aldoc 0.819839   -0.09 0.113404   -0.78 
2,3-bisphosphoglycerate mutase Bpgm 0.359882   0.35 0.127002   0.68 
Citrate synthase Cs 0.567867   0.42 0.057028   -0.21 
Dihydrolipoamide S-acetyltransferase Dlat 0.538224   0.52 0.257482   -0.45 
Dihydrolipoamide dehydrogenase Dld 0.384469   0.92 0.805230   -0.02 
Dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-
glutarate complex) 
Dlst 0.824887 0.16 0.080166† -0.3 
Enolase 1, (alpha) Eno1 0.676376   0.07 0.359418   0.34 
Enolase 2, gamma, neuronal Eno2 0.814807   0.03 0.473007   0.35 
Enolase 3, beta, muscle Eno3 0.629575   0.14 0.502520   -0.22 
Fructose-1,6-bisphosphatase 1 Fbp1 0.919005   -0.01 0.287978   -1.4 
Fructose-1,6-bisphosphatase 2 Fbp2 0.676015   -0.04 0.505544   -1.04 
Fumarate hydratase 1 Fh 0.358126   0.13 0.383882   -0.18 
Glucose-6-phosphatase, catalytic subunit G6pc 0.872923   0.03 0.007638*   -1.84 
Glucose 6 phosphatase, catalytic, 3 G6pc3 0.810169   0.05 0.059505†   -0.95 
Glucose-6-phosphate dehydrogenase G6pd 0.576016   0.12 0.144316   -0.41 
Galactose mutarotase (aldose 1-epimerase) Galm 0.650490   0.19 0.312772   0.35 
Glyceraldehyde-3-phosphate dehydrogenase Gapdh 0.276757   0.36 0.251625   0.37 
Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic Gapdhs 0.462385   0.29 0.426497   -0.48 
Glucokinase Gck 0.929796   -0.03 0.168133   -1.33 
Glucose phosphate isomerase Gpi 0.779812   0.03 0.493985   -0.1 
Glycogen synthase kinase 3 alpha Gsk3a 0.613481   0.1 0.247874   -0.2 
Glycogen synthase kinase 3 beta Gsk3b 0.404445   0.09 0.079423†   0.45 
Glycogen synthase 1, muscle Gys1 0.647872   -0.14 0.110067   -0.8 
Glycogen synthase 2 Gys2 0.600890   0.28 0.573863   0.26 
Hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) H6pd 0.567968   -0.16 0.269001   -0.3 
Hexokinase 2 Hk2 0.360123   -0.32 0.844049   -0.01 
Hexokinase 3 (white cell) Hk3 0.527202   0.08 0.865241   0.02 
Isocitrate dehydrogenase 1 (NADP+), soluble Idh1 0.227221   -0.17 0.193151   0.58 
Isocitrate dehydrogenase 2 (NADP+), mitochondrial Idh2 0.592548   0.06 0.073399†   -1.97 
Isocitrate dehydrogenase 3 (NAD+) alpha Idh3a 0.961088   0.09 0.075077†   -0.39 
Isocitrate dehydrogenase 3 (NAD+) beta Idh3b 0.534927   -0.07 0.373165   -0.15 
Isocitrate dehydrogenase 3 (NAD), gamma Idh3g 0.261828   0.07 0.351370   -0.32 
Malate dehydrogenase 1, NAD (soluble) Mdh1 0.413280   0.1 0.241708   0.42 
Malate dehydrogenase 1B, NAD (soluble) Mdh1b 0.562679   -0.39 0.489485   -0.54 
Malate dehydrogenase 2, NAD (mitochondrial) Mdh2 0.338297   -21.92 0.166786   -0.35 
Oxoglutarate dehydrogenase-like Ogdhl 0.240227   -0.17 0.123835   -0.63 
Pyruvate carboxylase Pc 0.511677   -0.14 0.764769   -0.06 
Phosphoenolpyruvate carboxykinase 1 (soluble) Pck1 0.683443   -0.25 0.647213   0.09 
Phosphoenolpyruvate carboxykinase 2 (mitochondrial) Pck2 0.447316   -0.2 0.089265†   -0.9 
Pyruvate dehydrogenase (lipoamide) alpha 2 Pdha2 0.242983   -0.22 0.311628   -1.75 
Pyruvate dehydrogenase (lipoamide) beta Pdhb 0.235421   -0.25 0.418468   0.09 
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Pyruvate dehydrogenase complex, component X Pdhx 0.713113   0.15 0.200738   -0.39 
Pyruvate dehydrogenase kinase, isozyme 1 Pdk1 0.177869   -0.15 0.478618   -0.17 
Pyruvate dehydrogenase kinase, isozyme 2 Pdk2 0.258785   -0.16 0.093081†   -0.56 
Pyruvate dehydrogenase kinase, isozyme 3 Pdk3 0.963417   -0.01 0.288269   -0.32 
Pyruvate dehydrogenase kinase, isozyme 4 Pdk4 0.014980*   0.35 0.090272†   0.37 
Pyruvate dehyrogenase phosphatase catalytic subunit 2 Pdp2 0.039831*   -0.19 0.988424   -0.01 
Pyruvate dehydrogenase phosphatase regulatory subunit Pdpr 0.470951   -0.12 0.099850†   0.1 
Phosphofructokinase, liver Pfkl 0.201969   -0.41 0.131916   -0.55 
Phosphoglycerate mutase 2 (muscle) Pgam2 0.560662   -0.09 0.618281   -0.1 
Phosphoglycerate kinase 1 Pgk1 0.340109   -0.38 0.231464   -0.39 
Phosphoglycerate kinase 2 Pgk2 0.894652   -0.04 0.284540   -0.84 
6-phosphogluconolactonase Pgls 0.575543   -0.13 0.191813   -0.66 
Phosphoglucomutase 1 Pgm1 0.681927   -0.06 0.119746   -0.35 
Phosphoglucomutase 2 Pgm2 0.512691   -0.08 0.110986   -0.32 
Phosphoglucomutase 3 Pgm3 0.334640   -0.18 0.082189†   -0.47 
Phosphorylase kinase, alpha 1 Phka1 0.047853*   -0.33 0.697097   0.08 
Phosphorylase kinase, beta Phkb 0.619762   -0.13 0.443373   -0.78 
Phosphorylase kinase, gamma 1 Phkg1 0.623883   -0.12 0.855811   -0.01 
Phosphorylase kinase, gamma 2 (testis) Phkg2 0.652275   0.05 0.416117   0.17 
Pyruvate kinase, liver and RBC Pklr 0.080488†   -0.72 0.750707   0.03 
Phosphoribosyl pyrophosphate synthetase 1 Prps1 0.476081   0.05 0.640634   -0.23 
Phosphoribosyl pyrophosphate synthetase 1-like 1 Prps1l1 0.478036   -0.2 0.487140   0.59 
Phosphorylase, glycogen, liver Pygl 0.811363   -0.13 0.099240†   -0.74 
Phosphorylase, glycogen, muscle Pygm 0.362372   -0.14 0.297640   0.36 
Ribokinase Rbks 0.658595   0.18 0.143132   -0.84 
Ribose 5-phosphate isomerase A Rpia 0.308363   -0.12 0.096241†   -0.78 
Succinate dehydrogenase complex, subunit A, flavoprotein (Fp) Sdha 0.460289   19.55 0.198160   -0.28 
Succinate dehydrogenase complex, subunit B, iron sulfur (Ip) Sdhb 0.187586   -0.1 0.181449   -0.55 
Succinate dehydrogenase complex, subunit C, integral 
membrane protein 
Sdhc 0.188390 -0.14 0.039619* -0.65 
Succinate dehydrogenase complex, subunit D, integral membrane 
protein 
Sdhd 0.063955† -0.2 0.202560 -0.68 
Succinate-CoA ligase, ADP-forming, beta subunit Sucla2 0.119000   -0.07 0.116385   0.36 
Succinate-CoA ligase, alpha subunit Suclg1 0.381353   -0.1 0.049259*   -0.59 
Succinate-CoA ligase, GDP-forming, beta subunit Suclg2 0.432898   -0.07 0.075873†   -0.91 
Transaldolase 1 Taldo1 0.596663   -0.05 0.095173   -0.55 
Transketolase Tkt 0.424777   0.12 0.100861   -0.75 
Triosephosphate isomerase 1 Tpi1 0.656505   0.08 0.630511   -0.11 
UDP-glucose pyrophosphorylase 2 Ugp2 0.842375   0.16 0.542613   0.09 
Actin, beta Actb 0.546930   -0.06 0.119631   -0.31 
Beta-2 microglobulin B2m 0.278627   -0.33 0.043742*   -0.36 
Hypoxanthine phosphoribosyltransferase 1 Hprt1 0.256585   0.05 0.140881   0.57 
Lactate dehydrogenase A Ldha 0.833449   20.03 0.637703   -0.17 
Ribosomal protein, large, P1 Rplp1 0.254518   -0.04 0.182563   -0.57 
 
Table 1.  Effect of PM exposure on ovarian expression of glucose metabolism genes.    
PND4 rat ovaries were treated with 1% DMSO (vehicle control), PM (30 µM), or PM (60 
µM) for 2 d.  Following RNA isolation, mRNA levels were quantified with an RT
2
 Profiler 
PCR array.  Values represent fold-change ± SEM relative to a control value of 1, normalized 
to Hprt1 and Rplp1.  * = different from control, P < 0.05; 
†
= P < 0.1 
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Abstract 
4-vinylcyclohexene diepoxide (VCD) destroys ovarian primordial and small primary 
follicles via apoptosis.  In mice, VCD exposure induces ovarian mRNA expression of 
glutathione S-transferase (GST) family members, including isoform mu (Gstm).  Extra-
ovarian GSTM negatively regulates pro-apoptotic apoptosis signal-related kinase 1 (ASK1) 
through protein complex formation, which dissociates during stress, thereby initiating ASK1-
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induced apoptosis.  The present study investigated the ovarian response of Gstm mRNA and 
protein to VCD. Induction of Ask1 mRNA at VCD-induced follicle loss onset was 
determined.  Ovarian GSTM:ASK1 protein complex formation was investigated and VCD 
exposure effects thereon evaluated.  Phosphatidylinositol-3 kinase (PI3K) regulation of 
GSTM protein was also studied.  Postnatal day (PND) 4 rat ovaries were cultured in control 
media ±: 1) VCD (30 M) for 2-8d; 2) VCD (30 M) for 2d, followed by incubation in 
control media for 4d (acute VCD exposure); or 3) LY294002 (20 M) for 6d.  VCD exposure 
did not alter Gstm mRNA expression, however, GSTM protein increased (P < 0.05) after 6d 
of both the acute and chronic treatments.  Ask1 mRNA increased (0.33-fold; P < 0.05) 
relative to control after 6d of VCD exposure. Ovarian GSTM:ASK1 protein complex 
formation was confirmed and, relative to control, the amount of GSTM bound to ASK1 
increased 33% (P < 0.05) by chronic but with no effect of acute VCD exposure.  PI3K 
inhibition increased (P < 0.05) GSTM protein by 40% and 71% on d4 and d6, respectively.  
These findings support involvement of GSTM in the ovarian response to VCD exposure, 
through regulation of pro-apoptotic ASK1. 
 
Introduction 
The ovary is the female gonad composed of oocyte-containing follicles at various 
stages of development.  Females are born with a finite number of the most immature 
follicular stage, termed primordial follicles, which, once destroyed, cannot be regenerated 
(Hirshfield, 1991).  Exposure to environmental factors that cause follicular damage and 
depletion can impair fertility and induce ovarian failure (menopause; Mattison et al., 1980).  
An occupational chemical known to selectively destroy primordial and small primary 
155 
 
 
follicles in the ovaries of mice and rats is 4-vinylcyclohexene diepoxide (VCD, Kao et al., 
1999; Smith et al., 1990).  VCD is the active metabolite of 4-vinylcyclohexene (VCH), an 
industrial diluent for epoxides (IARC, 1976).  Repeated daily dosing of rats with VCD (80 
mg/kg/day, intraperitoneal) for 15 days results in approximately 50% depletion of primordial 
and small primary follicles relative to controls, with no significant effect on larger follicles or 
corpora lutea (Smith et al., 1990; Flaws et al., 1994; Springer et al., 1996a,b).  VCD-induced 
primordial and small primary follicle loss begins on day 6 of in vitro exposure in postnatal 
day (PND) 4 cultured Fisher 344 (F344) rat ovaries (Keating et al., 2009).  Mechanistic 
studies have revealed that VCD induces follicle loss by accelerating the natural process of 
atresia (apoptosis) in both a time- and dose-dependent manner (Springer et al., 1996a; Hu et 
al., 2001a; Devine et al., 2002).    
VCH may be metabolized (bioactivated) in the ovary to VCD by the action of the 
cytochrome P450 (CYP) family member CYP 2E1 (Cannady et al., 2003; Rajapaksa et al., 
2007).  Cyp 2e1-null mice had less follicle loss compared to their wild type control 
littermates (Rajapaksa et al., 2007), suggesting the involvement of CYP 2E1 in VCH 
bioactivation.  Conversely, VCD can be detoxified in the ovary to a less ovotoxic tetrol 
metabolite through the action of microsomal epoxide hydrolase (mEH) (Flaws et al., 1994; 
Cannady et al., 2002; Keating et al., 2008; Bhattacharya et al., 2012).  Studies have shown 
that VCD induces mEH mRNA and protein expression both in vivo and in vitro prior to an 
observed follicle loss in mice and rats (Cannady et al., 2002; Keating et al., 2008; 
Bhattacharya et al., 2012).  Additionally when mEH is inhibited in vitro using cyclohexene 
oxide (CHO) in the presence of VCD, more follicle loss results relative to those ovaries 
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treated only with VCD, thereby supporting an ovarian detoxification role for mEH during 
VCD exposure (Bhattacharya et al., 2012).  
Glutathione (GSH) is a ubiquitous antioxidant that protects cells against oxidative 
stress and electrophilic compounds (DeLeve and Kaplowitz, 1991).  GSH functions in two 
major ways: 1) through conjugation to electrophilic compounds resulting in their more rapid 
excretion from the body; or 2) directly reducing and neutralizing reactive oxygen 
intermediates in a coupled reaction involving GSH peroxidase (DeLeve and Kaplowitz, 
1991).  The glutathione S-transferase (GST) enzyme family catalyze conjugation of GSH to 
xenobiotics (Jakoby et al., 1978), and the ovary is capable of synthesizing GSH (Luderer et 
al., 2001).  The mRNA encoding the GST isoforms pi (Gstp) and mu (Gstm) are increased in 
response to VCD exposure in cultured PND4 mouse ovaries (Keating et al., 2008).   
Additionally, VCD increases Gstp mRNA and protein in cultured PND4 rat ovaries prior to 
(d4) and at times of (d6, d8) VCD-induced follicle loss (Keating et al., 2010). These 
observations support that the GST isoforms mu and pi are involved in the ovarian response to 
VCD exposure, and may potentially catalyze VCD:GSH conjugation.   
In addition to GSH conjugation, GST enzymes are involved in cell signaling pathway 
regulation (Cho et al., 2001; Dorion et al., 2002; Keating et al., 2010).  GSTP forms a protein 
complex with c-JUN N-terminal kinase (JNK; Adler et al., 1999) and is likely to negatively 
regulate its action in the rat ovary (Keating et al., 2010).  The amount of JNK protein bound 
to GSTP increased after 6 days of VCD exposure (Keating et al., 2010) with a concomitant 
decrease in unbound JNK and phosphorylated c-JUN (p-c-JUN) protein levels.   
Furthermore, a decrease in p-c-JUN preceded the increase in JNK bound to GSTP, indicating 
that JNK activity was impaired through the GSTP interaction (Keating et al., 2010).   
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Apoptosis signal-regulating kinase 1 (ASK1) is a mitogen-activated protein kinase 
kinase kinase (MAPKKK) which is capable of activating the pro-apoptotic JNK and p38 
MAPK signaling pathways (Ichijo et al., 1997).  In extra-ovarian tissues, GSTM physically 
interacts with ASK1 and functions to repress ASK1-mediated apoptosis (Cho et al., 2001).  
The GSTM:ASK1 protein complex dissociates in response to stress and thereby triggers 
activation of apoptosis by ASK1 (Dorion et al., 2002).  It is therefore known that GSTM 
modulates stress-activity signals by suppressing ASK1.  Interestingly, VCD-induced 
apoptosis involves the action of JNK and p-c-JUN (Hu et al., 2002).  Thus, ovarian GSTM is 
potentially involved in the ovarian response to VCD exposure. 
Phosphatidylinositol 3-kinase (PI3K) is a lipid kinase involved in various cellular 
functions including cell growth and survival, proliferation, and differentiation (Vivanco and 
Sawyers, 2007).  In the ovary, the PI3K signaling pathway plays an important role in 
primordial follicles by maintaining oocyte viability and directing their recruitment into the 
growing follicular pool (Castrillon et al., 2003; Reddy et al., 2005; Liu et al., 2006).  
Impairment of PI3K signaling occurs during VCD-induced ovotoxicity (Keating et al., 2011), 
while PI3K inhibition prevented VCD-induced primordial follicle loss in cultured PND4 rat 
ovaries (Keating et al., 2009).  Recently, it has been shown that the xenobiotic 
biotransformation enzymes mEH and Gstp are regulated by PI3K signaling in cultured PND4 
rat ovaries and Gstm mRNA was increased by PI3K inhibition (Bhattacharya et al., 2012; 
Bhattacharya and Keating, 2012).  Taken together, these findings also point to regulation of 
Gstm by PI3K signaling.  
To determine if GSTM is associated with the ovarian response to VCD as well as in 
regulation of pro-apoptotic ASK1, several approaches were taken: the first was to study the 
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temporal pattern of Gstm mRNA and protein expression in response to VCD.  The second 
was to determine any effect of VCD on Ask1 mRNA expression at the time of the onset of 
VCD-induced follicle loss.  The third approach was to establish the presence of a 
GSTM:ASK1 protein complex in the rat ovary and to study the effect of VCD exposure (both 
acute and chronic) upon this complex.  Finally, because Gstm mRNA expression is increased 
in cultured PND4 rat ovaries during inhibition of the PI3K pathway (Bhattacharya and 
Keating, 2012) regulation of GSTM by PI3K was evaluated.     
 
Materials and Methods 
Reagents:   
4-vinylcyclohexene diepoxide (VCD, mixture of isomers, >99% purity), ascorbic acid, 
transferrin, bovine serum albumin (BSA), 2--mercaptoethanol, 30% acrylamide/0.8% bis-
acrylamide, ammonium persulphate, glycerol, N’N’N’N’-Tetramethyl-ethylenediamine 
(TEMED), Tris base, Tris HCL, sodium chloride, Tween-20 were purchased from Sigma-
Aldrich Inc. (St Louis, MO).  Dulbecco’s Modified Eagle Medium: nutrient mixture F-12 
(Ham) 1x (DMEM/Ham’s F12), Albumax, penicillin (5000U/ml), Hanks’ Balanced Salt 
Solution (without CaCl2, MgCl2 or MgSO4), Gstm and β-actin primers, and superscript III 
one-step RT-PCR system were obtained from Invitrogen Co. (Carlsbad, CA).  Gapdh and 
Ask1 primers were obtained from the DNA facility of the Office of Biotechnology at Iowa 
State University.  Millicell-CM filter inserts and anti-GSTM antibodies were purchased from 
Millipore (Bedford, MA).  The anti-ASK1 primary antibody was obtained from Cell 
Signaling Technology (Danvers, MA).  48-well cell culture plates were purchased from 
Corning Inc. (Corning, NY). RNeasy Mini kit, QIA shredder kit, RNeasy Mini Elute kit, and 
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Quantitect
TM
 SYBR Green PCR kit were purchased from Qiagen Inc. (Valencia, CA).  
RNAlater was obtained from Ambion Inc. (Austin, TX).  2-(4-morpholinyl)-8-phenyl-4H-1-
benzopyran-4-one (LY294002; CAS#154447-36-6) was purchased from A.G. Scientific, Inc. 
(San Diego, CA).  Pierce BCA protein Assay Kit was purchased from Thermo Scientific 
(Rockford, IL).  The goat anti-rabbit secondary antibody was obtained from Thermo 
Scientific, (Lafayette, CO).  Ponceau S was from Fisher Scientific (Asheville, NC). ECL plus 
chemical luminescence detection kit was obtained from GE Healthcare, Amersham 
(Buckinghamshire, UK).  
 
Animals:   
Rats were housed two per cage in plastic cages and maintained in a controlled environment 
(22 ± 2
o
C; 12h light/12h dark cycles).  The animals were provided a standard diet with ad 
libitum access to food and water, and allowed to give birth.  All animal experimental 
procedures were approved by the Iowa State University’s Institutional Animal Care and Use 
Committee. 
 
In vitro ovarian cultures:   
Ovaries from PND4 Fisher 344 (F344) rats were cultured as described by Parrott and Skinner 
(1999).  Briefly, pups were euthanized by CO2 inhalation followed by decapitation.  Ovaries 
were removed, trimmed of oviduct and other excess tissue and placed onto Millicell-CM 
membrane floating on 250 µl of DMEM/Ham’s F12 medium containing 1 mg/ml BSA, 1 
mg/ml Albumax, 50 µg/ml ascorbic acid, 5 U/ml penicillin and 27.5 µg / ml transferrin per 
well in a 48 well plate previously equilibrated to 37
o
C.  One ovary was placed in the control 
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treatment, while the contralateral ovary was exposed to the experimental treatment.  A drop 
of medium was placed on top of each ovary to prevent it from drying.  Ovaries were treated 
with vehicle control medium (1% DMSO), VCD (30 µM) or LY294002 (20 µM) and 
maintained at 37
o
C and 5% CO2 for 2-8 d.  For chronic VCD exposure, ovaries were 
continuously exposed to VCD (30 µM) on alternate days and samples were collected 
accordingly.  For the acute VCD exposure, ovaries were exposed for 2d to VCD (30 µM) 
beginning at the onset of culture and were subsequently incubated in control medium for a 
further 4d for a total of 6d of culture.  The concentration (30 µM) of in vitro VCD exposure 
was previously determined to cause about 50% loss of both primordial and small primary 
follicles after 6d (Devine et al., 2002; Keating et al., 2009).  The concentration of LY294002 
(20 µM) was previously shown to be effective in the rat PND4 ovary culture system (Keating 
et al., 2009).  For cultures lasting for more than 2d, media was changed every alternate day 
and treatment added. 
 
RNA isolation and polymerase chain reaction (PCR):   
Following 2, 4, 6 or 8 d of in vitro culture, ovaries treated with control or VCD (30 µM) were 
stored in RNAlater at -80
o
C.  Total RNA was isolated from ovaries (n=3; 10 ovaries per 
pool) using an RNeasy Mini kit (Qiagen) following the manufacturer’s instructions.  RNA 
was eluted in 14ul of RNase-free water and the concentration was determined using a 
NanoDrop (=260/280 nm; ND 1000; Nanodrop Technologies Inc, Wilmington, DE).  Total 
RNA (500 ng) was reverse transcribed to cDNA using Superscript III One-Step RT-PCR 
System (Invitrogen).  Gstm and -actin (Actb) were amplified on a Rotor-Gene 3000 (Corbett 
Research, Sydney, Australia).  An Eppendorf mastercycler (Hauppauge, NY) was used to 
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amplify Gapdh and Ask1.  A Quantitect
TM
 SYBR Green PCR kit (Qiagen Inc.Valencia, CA) 
was used for amplification.  The primers used for Gstm and Actb were those described in 
(Keating et al., 2008).  The Gapdh primers were from Bhattacharya and Keating (2012). 
Ask1 primers were: forward - 5’-AGAAAAGGACCAAGAAATTAAGCAC-3’; reverse-5’-
AACCGACTTATAGTGTCTTCGTCAG-3’.  There was no difference in Actb or Gapdh 
mRNA expression level between vehicle control and VCD treated ovaries. 
 
Protein isolation:  
Pools (n = 3 pools; 10 ovaries per pool for Western blotting; 20 ovaries per pool for 
immunoprecipitation) of whole ovarian protein suspensions were obtained by 
homogenization in tissue lysis buffer containing protease and phosphatase inhibitors 
(Thompson et al., 2005).  SDS-free lysis buffer was used to isolate protein for 
immunoprecipitation.  After homogenization, samples were placed on ice for 30 min, 
followed by two rounds of centrifugation at 10,000 rpm for 15 min.  Protein quantification 
was performed using a standard BCA protocol on a 96-well assay plate.  Emission 
absorbance was detected with a = 540nm excitation on a Synergy™ HT Multi-Detection 1 
Microplate Reader using KC4™ software (Bio-Tek® Instruments Inc., Winooski, VT).  
Protein concentrations were calculated from a BSA protein standard curve.    
 
Protein immunoprecipitation:  
Protein immunoprecipitation was performed as previously described (Bhattacharya and 
Keating, 2012).  Briefly, ovarian protein (30 µg) was incubated overnight at 4
oC with 15 μl 
of anti-ASK1 antibody.  Protein G agarose beads were washed, added to the protein-antibody 
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mixture and incubated at 4
o
C for 3 h with shaking, followed by centrifugation at 10,000 rpm 
for 10 mins.  The supernatant containing the unbound protein was saved for Western blotting.  
After washing with lysis buffer beads were incubated with Laemmli sample buffer (40 μl) at 
95
o
C for 10 min.  Thereafter, the beads were centrifuged and the bound protein (supernatant) 
fraction (40 μl) was collected. 
 
Western blot analysis:   
10% SDS-PAGE gels were used to separate proteins (n=3; 10 g total protein or 20 μl 
unbound or bound immunoprecipitation fractions) followed by transfer onto nitrocellulose 
membranes as previously described (Thompson et al., 2005).  Membranes were blocked for 1 
h with shaking at 4
o
C in 5% milk in Tris-buffered saline with Tween-20 (TTBS).  Primary 
antibody diluted in 5% milk in TTBS was added to the membranes and incubated overnight 
at 4
o
C with rocking.  The GSTM and ASK1 antibody dilutions used were 1:200 and 1:1000. 
Membranes were washed three times (10 min) in TTBS and incubated in appropriate HRP-
conjugated secondary antibody (1:2000) for 1hr at room temperature.  Membranes were 
washed three times (10 min) in TTBS followed by a single wash for 10 min in Tris Buffered 
Saline (TBS).  Membranes were incubated in ECL plus chemiluminescence detection 
substrate for 5 min and exposed to X-ray film.  Equal total protein loading was confirmed by 
Ponceau S staining of membranes.  Densitometry of the appropriate bands was quantified 
using ImageJ software (NCBI).  Each band was normalized to an appropriate internal control 
– Ponceau S for total protein measurements and to ASK1 for immunoprecipitation.  The 
treatment values were compared to control values using Prism 5.04 software to determine 
any difference between experimental treatments. 
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Statistical analysis:   
All statistical analyses were performed using Prism 5.04 software (GraphPad Software).  One 
ovary from each animal was placed in control media while the contralateral ovary was placed 
in the experimental treatment, thus data were analyzed by paired t-tests comparing the treated 
ovaries to controls.  Statistical significance was defined as P < 0.05.  For Western blotting, 
statistical analysis was performed on the raw data comparing experimental treatment to the 
respective control at each time-point.  For each experiment, the n-value equals three groups 
that consisted of 8-10 ovaries per group, and data are presented as mean value +/- standard 
error.     
 
Results 
Temporal effect of chronic VCD exposure on Gstm mRNA expression in PND4 F344 rat 
ovaries 
To investigate the effect of VCD on ovarian Gstm mRNA, real-time PCR was 
performed over the time-course of VCD exposure; 2d, 4d, 6d or 8d.  Relative to control 
ovaries, no change in Gstm mRNA expression was observed at any time point (Figure 1).   
 
Temporal effect of chronic VCD exposure on GSTM protein in F344 rat ovaries 
To determine any impact of VCD exposure on GSTM protein level, PND4 rat ovaries 
were cultured in control media or media containing VCD (30 M) for 4d, 6d or 8d.  There 
was no effect of VCD on GSTM protein level on d4.  Relative to control-treated ovaries, 
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VCD increased (P < 0.05) GSTM protein level on d6 by 13% and on d8 by 9% (Figure 2A, 
B). 
 
Induction of Ask1 mRNA in F344 rat ovaries by VCD at the time of follicle loss onset 
 To study if VCD induces Ask1 mRNA, PND4 rat ovaries were cultured in control 
media or media containing VCD (30 M) for 6 d.  Ask1 expression was measured on d6 
since this time point coincides with the beginning of VCD-induced follicle loss.  Relative to 
control-treated ovaries, Ask1 mRNA was increased (0.33-fold; P < 0.05) by VCD exposure 
(Figure 3).   
 
Effect of chronic VCD exposure on GSTM:ASK1 protein complex formation in F344 rat 
ovaries 
To evaluate the presence of a GSTM:ASK1 protein complex in the ovary as well as to 
investigate the effect of VCD exposure on this complex during VCD exposure, PND4 F344 
rat ovaries were collected at the time points prior to (d4) and at the time of (d6) VCD-
induced follicle loss.  A GSTM:ASK1 protein complex was detected in ovarian tissue (Figure 
4A).  There was no effect of VCD on the amount of GSTM bound to ASK1 on d4  but this 
was increased by 33% (P < 0.05) on d6 (Figure 4B).  There was no impact of VCD exposure 
or ASK1 interaction on GSTM protein that was unbound to ASK1 at either time point 
(Figure 4C, D). 
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Acute VCD exposure effects on GSTM protein level in F344 rat ovaries 
 Whether a single (acute) exposure of PND4 rat ovaries for 2d to VCD was sufficient 
to induced increased GSTM protein levels was determined.  Protein was collected 6d after 
the onset of culture. Relative to control-treated ovaries, GSTM protein was increased (P < 
0.05) on d6 by 6% (Figure 5A, B). 
 
Determination of VCD acute exposure effect on the GSTM:ASK1 protein complex in F344 
rat ovaries 
To determine if acute VCD exposure could cause dissociation of the GSTM:ASK1 
protein complex, ovaries were exposed to VCD for 2d and ovaries collected 6d after the 
onset of culture.  There was no effect of VCD exposure on the amount of GSTM protein 
bound to ASK1 (Figure 6A, B).  Also, no impact on the amount of GSTM in the unbound 
protein fraction was observed (Figure 6C, D). 
  
Effect of PI3K inhibition on ovarian GSTM protein level 
 An increase in Gstm mRNA was previously demonstrated after 2d and 4d of PI3K 
inhibition (Bhattacharya and Keating, 2012).  In order to investigate whether altered Gstm 
mRNA was correlated with GSTM protein after PI3K inhibition, LY294002 treated ovaries 
were collected on 4d and 6d.  Inhibition of PI3K increased (P < 0.05) GSTM protein levels 
by 40% and 71% on d4 and d6, respectively (Figure 7A, B).   
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Effect of PI3K inhibition on ovarian Ask1 mRNA level 
Any impact of PI3K inhibition on Ask1 mRNA expression was determined in ovaries 
that had been treated for 6d with LY294002.  There was no effect of LY294002 treatment on 
Ask1 mRNA, relative to control treated ovaries (Figure 8). 
 
Discussion 
Ovarian GSTP is increased in response to VCD exposure and inhibits JNK activity 
through a protein:protein interaction, potentially contributing to the ovarian xenobiotic 
protective response (Keating et al., 2010).  In the PND4 mouse ovary, it has been shown that 
VCD (30 M) exposure increases Gstm mRNA expression prior to observed VCD-induced 
follicle loss (Keating et al., 2008).  However, further investigation into a functional role for 
GSTM during VCD-induced ovotoxicity has been lacking.  Therefore, this study investigated 
the ovarian response of Gstm to VCD exposure in cultured PND4 rat ovaries.  Although there 
was no change at the mRNA level at any time point studied, GSTM protein level was 
increased at both 6d and 8d, and was highest at the time point at which follicle loss is first 
observed (d6).  These results support an involvement of GSTM in the ovarian protective 
response to VCD exposure in rats. 
Several studies have reported that GSTM inhibits the action of pro-apoptotic ASK1 
(Cho et al., 2001; Dorion et al., 2002).  This negative regulation of ASK1 by GSTM is 
through formation of an ASK1:GSTM protein complex.  The complex is disrupted following 
external environmental stress stimulus such as heat shock (Dorion et al., 2002).  Such stress 
releases GSTM from ASK1, and the unbound ASK1 initiates the c-JUN and p38 MAPK 
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signaling pathways in favor of apoptosis (Dorion et al., 2002; Ichijo et al., 1997).  Thus, 
ASK1 is involved in activating apoptotic signaling pathways.  
It is known that VCD-induced primordial and small primary follicle loss is via 
apoptosis (Hu et al., 2001; Devine et al., 2002; Springer et al., 1996a).  Moreover, VCD-
induced apoptosis involves activation of JNK resulting in phosphorylation of c-JUN in small 
pre-antral follicles which are the selective target of VCD (Hooser et al., 1994; Hu et al., 
2002).  Because ASK1 activates JNK signaling, a role for ASK1 during VCD-induced 
ovotoxicity was hypothesized.  Additionally, GSTM is increased in response to VCD 
exposure, and can form a complex with ASK1 in extra-ovarian tissues as an anti-apoptotic 
mechanism.  Thus, it was logical to investigate whether this was part of an ovarian protective 
response to VCD exposure.  Our data demonstrates induction of Ask1 mRNA at the time of 
VCD-induced follicle depletion, thus supporting pro-apoptotic Ask1 involvement during 
VCD-induced ovotoxicity.  It was further shown that ovarian GSTM protein is bound to 
ASK1 and that this complex is increased in response to VCD exposure at the time of follicle 
loss.  This is similar to the response of a GSTP:JNK complex during both VCD (Keating et 
al., 2010) and DMBA exposures (Bhattacharya and Keating, 2012).  There was no disruption 
of the GSTM:ASK1 protein complex by VCD in terms of changes in the unbound form of 
GSTM.  Since the ovaries were exposed to VCD every alternate day, we surmised that this 
chronic exposure may be the reason for lack of a clear disruption in the protein complex, 
since GSTM may be continuously activated, and thus constantly binding ASK1.  For this 
reason an experiment was performed to determine if a single acute VCD exposure would 
unveil more radical changes in the GSTM:ASK1 complex.  GSTM protein was confirmed to 
increase in this paradigm, albeit marginally, however no major impact on GSTM:ASK1 
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protein binding was observed.  It may however be the case that more distinct changes may 
have taken place immediately after VCD exposure (d2 or d4).  Collectively, from both the 
chronic and acute VCD exposures, it is evident that GSTM binds pro-apoptotic ASK1.  
GSTM-induced inactivation of ASK1 may also lead to reduced JNK activity as was evident 
during VCD-exposure (Keating et al., 2010) since ASK1 is an upstream regulator of JNK 
(Tobiume et al., 2001).  Therefore, it is hypothesized that the complexing of GSTM with 
ASK1 is part of an ovarian protective response to VCD.  That is, in response to VCD-
induced apoptosis, GSTM may be involved in an effort to prevent toxicity through binding 
and suppressing pro-apoptotic action of ASK1 in cultured rat ovaries.  Whether GSTM plays 
an additional role in GSH conjugation cannot be confirmed by these studies.    
Inhibition of PI3K prevents VCD-induced primordial follicle loss (Keating et al., 
2009) and VCD has been shown to inhibit phosphorylation of the PI3K members c-KIT, 
pAKT and to decrease total FOXO3 protein (Keating et al., 2011).  Inhibition of PI3K 
signaling increases both mEH (Bhattacharya et al., 2012) and Gstp mRNA and protein 
expression (Bhattacharya and Keating, 2012), indicating that this pathway regulates ovarian 
xenobiotic metabolism gene expression.  Also, inhibition of PI3K increases Gstm mRNA 
levels in the rat ovary (Bhattacharya and Keating, 2012).  Because a role for GSTM in VCD-
induced toxicity was supported by the data herein, an investigation of a regulatory role for 
PI3K in GSTM translation was made.  GSTM protein was increased by PI3K inhibition on 
d4 and d6 of culture.  Although we did not observe any impact of PI3K inhibition on Ask1 
mRNA induction, it is possible that increased GSTM binding to ASK1 could result during 
PI3K inhibition however, this study cannot confirm that this is the case.  Thus, these data 
further add to an understanding of the involvement of PI3K in xenobiotic biotransformation 
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enzyme regulation (Bhattacharya et al., 2012; Bhattacharya and Keating et al., 2012).  Gstm 
mRNA was increased in mouse ovaries exposed to VCD, while protein levels were not 
affected (Keating et al., 2008), thus there appears to be some species-specific differences in 
Gstm regulation.  Whether this regulation is through control of Gstm transcription or 
translation remains to be determined, but could potentially involve the action of 
microRNA’s, as is the case for Gstp (Zhang et al., 2012; Patron et al., 2012).   
VCD exposure decreases PI3K signaling (Keating et al., 2011) and it is hypothesized 
that this leads to impaired follicle viability, and accelerate activation of primordial follicles 
into the growing follicular pool, both of which would lead to premature ovarian failure 
(Keating et al., 2009). During the same time frame VCD also increases ovarian expression of 
mEH (Bhattacharya et al., 2012), Gstp (Keating et al., 2010) and Gstm, likely as a result of 
PI3K inhibition (summarized in Figure 9).  PI3K regulates ovarian arylhydrocarbon receptor 
(Ahr) and nuclear factor (erythroid-derived 2)-like 2 (Nrf2) mRNA and protein expression 
(Bhattacharya et al., 2012), both transcription factors that regulate xenobiotic metabolism 
genes, including Gstm, thus they may be involved in VCD-induced Gstm activation.  Why 
the increased expression of the xenobiotic metabolism enzymes is insufficient to protect 
against VCD-induced follicular destruction remains unclear, but may result either because 
the enzymes are overwhelmed by continuous VCD exposure, or because VCD-induced 
impairment of oocyte viability becomes impossible to counteract.          
In summary, GSTM appears to be involved in the ovarian response to VCD; 
potentially contributing to both VCD detoxification and prevention of apoptosis.  Future 
studies are aimed at further characterizing Gstm involvement during VCD-induced 
ovotoxicity.    
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Figures 
 
Figure 1. Temporal effect of chronic VCD exposure on Gstm mRNA expression.  
F344 PND4 rat ovaries were cultured in control (CT) media or media containing 30 µM 
VCD for 2-8 d. Following incubation, total RNA was isolated, reverse transcribed to cDNA 
and analyzed for Gstm and Actb mRNA expression by RT-PCR as described in materials and 
methods. Values are expressed as fold-change relative to control ± SE; n=3 (10 ovaries per 
pool).  
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Figure 2. Temporal effect of chronic VCD exposure on GSTM protein level.  
F344 PND4 rat ovaries were cultured in control (CT) media or media containing 30 µM 
VCD for 4-8 d. Following incubation, total protein was isolated and Western blotting was 
performed to detect GSTM protein as described in materials and methods. (A) Representative 
GSTM Western blot on d6. (B) Quantification of GSTM protein levels on d4, d6, d8; Values 
are expressed as a percentage of control; n=3 (10 ovaries per pool). * P < 0.05; different from 
control. 
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Figure 3. Effect of chronic VCD exposure on Ask1 mRNA expression.  
F344 PND4 rat ovaries were cultured with control (CT) media or media containing 30 µM 
VCD for 6d. Following incubation, total RNA was isolated, reverse transcribed to cDNA and 
analyzed for Ask1 mRNA expression by RT-PCR as described in materials and methods.  
Values are expressed as fold-change relative to control ± SE; n=3 (10 ovaries per pool). * P < 
0.05; different from control.   
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Figure 4. Effect of chronic VCD exposure on the GSTM:ASK1 protein complex.  
Ovaries from F344 PND4 rats were cultured in control media (CT) or media containing VCD 
(30 µM) for 4 or 6 d. Ovaries were exposed to VCD on alternate days from the beginning of 
culture.  Following incubation, total protein was isolated and immunoprecipitation was 
carried out as described in materials and methods.  (A) ASK1 immunoprecipitation followed 
by detection of GSTM protein on d4 or d6; control = c, VCD = v. (B) Quantification of the 
amount of GSTM protein bound to ASK1.  (C) Representative Western blot for unbound 
GSTM protein on d6.  (D) Quantification of the amount of unbound GSTM protein levels on 
d4 and d6.  Values are expressed as a percentage of control; n=3 (20 ovaries per pool).  * P < 
0.05; different from control. 
175 
 
 
 
Figure 5. Effect of acute VCD exposure on GSTM protein level.  
Ovaries from F344 PND4 rats were cultured in control (CT) media or media containing VCD 
(30 µM) for 6d with exposure to VCD at the onset of culture for 2d.  Following incubation, 
total protein was isolated and Western blotting was performed to detect GSTM protein as 
described in materials and methods. (A) Representative Western blot on d6; control = c, 
VCD = v. (B) Quantification of GSTM protein levels, values are expressed as a percentage of 
control; n=3 (10 ovaries per pool). * P < 0.05; different from control. 
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Figure 6.  Effect of acute VCD exposure on GSTM:ASK1 protein complex formation.  
Ovaries from F344 PND4 rats were cultured in control (CT) media or media containing VCD 
(30 µM) for 6d with exposure to VCD at the onset of culture for 2d.  Following incubation, 
total protein was isolated and immunoprecipitation was carried out as described in materials 
and methods. (A) ASK1 immunoprecipitation, followed by detection of GSTM protein by 
Western blotting on d6; control = c, VCD = v. (B) Quantification of the amount of GSTM 
protein bound to ASK1, values are expressed as a percentage of control; n=3 (10 ovaries per 
pool). * P < 0.05; different from control.  (C) Western blotting was performed on the 
unbound protein fraction to detect GSTM protein; control = c, VCD = v.  (D) Quantification 
of the amount of unbound GSTM protein levels, values are expressed as a percentage of 
control; n=3 (20 ovaries per pool). * P < 0.05; different from control. 
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Figure 7. Effect of PI3K inhibition on ovarian GSTM protein level.  
F344 PND4 rat ovaries were cultured in media containing control or LY294002 (20 µM) for 
4d or 6d. Total protein was isolated and Western blotting was performed to detect GSTM 
protein levels. (A) Representative Western blot on d6; control = c, LY294002 = LY. (B) 
Quantification of Western blotting for GSTM protein, values are expressed as a percentage of 
control; n=3 (20 ovaries per pool). * P < 0.05; different from control. 
178 
 
 
 
Figure 8. Effect of PI3K inhibition on Ask1 mRNA expression.  
F344 PND4 rat ovaries were cultured with control (CT) media or media containing 20 µM 
LY294002 for 6d. Following incubation, total RNA was isolated, reverse transcribed to 
cDNA and analyzed for Ask1 mRNA expression by RT-PCR as described in materials and 
methods.  Values are expressed as fold-change relative to control ± SE; n=3 (10 ovaries per 
pool).  
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Figure 9.  Proposed mechanistic model.   
VCD exposure inhibits PI3K signaling, leading to increased GSTM protein, resulting in 
increased GSTM:ASK1 protein interaction.   
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